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Sommario
Cellule e tessuti umani sono sistemi essenziali per lo studio della biologia e fisiologia
del corpo umano e per lo sviluppo di nuove strategie e farmaci per la cura di varie
patologie. Il coinvolgimento di persone in casi studio di ricerca e testing farmacologici
espone i soggetti ad elevato rischio e introduce problematiche tecniche ed etiche
non facilmente risolvibili. Lo sviluppo di nuove strategie in vitro è di fondamentale
importanza per ricavare informazioni sull’organismo umano e limitare l’uso di sistemi
animali non pienamente predittivi. La richiesta di sistemi efficaci, rappresentativi e
a basso costo in campo clinico ed industriale è indubbiamente in aumento.
I sistemi convenzionali per colture cellulari sono normalmente costituiti da re-
cipienti con dimensioni caratteristiche dell’ordine dei centimetri. I nutrienti sono
veicolati alle cellule tramite mezzi di coltura liquidi che contengono buffer salini e
oligoelementi. Un quantitativo di medium minimo è necessario per garantire un
battente omogeneo al di sopra della coltura cellulare e deve essere sostituito peri-
odicamente per apportare nuovi nutrienti e rimuovere i prodotti di scarto. Molti
studi e applicazioni richiedono reagenti costosi e sono soggetti a una ridotta capacità
di ricavare dati. La scoperta del processo di riprogrammazione cellulare da parte del
Premio Nobel 2012 Yamanaka hanno aperto nuove esaltanti prospettive in ambito
di ricerca e applicazioni cliniche. In tale processo, da una biopsia cutanea di un
paziente è possibile ricavare cellule staminali pluripotenti indotte (iPSC) e derivare
nuovi tessuti per una riparazione autologa ad hoc dei tessuti.
Ad oggi, le iPSC umane (hiPSC) non sono ancora state utilizzate in ambito clinico
a causa di aspetti sulla loro derivazione non ancora pienamente caratterizzati, di
metodologie non a livello clinico e del costo significativo della derivazione di hiPSC
per singolo paziente. La micronizzazione del processo di riprogrammazione può dare
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un’opportunità notevole per la derivazione di hiPSC a basso costo e per ottenere
tessuti umani in vitro.
Scopo di questa tesi è lo sviluppo di una piattaforma per la riprogrammazione di
cellule umane in microscala. Per la sua realizzazione, abbiamo focalizzato la ricerca
sullo sviluppo di un microambiente cellulare che tenga conto sia dell’ambiente solubile
che dei componenti solidi per l’adesione cellulare.
Durante questo dottorato, sono stati sviluppati degli idrogel sintetici e biodegrad-
abili. La produzione su larga scala di substrati a rigidità variabile a base di poliacril-
ammide è stata fondamentale per rivelare le interazioni tra la rigidità del substrato e
il comportamento e destino cellulare. L’ingegnerizzazione di idrogel biodegradabili ha
rivelato il potenziale nello sviluppare tessuti in vitro funzionali e la loro integrazione
nel paziente. Il know-how acquisito sulle modifiche chimiche è stato trasferito al
controllo della topologia del substrato e all’interno dell’ambiente microfluidico.
L’ambiente microfluidico e la sua amministrazione sono stati ottimizzati per
garantire l’adesione e la crescita cellulare a lungo-termine e registrare importanti
fenomeni biologici. Le proteine di adesione fondamentali per la crescita delle cel-
lule sono state modificate e integrate in un ambiente in microscala. In microflu-
idica, poiché il medium necessario alle colture viene perfuso all’interno del ciruito,
un flusso continuo o periodico possono essere applicati. Abbiamo così studiato
l’amministrazione della distribuzione del medium per determinare le migliori strate-
gie per colture a lungo termine in microfluidica.
I risultati ottenuti nello sviluppo dei substrati e ambienti microfluidici per col-
ture cellulari sono stati applicati alla generazione di una nuova piattaforma per
la derivazione delle hiPSC, differenziamento e validazione in microscala. Per la
prima volta in letteratura, è possibile ottenere cloni hiPSC in microfluidica con una
riduzione sostanziale dei requisiti minimi (materiali, reagenti, spese globali).
La produzione di hiPSC a basso costo può portare a una produzione di massa di
tessuti caratterizzati e funzionali che possono in seguito essere integrati in supporti
3D e servire come valida fonte di derivazione per lo sviluppo di nuovi farmaci. La
nostra piattaforma apre nuove prospettive nello studio e trattamento di malattie
diffuse e rare coinvolgendo scienziati e imprenditori.
Summary
Human cells and tissues are key systems to study human biology and physiology, and
to develop new strategies and targeting drugs for human diseases. Since the study
and testing on human beings may not be acceptable due to exposure to risks and
practical and ethical concerns, in vitro strategies are of paramount importance to
rely on human organism and avoid non-fully predictive animal models. The demand
of research in clinical and industrial fields for effective, representative and affordable
strategies is undoubtedly increasing.
Conventional cell culture systems and drug discovery are normally performed in
vessels with a characteristic dimension in the order of centimeters. Nutrients are
delivered to cells through liquid media containing balanced saline buffers and oligo-
elements. A reasonable amount of medium is necessary to homogeneously cover a cell
layer and must exchanged with fresh media to maintain a proper amount of available
nutrients and remove released waste products. Many studies and applications require
expensive reagents and are subjected to limited data throughput. The discovery of
reprogramming process by 2012 Nobel Prize Yamanaka opened breakthrough new
perspective on research and clinical applications. Basically, from a patient’s skin
biopsy it is now possible to derive induced pluripotent stem cells (iPSC) and to
obtain new tissues for an ad hoc self-repair. So far, human iPSC (hiPSC) have
not been applied to clinics due to some unexplored aspects on their derivation, non
clinical-grade methods and the significative cost of hiPSC derivation per patient.
The down-scale of reprogramming process could provide an unique opportunity to
derive cost-effective hiPSC and obtain valuable human in vitro tissues.
The aim of this thesis is the development of a comprehensive platform for the
reprogramming of human cells at the microscale. To this end, we focused on the
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development of cell microenvironment which is composed by both soluble and solid
components.
During this thesis, synthetic and biodegradable hydrogels were developed. The
large-scale production of mechanically-tunable poly-acrylamide-based substrates were
fundamental to reveal the interaction occurring between substrate stiffness and cell
behavior and fate. Engineering of biodegradable hydrogels has revealed the poten-
tial to develop in vitro functional tissues and to integrate them at a later stage in
patients. Chemical modifications were transferred to topological substrate control
and in turn in microfluidic platforms.
Microfluidic chip environment and management was designed in order to allow
long-term adhesion, culture and biologically relevant cell behaviors. Adhesion pro-
teins fundamental for cell attachment and growth were modified and integrated with
the micronized substrates. Since medium for microfluidic cell culture relies on perfu-
sion, continuous or periodic flow could be applied. Thus, we studied the management
of media delivery in order to determine the best strategy for long-term cell cultures.
The achievements obtained with both substrate and microfluidic cell culture de-
velopment was applied to the generation of a new platform for hiPSC derivation,
differentiation and testing at the microscale. For the first time, it is possible to
obtain human iPSC clones in microfluidics with a remarked reduction of minimum
requirements (materials, reagents, overall expenses).
The production of cost effective hiPSC can lead to a mass production of character-
ized and functional tissues that can be either integrated in 3D developed constructs
and serve as valuable tissue source derivation for drug development. Our platform
opens new perspectives in studying and treating both abundant and rare diseases
involving both scientists and entrepreneurs.
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Chapter 1
Engineering the Generation of
Human Pluripotent Stem Cells
Human somatic cells of an adult can be reprogrammed to an embryonic-like state
through the subministration of defined molecular factors. In this state, cells have
the potential to generate all the cell of an adult organism, the so called pluripo-
tency. Reprogrammed cells, namely Induced Pluripotent Stem Cells (iPSC), can be
programmed further to indefinitely obtain different desired somatic cell types [1–3].
For this finding, prof. Shynia Yamanaka has been awarded for the Nobel Prize in
2013. Since the original publication in 2006, the reprogramming efficiency has been
revealed as a barrier to an intense application of iPSC. Despite recent efforts and
new technology available, many other barriers limit the use of iPSC both in research
and preclinical approaches.
Nowadays, the reprogramming process is unfeasible and not affordable for more
than a few tens of people [4]. In the standard process, before, during and after
the reprogramming phase, cells must be expanded, evaluated to assess the proper
phenotype, stored for cells banking and programmed towards adult phenotypes. For
a few samples from a single patient, thousands of euros and a full-time dedicated
expert are required over a 1-2 months period. Hence, big efforts have to be invested
to scale-up the iPSC production.
1
2 CHAPTER 1. ENGINEERING THE GENERATION OF HUMAN PSC
1.1 Introduction
The majority of the cells in a adult human body are terminally differentiated cells
with defined properties and functions to support the activities of different tissues
and organs. A very low number of partially specified cells, namely adult stem cells
(ASC), support the renewal of differentiated cells undergoing senescence and death
[5]. Other than these somatic cells, germ cells (GC) (i.e. spermatozoa and egg cells)
are specialized for the generation of a new individual.
When an egg is fertilized, several cell divisions occur ending up with a hollow
structure, the blastocyst (Figure 1.1.1A). The inner cell mass (ICM) is surrounded
by cells of the trophoblast, which are responsible for the placenta development. The
ICM cells are defined as pluripotent since they account for the formation of all the
cells necessary for the development of the embryo and finally of the adult. When a
part of the ICM is cultured in vitro, the cultured cells maintain the pluripotent state
under specific conditions. This cells are called human Embryonic Stem Cells (hESC)
(Figure 1.1.1A).
The 2012 Nobel prize Shynia Yamanaka and colleagues evidenced that differen-
tiated cells from ad adult, can be reprogrammed back to a state similar to hESC.
Thanks to the forced-expression of genetic regulators of the pluripotent state (OCT4,
SOX2, KLF4, c-MYC) via viral vectors, human iPSC (hiPSC) were derived from dif-
ferentiated fibroblasts [2]. Since hiPSC can be derived from cells of an adult tissue,
they can solve ethical problems rising from the use of hESC and they offer the op-
portunity for a theoretical unlimited source of pluripotent stem cells (Figure 1.1.1B).
The means to derive hiPSC have extended in the past 5 years [2, 4, 6–9]. De-
spite little is known of the reprogramming and its players during the whole process,
some common aspects have been defined: for instance, the ectopic forced-expression
of a ‘consensus’ class of factors is necessary [10, 11]. These transcription factors
are recapitulated by a list of four, comprising OCT4, SOX2, KLF4, c-MYC and
more defined cocktails and variants can be found in the literature. The delivery
method of these factors account for part of the process efficiency. Viral vectors were
the first to be used thanks to they ability to transfer genes inside the cell. Both
genome-integrating and transient viruses were used. Firsts efforts to develop non-
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Figure 1.1.1 – Pluripotent stem cells. (A) The egg fertilization produce a globular cell
structure (the blastocyst, here sectioned) that is the source for embryonic stem cells. Cells
depicted in grey form the trophoblast and the ICM is facing inside (black). The ICM cells
are defined as pluripotent stem cells since they can produce all the differentiated cells in our
body (e.g. neurons, cardiac cells, etc.). (B) Patient’s derived cells (e.g. a skin biopsy or
blood sample) can be turn back in time through a reprogramming process that erase actual
cell functions. The delivery of Yamanaka’s factors induce pluripotency in cells leading to
an analog state of embryonic stem cells. This cells being pluripotent can generate new cell
types valid for the self-repair (autologous) of patient’s tissues.
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viral vectors (e.g. proteins, mRNAs, chemical compounds, etc.) have offered limited
reprogramming efficiency [12, 13]. Recently, modified mRNAs (mmRNAs) and small
synthetic molecules emerged as a powerful and potentially clinical-grade tool for the
reprogramming of human cells [9, 14].
Since the various steps towards the iPSC depend on the sustained delivery and
expression of the reprogramming factors - which is not fully efficient - , and on the
state of each individual cell, the target cells to be reprogrammed do not show the
same capacity to enter and complete the process [15]. Beyond others, an evident
morphological cell rearrangement (mesenchymal-epithelial transition, MET) and an
epigenetic reorganization of the genome are key factors of the process concomitant
with cell sustained proliferation [16]. A recent study shows that cells can be deter-
ministically reprogrammed by abolishing defined key factors [17]. However, only cells
that are transfected with the reprogramming factors enter the process.
Significative advances have been introduced to ameliorate the reprogramming
of human cells but the overall process remains far to be extensively applicable. In
this Chapter, we introduce the key aspects to develop cost effective and clinical-grade
solutions for the reprogramming of human cells. Advantages of substrate engineering
and microfluidic technology will be evidenced and their development will be reported
for the efficient generation of hiPSC.
1.2 Motivation for technology development
Since cell continuously interact with their microenvironment, its control is crucial
to drive cell behavior and fate. Soluble and solid biochemical species are the two
major components surrounding cells, thus, the understanding and modeling of their
dynamics can effectively impact on tightly balanced biological processes such as
reprogramming.
1.2.1 Mechanical control and physical barriers - substrates
Besides soluble components of the cell niche, the adhesion substrate has a key role
on cell behavior and is continuously modeled to accomplish different biochemical
and mechanical roles [5]. Rigidity, topology and chemical properties of the substrate
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Figure 1.2.1 – Engineering 2D artificial stem-cell niches. (A) Surfaces can be functionalized
with pro-adhesion molecules of the ECM that specificaly bind cellular receptors exposed at
the surface. (B) Different types of ECM molecules can be used to trigger differential path-
ways and signals. (C) Substrate stiffness can be tuned in order to elicit different mechanical
stimuli on cells. Stiffer substrates promote cell spreading and flattening. (D) Surface can be
functionalized in order to allow cell adhesion on defined patterned regions exposing ECM
components. Image adapted from [18].
are recognized by adhesion proteins and receptors at the cell surface and can trigger
either direct mechanical or biomolecular soluble transduction to various cell com-
partments (Figure 1.2.1) [18].
Cells can vary their gene expression in order to respond to the substrate stimulus.
Various examples of the mechanical importance of substrates were demonstrated in
non-pluripotent cells, comprising cell maturation [19], functional activity [20], growth
and death [21]. Conversely, little is known regarding the interaction of hPSC with
their culture substrate.
A new way to control the pluripotency state through substrates may reduce the
need of expensive soluble factors and reduce the operations and time required to
maintain culture purity and remove spontaneous events of differentiation [18, 22,
23]. Moreover, substrates mechanics, topology and biochemical features can influ-
ence the reprogramming process [8, 24]. The imposition of a hPSC-like shape or the
biochemical composition of the substrate may favor the remodeling of differentiated
cells fastening the transition to pluripotency.
1.2.2 Soluble control and micronization - microfluidics
The reprogramming process is tightly controlled by cell internal events and external
surroundings. Outside the cell, extrinsic factors play as environmental stimuli which
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occur at a few cell distances. Figure 1.2.2A illustrates the major players in the so
called “cell niche”. As described in the previous section 1.2.1, the extracellular matrix
substrate has a part in affecting some biological processes. Many other stimuli are
soluble factors that are released by neighboring cells (paracrine) or by the cell itself
(autocrine) [5]. These factors account for endogenous (EnF) signals while exogenous
(ExF) ones are derived from the culture medium supplemented to the cells. Bio-
chemical pathways are activated upon the recognition of these extrinsic factors by
receptors at the cell membrane (Figure 1.2.2A).
Since many soluble factors can act at the same time and insist on even redun-
dant pathways, the control of the soluble environment is crucial to support proper
stimulation of cell under reprogramming. Typically, established protocols suggest
daily medium changes in order to prevent the accumulation of toxic signals (EnF)
and continuously stimulate cells with fresh exogenous and controlled factors (ExF).
Deprivation of nutrients and accumulation of waste products of cell metabolism and
cell turnover can trigger cell death or induce differentiation of non terminally diffe-
rentiated cell types. Figure 1.2.2B-C shows a comparison of medium usage between
conventional vessels and emerging microfluidic technology. Standard culture systems
like Petri dishes require a minimum amount of medium volume over a 24 h cycle in
order to:
• provide a minimum height to homogeneously cover the entire culture surface;
• reduce the concentration of medium components due to evaporation at 37 °C;
• provide nutrients to high-demanding cells like hPSC;
• dilute waste and unwanted cell product.
Microfluidics represents a way to deliver tiny amounts of media (nanoliters to
microliters) over a cell layer with homogeneous distribution and tight control of cell
species inside the fluidic environment both in space and time (Figure 1.2.2B-C) [25].
Adjusting the perfusion rate of media through the channels it would be possible to
control the balance of the extrinsic factors either produced by cells or carried within
the fresh medium (Figure 1.2.2C).
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Figure 1.2.2 – Cell niche and comparison between conventional cell culture environment
and microfluidics. (A) Cell biology is based on extrinsic (outside the cells) and intrinsic
(inside the cell) signals of the microenvironment. While intrinsic signals directly acts on
internal cell system, extrinsic signals can be further classified. Besides the interaction with
the substrate where cells adhere, soluble environment is bases on exogenous molecules (e.g.
provided nutrients) and cell-produced molecules such important cell signaling species or by-
products and waste. (B) Longitudinal sections of a common culture dish and a microfluidic
chip. Most used cell culture vessels require some milliliters of culture medium in order to
provide a homogeneous and sufficient height above cells. In a common 35-mm-wide Petri dish
this consist in 2 ml of media ( ⇠2 mm height). Microfluidic chips have inlets and outlet for
media delivery into channels. Channels height ranges from 100 to 200 micrometers, a tenth
of conventional vessels. (C) Micro-environments at the cell culture surface. Large amounts
of media in conventional vessels allow a nutrients supply for 1-4 days, depending on the cell
type and density. Cell metabolism produces biochemical signals (e.g. cytokines, hormones,
etc.) important for cell communications and to sustain cell proliferation and activities.
Since waste products are also produced medium exchange is necessary to avoid toxic effects.
Oxygen, carbon dioxide and water vapor diffuse across the medium-air interface. Excessive
evaporation leads to unbalanced osmotic pressure in the medium that can dramatically
affect cell viability. Microfluidic liquid environment results in a tiny volume above the cell
layer. The perfusion of the channel allow to apport fresh nutrients while washing out waste
products. Since perfusion may also alter the balance of factors secreted by cells a proper
strategy should be defined using living systems. Gases and vapor can diffuse through the
roof of the channel based on permeable polymers. Due to the small amount of medium,
osmotic pressure must be tightly monitored.
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Culture components for hPSC are considerably expensive compared to other cell
lines and may limit the use of these pluripotent cells. For these reasons, a reduced
volume for culture reagents and a homogeneous long-term hPSC culture system are
fundamental. A such micronized system would benefit of a controlled and automated
liquid handling integration.
Microfluidic derivation and expansion of hiPSC can guarantee a new system to
match the precise requirements of hPSC and to boost their applicability with cost-
effective and automated production and maintenance.
1.3 State of the art
1.3.1 Reprogramming
The scientific community is pursuing a translational approach for human pluripotent
stem cells (Center for Commercialization of Research Medicine, Toronto, Canada)
[26]. Overcoming the ethical issue of hESC, hiPSC derivation capabilities have been
improving in the latest years. Despite the present process efficiency may not sustain
a full translational procedure, safe and clean ways have been introduced to prove the
feasibility of clinical grade operations and materials [14, 27].
After the first selection of optimal reprogramming factors by Yamanaka’s group,
others concentrated on the optimal stoichiometry of each factor [10, 28, 29] and on
the expansion of the original pool of factors [30, 31]. Other groups evidenced other
components and pathways affecting the reprogramming process and the morpholog-
ical evolution of transforming cells [6, 15, 16, 32–35].
Figure 1.3.1 illustrates the major classes of reprogramming tools to deliver ex-
ogenous factors that initiate the process.
Various reprogramming efforts have adopted genome-integrating viruses to de-
liver Yamanaka-like factors [2, 7, 10, 15, 16, 36]. Modified retroviruses and lentiviruses
have the ability to infect a cell, to integrate within its genome and to use the cell
machinery to produce ad hoc factors [7, 28]. However, a permanent random genome
integration of viral nucleic information can lead to alterations and instability of the
cell genome and related activities. Non-integrating viruses have been modified to
1.3. STATE OF THE ART 9
Figure 1.3.1 – Exogenous factors for cell reprogramming. Various biochemical approaches
have been used to deliver reprogramming factors inside cell. Genome-integrating viruses
have been the most used system since it is easy to take advantage of their innate capacity
of infecting cells; major limits of this system are the modification of host genome and the
low reprogramming efficiency. Non-integrating viruses such Sendai have significant higher
efficiency and do not integrate in the cell genome. Proteins of the reprogramming factors can
directly be delivered inside cells. They require at least a modification with a tag sequence
to enter cells and must be provided repeatedly since they are naturally degraded. Modified
mRNAs are being commercialized as the method with highest yeald. They need a lipophilic
vesicle in order to enter cells and an protectant must be provided to block the activation of
immune cellular response. Small chemicals can offer a new frontier to reprogram cells in a
fully defined and synthetic way. These molecules can act either as activators or repressors
of biological functions to elicit the reprogrammig.
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prevent replication [37, 38]. After cell infection, they rely in the cell cytoplasm and
are diluted during the progress of cell divisions. Adenoviruses and Sendai virus (SeV)
are based on DNA and RNA, respectively. Adenovirus have a short transient expres-
sion and require various transfections during the reprogramming window, whereas
SeV is retained for various weeks after a single transfection with a reprogramming
efficiencies up to 1% of the starting transfected cells [39].
In order to avoid the virus-mediated delivery of reprogramming factors, three
ways have been explored:
• direct proteins subministration;
• modified mRNAs delivery;
• chemicals.
Recombinant proteins with tagged epitopes can enter the cell and directly operate
as transcription factors [40, 41]. The total amount and stoichiometry needed is a
major limitation to promote an efficient reprogramming. Modified RNA messengers
(mmRNA) have been introduced in the last 2 years and provide the most efficient
methodology to produce hiPSC (up to 3% of efficiency) [9, 14, 42]. Chemicals are
being improved and tested in order to provide the most elegant way to revert dif-
ferentiated cells into iPSC. Chemicals were mostly used for the reprogramming of
murine cells [12, 13, 43]. Using degradable chemicals in the same way we take drugs,
no biological derivates will be adopted without leaving any footprint of the delivery
of the reprogramming factors.
Since mouse embryonic stem cells (mESC) represent a different and earlier stage
of embryonic development compared to hESC, mouse and human induced pluripo-
tent stem cells recapitulate different stages [44]. Mouse pluripotent cells have different
requirements in terms of culture conditions and are the typical case study in liter-
ature. hPSCs require more restrictive conditions both at the maintenance and at
the reprogramming phase. For example, hPSC require additional cells that help in
supporting the pluripotency or defined media with stimulating degradable factors
(i.e. cytokines) that sustain their state. In this context, the mechanisms underlying
the relationship between hPSC and their environment are poorly characterized.
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1.3.2 Substrates for cell culture
Cell cultures are normally performed on tissue-culture-treated poly-styrene plates
with different dimensions and shapes. In vivo, cells experience a complex niche
made of various biochemical species, structural proteins and polysaccharides that
cooperate to the peculiar biochemical and biophysical properties of each tissue [20,
45–48].
Advantages in substrate development to study cell behavior in physiological en-
vironment have been obtained in the past on different cell types. Discher and Engler
were pioneers in using compliant matrices for muscular cells and underlining the in-
terplay between stiffness and biological activities [19, 49, 50]. Physical contribution
to biological activities has been termed mechanotransduction since external forces
are transferred through the cell’s anchor sites binding the ECM to the internal cel-
lular cytoskeleton and converted in biochemical soluble signals down to the nuclear
regulation [51–56].
Although a multitude of studies have been published on the relationship between
substrates and cells dynamics, little is still known on how hPSCs relate to substrates
[18, 57]. Research groups have focused on two issues: the intrinsic mechanical pro-
perties of PSC compared to other cells [58–64] and the effect of different substrates
on PSC maintenance (both for mouse and human) [22, 57, 65–74].
Little is known about the implications of substrates on the reprogramming pro-
cess [8, 24, 54, 75, 76]. The use of defined substrates may significantly contribute
to remove machanotransduction barriers that naturally prevent cell transformation
and determine a reprogramming pathway in cultured cells. In the future, this studies
may also shed light on the role of substrate in tumor formation and metastases which
gain independence from the original substrate.
1.3.3 Cell culture in microfluidics
Microfluidics offers an unique way to deliver nanoliters to microliters over a fluidic
circuit. It has expanded both in research and industry thanks to the availability of
technology and the cost reduction of components and machinery to build fluidic chips.
Microfluidic devices are being used for low cost and high-throughput biomolecular
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assays and chemical reactions [77–84], however the integration of living systems is
still at the beginning. Despite interesting properties such efficient mass transport and
low volumes, some drawback may impair the integration of cell and tissues cultures
[85, 86].
Cells need a balanced soluble environment, with fresh nutrients, removal of waste
products, defined pH and osmolarity (Figure 1.2.2). For instance, at the microscale,
evaporation and medium exchange, can significantly affect these issues [85, 87]. In
order to acquire the advantages of the microscale and to look at biological system
from a new perspective, microfluidics must sustain viable and healthy cell cultures
for prolonged periods. Despite various authors proposed long-term culture systems
for particular purposes [68, 82, 83, 87–93], no clear and comprehensive advance has
been proposed for long-term cell cultures in the last decade.
Various groups focused on the integration of chip tools and add-ons [87] but
poorly characterized the role of the soluble environment at different conditions.
Among others, pluripotent stem cells are particularly sensitive to an unbalanced
environment and precise medium management must be found in order to preserve
their phenotype. As depicted in a review by Voldman and colleagues [86], before
being widely adopted, microfluidic system for robust long-term cell cultures must be
developed.
The translation of cell cultures from open macroscopic vessels to non directly
accessible microfluidic circuits undoubtedly requires a comprehensive study of ma-
terial adoption, medium management and environmental conditions. In this thesis,
we propose an advance for long-term cell cultures, pointing out the importance of
medium management strategies and adhesion substrates at the microscale.
1.4 Rationale of substrate and microfluidic development
for the high-throughput generation of hiPSC
Expectations on new ways of drug development and regenerative medicine are con-
siderably high because of the social and economical impact. The classical way of
drug development and commercialization results in a long process which can span
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over 15 years [81]. Even if the screening of molecular candidates may be accelerated
in some phases by bioinformatic means, the testing on animal or human candidates
still requires a lot of effort in terms of time, money and proper testers.
The development of new technologies and biological tools can dramatically favor
this process:
• first, new lab-on-a-chip technology aims to improve and extend the possibilities
of bioassays, cell biology and biomedical research by mimicking the environ-
ment and the physics of biological tissues [80, 81, 94–96];
• second, hiPSC are a promising and unlimited source for the in vitro derivation
of adult-like cells and tissues [97, 98].
Up to the in vivo early trials for drug discovery, hiPSC may represent the key to a
better, safer, faster and parallelized description of the drug-related human biology
and physiology, rather than animal models or adult people. Additionally, self-derived
hiPSC can offer a attractive way to easily sustain the development of personal drug
therapies. Community of regenerative medicine is expecting great promise o hiPSC
and it is deepening into translational approaches for clinical applications. hiPSC not
only represent a possible source for autologous tissue regeneration, but can provide
extended informations related to human development and disease outcomes.
In this perspective, the high-throughput generation of hiPSC can represent a
paramount advance in drug discovery and regenerative medicine. The development
of defined substrates controlling cell shape and behavior, and the automated mana-
gement of defined soluble micro-engineered environments can resolve the technical
issues that currently limit hiPSC adoption.
1.5 Aim of the thesis
This thesis aims at the developing of technological tools for the generation of human
induced pluripotent stem cells (hPSC), a promising source for tissue engineering and
pharmaceutical development and assays. Since hPSC generation (reprogramming),
maintenance and differentiation are highly amenable to soluble microenvironment
and culture substrate, and require considerable efforts, microfluidic cell culturing
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Figure 1.5.1 – Aim of the thesis. A platform for high-throughput reprogramming and
programming at population scale. Cells derived from hundreds of patients can be repro-
grammed in order to produce a comprehensive library of hiPSC. These cells, beside being
expanded, can be directly differentiated in order to provide additional libraries on various
tissues. Each of them could be used for assays such as drug screening, and biological and
medical research.
and biomimetic materials were developed to provide a defined microenvironment
with a considerable reduction in costs and manual labour.
Since substrates determine the behavior of adherent cell cultures we focused on
the development of hydrogels to study the role of mechanical and biochemical pro-
perties exerted on cells. The microscale culturing offers consistent reagents reduction
and flow control but requires unique management to permit restrictive cell culture
conditions. Cell cultures were integrated in microfluidic devices specifically aiming
at the implementation of robust, healthy and long-term culture conditions and at the
efficient delivery of biochemicals for reprogramming process. Optimal management
of culture conditions revealed as a mandatory requirement for subsequent studies
on reprogramming at the microscale. Achievements gained with the engineering of
cell microenvironments allowed to build a reprogramming platform of human patient
cells at the microscale. Figure 1.5.1 depicts the final aim of the entire thesis. By pro-
ducing hiPSC in a cost effective and high-throughput manner, derived cells can be
programmed further to adult tissues of various organs to provide a population-scale
library of functional cells. This library can be then used to perform population-scale
assays valuable for drug discovery, screening and disease characterization. Thanks
to the clinical-grade approaches and reduced requirements and expenses hiPSC can
be easily be adopted in medical tissue engineering.
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In this thesis, the development of substrates and microfluidic systems to control
cell behavior is proposed as follows:
• in Chapter 2, substrates have been developed to study the relations of cells
and their adhesion support;
• in Chapter 3, the long-term integration for cell cultures in microfluidics is
illustrated;
• in Chapter 4, the advances in substrate-optimized microfluidic cell cultures are
adopted to derive hiPSC at the microscale for the first time;
• in Chapter 5, early results on the use of substrates to promote reprogramming
are introduced.
• in Chapter 6, the perspectives on microscale tissue an organ development.
1.6 Conclusions
The development of in vitro screenings strongly based on human biology and physiol-
ogy is a future step for ad hoc biomedical applications and pre-clinical pharmaceutical
screenings. In this perspective, new tools and technologies are emerging to obtain
reliable system and provide faster high-throughput data. Human pluripotent stem
cells, especially hiPSC, are a promising source for unlimited personal screenings and
self-regeneration of our tissues. Engineered microenvironments can be designed to
finely control both adhesive and soluble properties of in vitro cell cultivation. The
synergic implementation of these two fields can unleash the potential of hiPSC that
has never been translated in clinical or industrial applications so far.
Thanks to the substantial cost reduction, delivery efficiency and chemically de-
fined surfaces, microfluidics and substrates can massively expand hiPSC clone pro-
duction and obtain new differentiated cell lines at a low cost - an affordable process
for limited samples nowadays. Parallelized one-step processes to obtain newly gen-
erated tissues can provide a platform to perform breakthrough screenings at the
population level, shortening the finding of new biological pathways and drug targets,
and making attractive the development of compounds for rare diseases.

Chapter 2
Substrate development
This chapter introduces to the development of substrates for cell cultures. Differ-
ent types of substrates have been developed for different purposes in 2D and 3D
applications: polymeric substrates presented in this chapter form tunable hydrogels
with biologically relevant physical and chemical properties. As a second task, we
focused on the functionalization of surfaces in order to control cell adhesion, shape
and behavior. The knowledge gained with this part of the thesis revealed crucial to
control cell behavior at the microscale for the reprogramming purpose presented in
Chapter 4 and 5.
2.1 Motivations
Tissues in our body are made of different type of cells embedded in a network of
a secreted extracellular matrix (Figure 2.1.1A) [45]. This external skeleton of pro-
teins, glycoproteins and polysaccharides, retains water and other soluble substances
that form the interstitial fluid. Since the composition of the ECM varies between tis-
sues and each bio-polymer has its own functionality and physical-chemical properties
each tissue displays a different global stiffness (Figure 2.1.1B). Since cells exert their
functions in a compliant microenvironment pairing defined chemical-mechanical pro-
perties (Figure 2.1.1C), it is necessary to develop substrates that mimic the natural
matrix in vitro [50, 99].
Cells actuate complex interaction with the extracellular substrate that is preva-
lently composed by structural proteins and glycosilated polymers which define the
17
18 CHAPTER 2. SUBSTRATE DEVELOPMENT
Figure 2.1.1 – Matrix mechanics. (A) Decellularization process reveal the extracellular
matrix is a major component of living tissues (adapted from [47]). (B) Each tissue has
its own stiffness. Bone and cartilage have high percentages of deposited matrix and result
particularly stiff. Muscles have a medium living stiffness in order to provide elasticity,
strength and power stroke. Softer tissues such brain and fat do not require particular
mechanical properties. (C) Each cell attached to a substrate exerts forces by organizing its
internal cytoskeletal architecture (adapted from [99]).
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Figure 2.1.2 – Cell and substrate interaction. Cells sense the chemistry, stiffness, morpho-
logy and topology of the substrate by mechanical intermediates that in turn act on soluble
biochemical players that control gene expression, cell fate, maturation and eventually local
or systemic diseases.
extracellular matrix (ECM). The physical and biochemical properties of the ECM
directly influence cells through a direct interaction with mechanical intermediates
connected to the internal cellular cytoskeleton (Figure 2.1.2). These players commu-
nicate in turn with soluble biochemical intermediates that trigger regulatory path-
ways ending in defined cell behaviors and eventually in local or systemic diseases.
In the last decades, de facto standards for in vitro culture system has remained
unchanged resulting in a poor mimicking of in vivo ECM. Conventional cell cultures
are mainly performed on treated poly-styrene (PS) that can be molded in different
types of open vessels. The treatment performed via plasma-oxidation turns the in-
ternal surface hydrophilic and more attractive for the adsorption of ECM proteins
and for cell ligands such as integrins [100, 101]. Each cell type may show affinity for
a particular subset of ECM components, requiring the adsorption of certain proteins
on the PS prior the cell seeding. When the material to support cell culture is changed
(e.g. glass), attention should be placed on the compatibility with the protein previ-
ously used on PS. Changes in treating concentration, time, and operative conditions
may be necessary prior to a change in ECM components.
Besides the advantage in using cheap plastic supports with various formats and
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the condition of de facto support for cell culture, PS shows some drawbacks:
• PS is not compatible with diffused fluorescent-based applications due to intrin-
sic autofluorescence;
• it is rigid, with a stiffness of a few GPa [102], 106-times the physiological range
[45, 50];
• it limits the diffusion of soluble components to the apical-lateral portion of
cells.
The development of new substrates for cell cultures is an active field, with the aim of
expanding current methodologies and mimic the in vivo extracellular environment.
Particular efforts have been made for the development of 3D scaffolds aimed at tissue
reconstruction and to provide an in vitro model to understand tissue dynamics [103,
104].
Among the abundance of materials applied to cell cultures (polymers, resins,
ceramics etc.), hydrogels emerged as unique opportunity to couple the chemical pro-
perties of the surface with the physical properties of the gel. Hydrogels are based
on a solid non-soluble network dispersed in a water environment: in their hydrated
state they allow solute to diffuse within the matrix accordingly to the cutoff of the
mesh. Since the major component is water, these substrate can be extremely soft
and stiffness can be tuned depending on the water/matrix ratio.
In the following sections, we report the achievements on substrate development.
In particular we focus the attention on:
• mechanically tunable biocompatible substrates to perform large studies on the
mechanotransduction cell behaviors.
• mechanically tunable substrates to be directly used as biosensors of cellular
activities.
• mechanically tunable biodegradable substrates for tissue engineering and in
vivo applications.
• chemistry for long-term and topological control of cell adhesion.
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2.2 Mechanically tunable biocompatible substrates
This section describes the development of synthetic substrates able to resemble the
mechanics of different tissues. Important results based on the formulation of these
substrates are presented.
Various studies revealed that the culture substrate can affect the behavior of
differentiated cell types [19, 50, 62, 105–108]. Beyond chemistry composition, the
stiffness revealed an important co-factor for cell maturation. Soft substrate may
also be used to study the earlier stages of human developmental process, tissue and
organ growth and the single-cell behavior. In this perspective, we wanted to study
the mechanotransduction behavior on immature cells like mesenchymal stem cells,
which are a key component of human body development.
In order to study mechano-related issues on cell cultures soft materials mimicking
the physiological in vivo stiffness were chosen. Here we describe the approach and a
summary of the obtained results. Extensive informations can be found in Appendix
A and B.
Biocompatibility of materials results from various aspects such as the release of
toxic species and the cellular recognition of antigens triggering an inflammatory re-
sponse [109]. First, we focused on substrates that results bio-compatible with a large
number of cell types. Starting from the pioneeristic work of Pelham and colleagues
[110], we introduced bidimensional poly-acrylamide hydrogels in our activities. These
gels are well known in molecular biology since - when dissolved in defined buffer solu-
tion - they have been used as a support for high-resolution electrophoresis for decades.
They result in a cross-linked matrix of linear poly-acrylamide fibers that is not de-
graded by the enzymatic activity of cells. Although acrylamide molecules alone are
toxic and carcinogenic, the polymerization process produces inert macromolecules
bridging with bis-acrylamide. Free monomers that can interfere with biological pro-
cesses are eventually extracted in a water bath.
Varying the proportions of acrylamide, bis-acrylamide and water it is possible
to change the stiffness of the gel and the diffusivity of species inside the matrix ac-
cording to their hydrodynamic radius. Although some guidelines report the stiffness
values associated with defined proportions of the three species [111], others report
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Figure 2.2.1 – Poly-acrylamide hydrogels at various nominal stiffnesses. Tuning the pro-
portion of acrylamide and bis-acrylamide it is possible to obtain soft and hard gels. Softer
hydrogels below 1 kPa have more than 97% of water and do not retain the shape of the tube
were they have been polymerized. Optical features can also be altered varying the ratio
between acrylamide and bis-acrylamide (see 40 kPa).
discordant values [112]: most of the times, details and procedures applied for the
measurements are not reported. Atomic force microscopy (AFM) is tool for mea-
suring the stiffness based on the deflection of a cantilever tapping the surface of the
material [113]: when we had the opportunity to measure the stiffness of our hydrogels,
softer gels were even impossible to detect even by an expert technician.
Due to the softness of the hydrogels, a glass coverslip is always used as a support
and treated for the adhesion of the acrylamide. Different chemistries can be used to
bound the gel to the glass surface and terminally-functionalized silanes are used as
a bridge. The height of the hydrogel above the glass must be considered since cells
on the top can feel differences in stiffness down to several micrometers [114].
A particular aspect when performing extensive experiments regarding many con-
dition to be tested and spanning various months of work is the consistency of each
produced piece within the lot and between lots. With this in mind, protocols are
normally defined for the production of a dozen of hydrogels. Due to the high demand
of our experiments (100-200 pieces at once per week) we rearranged the current avail-
able protocols to produce consistent hydrogels over months. Since poly-acrylamide
prevents proteins from adsorbing on its surface and in turn results cell-repellent, the
coating procedures with ECM proteins have been revisited.
Using hydrogels namely from 0.2 to 120 kPa, after a total of 5000 produced
pieces, we were able to resemble a physiological or pathological stiffness, controlling
the cell spreading, overall shape and in turn to study biological processes affecting cell
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Figure 2.2.2 – Role of YAP/TAZ in mechanotransduction. (A). On relatively rigid sub-
strates, cell and tissue growth controllers YAP/TAZ localize in the nucleus to promote cell
activity (active). YAP/TAZ immunofluorescence signal co-localizes with the nuclear marker
TOTO3. When cells are cultured on soft substrates below 1 kPa, YAP/TAZ localization
is prominently sparse in the cell cytoplasm (inactive). (B) When stem cells are cultured
on 1 kPa and 40 kPa different differentiation pathways occur. On 40 kPa hydrogels, cells
preferentially differentiate towards an osteogenic pathways mimicking the in vivo stiffness
of bones morphogenesis. Osteogenic markers are not identified on soft substrates or when
YAP/TAZ activity is blocked (siYT and C3). Adipogenesis occurs on soft gels and it is not
significantly present on stiff substrates. When YAP/YAZ are inactivated (siYT), cells do
not sense the rigid stiffness and adipogenesis is promoted.
behavior. Details on bidimensional hydrogel production are reported in Appendix
G.1. Appendix A reports the achievements obtained with these hydrogels and the
collaboration with Stefano Piccolo’s lab. It was found that substrate mechanics can
act as a master control over certain biochemical pathways and cells - perceiving
their microenvironment - remodel their overall shape and fate (Figure 2.2.2A). This
discovery opens implications on how our tissue and organs regulate their expansion
and homeostasis when subjected to mechanical forces and on how changes in ECM
composition and mechanical cues may be linked to differentiation and cancer (Figure
2.2.2B).
The same hydrogel technology also served another publication reported in Ap-
pendix B, pushing a step further the first research. A series of proteins have been
identified as transducers of the mechanical-responsiveness of transcription factors
(YAP/TAZ) responsible of the genetic activity and cell behavior (Figure 2.2.3).
Again, we gained evidence on how substrates mechanical properties can affect cellular
behavior in vitro and can be juxtaposed to physiological and pathological phenomena
occurring in our body.
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Figure 2.2.3 – Mechanical players drive cell fate. (A) Substrate stiffness affects proliferation
and cell shape. Softer hydrogels limit cell duplication and spreading on the substrate. (B)
When cells are included in a 3D matrix, soft gels induce a cell clustering with inactive
YAP/TAZ out of the nucleus (TOTO3). Stiff gels induce the speading of single cells and
the protrusion of the tissue. (C-D) Mechanical players inside the cells are responsible for
the ECM mechanotransduction. When cells are cultured of soft hydrogels (C), Capz, a
protein controlling cytoskeletal architecture, drive the inactivation of YAP/TAZ. When Capz
activity is abolished (siCapzb) YAP/TAZ activity is restored. Analog results were obtained
using cell confluence as YAP/TAZ inhibitor (D), demonstrating that cells perceive their
physical environment in different manner and these signals affect cell biochemistry and fate.
2.3 Mechanically tunable electroconductive substrates
Previously described hydrogels are used as scaffolds to integrate cell cultures. We
next thought to hydrogels as a compliant substrate to send stimuli and collect data
from cells in real-time.
Muscle cells exert contractions after the depolarization of the cell membrane
and the calcium influx. These cells are also implicated in high-impact pathologies
such as diabetes being a major player in the glucose-uptake and metabolism [115].
Cultivating these cells on a substrate capable of detecting the membrane potential
or the glucose consumption would be a direct tool to study pathological conditions.
With this perspective, we integrated the previously developed hydrogels with
the biosensors expertise in our lab. Carbon single-walled nanotubes (SWNTs) are
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Figure 2.3.1 – SWNT-doped hydrogels for biosensing. (A) Representation of biosensor
with a terminal hydrogel-based detector. (B) Evolution of concentration-dependent signal
of oxidized glucose by GOx. Conversion of oxidized glucose follow a Michaelis-Menten
profile. (C) SWNTs-doped hydrogel with nanotubes distribution. (D) Muscle cells are able
to differentiate properly on SWNT-doped hydrogels.
extremely conductive fibers meaning that a non-invasive doping procedure of the hy-
drogel may be performed [116]. In the publication reported in Appendix C we show
that a proper electron network could be successfully used to acquire electrons from
a redox enzymatic reaction that takes place within soft biomaterials. Figure 2.3.1
reports an hydrogel biosensor that enzymatically process glucose producing an elec-
tron transfer through SWNTs. The sensor detects different glucose concentrations
within a biologically relevant range. Muscular precursors were successfully cultivated
and differentiated on SWNT-doped compliant poly-acrylamide hydrogels, finalizing
the perspective of integrating a soft biosensor for dynamically monitoring metabolic
activity.
The use of SWNTs within the hydrogel matrix revealed effective without dra-
matically altering the mechanical properties of the substrates and allowing the cell
viability and maturation as normally performed in conventional methods. Thus, this
approach can allow the real time monitoring of detectable activities at the cell niche
in a compliant environment.
26 CHAPTER 2. SUBSTRATE DEVELOPMENT
2.4 Chemistry for long term cell adhesion
Poly-acrylamide hydrogels are a tunable tool to cultivate cells on a defined stiffness.
Since the hydrogel results in a repellent surface for standard ECM protein adsorption,
ECM species must be incubated for a few hours to result partially entrapped in the
superficial matrix mesh and allow cell attachment and propagation.
When hydrogel are used for short-term experiments and cells do not exert sub-
stantial force on the substrate, the physical adsorption/absorption of ECM molecules
is a convenient and fast way to finalize substrate ready for seeding. However, in our
experience, long-term experiments and cells with particularly active locomotion (e.g.
contracting muscle cells) necessitate an anchored and stable adhesive layer.
As stated in section 2.2, poly-acrylamide gels are established electrophoresis sup-
ports in molecular biology for their inertness versus proteins. A covalent coupling
of ECM proteins requires the surface activation with new reactive groups. Although
ad hoc commercially available UV-active cross-linkers can be used, they are expen-
sive, offer poor scalability in large hydrogel production, have poor solubility, rapid
decrease of cross-linking activity when solubilized, limited shelf life, and dependence
on UV lamp power and positioning [117]. Other techniques involve carbodiimide or
the straightforward inclusion of 6-((acryloyl)amino) hexanoic acid during the polyme-
rization of acrylamide: the N-hydroxysuccinimide ester reacts with amines exposed
by proteins, however only cross-linker molecules exposed on the surface can react.
Although in line with a limited hydrogel production, Damljanovic and colleagues
proposed a convenient alternative to functionalize poly-acrylamide, derived from the
fabrication process of oligonucleotide microchips: amide groups, once reduced by
highly reactive hydrazine hydrate can be coupled to oxidized proteins [117].
Since the hydrogel production and functionalization can be executed a priori
and protein oxidation revealed stable for weeks, the translation of this technique to
our large and frequent lot production was successfully adopted. Even after several
vigorous washes of the functionalize surface, poly-acrylamide hydrogel offered good
adhesion capability to different cell types. Cardiac and muscle cells were successfully
cultivated for various weeks on activated hydrogels (Figure 2.4.1). Tested techniques
and hydrazine protocol modification are reported in Appendix G.2.
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Figure 2.4.1 – Beating cardiac rat cardiomyocytes on long-term functionalized hydrogels.
Bar 250 µm.
Hydrazine chemistry revealed a cost effective alternative for the cross-linking of
fibronectin or laminin on poly-acrylamide surfaces and allows stable integration of
cells on soft gels.
2.5 Substrate development for large-scale studies
The production of large number of hydrogels at one time is extremely useful when
various conditions have to be tested along with technical replicates. However:
• hydrogel surface is usually limited to few square centimeters and certain appli-
cations require a large number of cells to be analyzed in the same sample;
• part of the cells are wasted because of hydrogel is attached to a glass support
that can not completely fit the entire plastic vessel; this point reveal particu-
larly tricky with cell obtained from precious and limited sources;
• acrylamide polymerization relies on a radical reaction that is inhibited by oxy-
gen; the outer ring of the hydrogel exposed to the air do not polymerize leaving
a thin glass adhesive surface for the attachment of cellular outliers not cultured
on a soft matrix (Figure 2.5.1A). These cells can interfere with the analysis of
the whole sample dynamics. Dedicated hypoxic working boxes would prevent
radical transfer inhibition.
Poly-acrylamide hydrogels covering the entire surface of common biological Petri
dishes and multiwell plates are now commercially available (Matrigen Life Tech-
nologies, USA) but were ineffective when we tried to replicate results reported in
section 2.2 and Appendix A and B. Maintaining the same hydrogel formulation
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in our hands, we tried to develop a similar tool on conventional biological dishes
made in poly-styrene. Details of fabrication are reported in Appendix G.3. A brief
description of results is reported here.
Although the priming of PS through an oxidation step is simple, plastic can ef-
fectively adsorb free molecular oxygen [118], preventing the coupling of acrylamide
at the PS level and previously used cross-linkers may not efficiently cover the surface
in a manner comparable to glass. In fact, various techniques and molecular bridges
failed to couple the hydrogel on the PS (diazonium salts, acryl-terminated silanes,
methacrylic anhydride), and in many cases the pre-polymer solution did not reacted
few micrometers above PS even after a degassing step of prepolymer solution (Figure
2.5.1B). Even with a lower efficiency, the same technique used with glass supports
in our previous works [108, 119] was effective when we considerably incremented the
concentration and reaction time of each coupling reagent and during the polymeri-
zation process. This supports are now being used for extended proteomic and gene
expression analysis for mechanotransduction and metabolic studies with ⇠ 106 cells
per sample. Previously performed assays evidenced same cell behavior of smaller
glass-supported hydrogels.
The opportunity to culture cell on conventional vessels but with a compliant
stiffness at the bottom can allow to dissect the behavior of an entire cell population
instead of looking at a few hundreds representative cells. These substrate could also
be applied to reprogramming studies to investigate the role of stiffness in hiPSC gen-
eration. Large surface are an indispensable prerequisite for statistical evaluation of
sporadic hiPSC colonies rising from differentiated cells cultured on a single stiffness.
Preliminary studies are reported in Chapter 5.
2.6 Mechanically tunable biodegradable substrates
Poly-acrylamide hydrogels are considerably useful since a broad range of biologically-
relevant stiffnesses can be explored. Some applications may require substrates that
can also actively interact with the cells. Since poly-acrylamide can not be degraded
by the cells, new hydrogel-based biodegradable polymers should be developed aiming
also at new research targets. Due to the continuous remodeling of ECM components
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Figure 2.5.1 – Soft hydrogels on standard Petri dishes. (A-C) Oxygen inhibition of radical
reaction is normally experienced at the air interface of the solution under polymerization. (B-
C) Arrows show glass (white) and hydrogel limit (black). (D) Oxygen inhibition occurs also
at surfaces that adsorb/absorb oxigen such plastics and rubbers. (E) Convalently bonded
hydrogel stained with a green dye
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by cells and the culture in three-dimensional scaffolds, biodegradable hydrogels can
further improve the in vitro microenvironment for a better mimicking of in vivo
tissues. In our experience of muscle tissue engineering, various substrate cues have
been proven to optimally drive in vitro tissue maturation [108, 119, 120].
Before seeking at synthetic polymers that can be degraded we focused on a
biomolecule known for implications on cell regeneration, the hyaluronic acid (HA).
HA is an unique non-sulfonated poly-saccharide based on D-glucuronic acid and D-
N-acetyl-glucosamine (NAG) present throughout the body. It is synthesized by cells
directly in the pericellular space with an sustained daily turnover and serves different
biological functions [121, 122]. Depending on the chain length, different roles have
been address to HA, even if some of them remain putative [98, 123]. Global cosmetic
industry has revamped HA for body and facial creams with the potential of skin re-
newal. HA has also found commercial applications in biomedical rehabilitation and
tissue repair with Fidia Farmaceutici s.p.a. located in Padova, Italy. HA chemical
derivates are also sold as hydrogel precursors for the maintenance of human stem
cells in 3D environments (Glycosan, Biotime, Inc., USA) [98, 123–125].
Since HA is a natural linear polymer, its hydrogel formulation would require an
inter-molecular cross-link (Figure 2.6.1). Current strategies presented by researchers
and companies propose a modification of HA backbone in order to bridge two macro-
molecules with an additional cross-linker [126, 127]. Since additional cross-likers may
not be fully degradable, we studied the opportunity of synthesizing an hydrogel only
based on modified HA and that can eventually be further functionalized with other
biomolecules, ending with a more complex biomimetic microenvironment (Figure
2.6.1).
Here we present the main results aimed at obtaining a new concept of an in
vitro biodegradable scaffold with geometrically controlled features for in vivo tissue
regeneration. A scaffold for the generation of bundled muscle fibers and subsequent
integration in a damaged muscle was engineered. Protocols and additional informa-
tions are available in Appendix G.4.
Starting from a method available in the literature [124, 125, 127], we derived a
methacrylated form (MeHA) of a naive 700 kDa HA produced by Fidia Farmaceutici
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Figure 2.6.1 – Native and modified biopolymers. (A) Polymers produced by cells can be
used to improve the biological responsiveness in an in vitro environment. Natural poly-
meric chains can be derived by chemically introducing new functional groups that are able
to cross-link together in defined conditions forming a soft hydrogel with active biological
functionality. (B) Hyaluronic acid have been derived with methacrylic groups to obtain UV-
or APS/TEMED-activatable hydrogels as well as poly-acrylamide gels.
s.p.a.. Since two methacrylated groups can react together forming a stable chemical
bond, a MeHA chain can be recursively cross-linked with neighbors, thus, forming a
hydrogel. Although we did not have the opportunity to characterize the gel, com-
paring it with poly-acrylamide gels, its bona fide stiffness ranges from ⇠0.2 to <10
kPa depending on the percentage in water.
Using a 3D mold with an array of fibers, we were able to produce a three-
dimensional hydrogel with a bundle of channels for the in vitro reconstruction of
muscle precursors. Figure 2.6.2A shows the main steps for the in vivo integration
of engineed muscle fibers. Cells can directly interact with HA through the recep-
tors CD44 and CD138 located on the plasma membrane but we experienced poor
long-term adhesion and spreading (data not shown). Thus, we further improved
the architecture of this 3D device cross-linking ECM proteins on the surface of each
channel (Figure 2.6.2 and 2.6.3A-C). Arranging the MeHA derivation protocol, we
adapted the reagents for the derivation of methacryated proteins such as gelatin or
collagen .
The in vitro degradability experienced with MeHA constructs was comparable to
literature with the use of additional cross-linkers [128]. Due to the high viscosity of
HA at >2% w/v, a minor percentage (0.5% v/v) of poly-ethylene-glycole di-acrylate
(PEGDA) was added to increase the cross-linking ratio and the stiffness up to the
physiological level of the muscle. Well-differentiated myotube fibers integrated with
the 3D hydrogel were obtained (Figure 2.6.3D). At this stage, the hydrogel platform
was mechanically laminated from the glass support for the in vitro cultivation and
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Figure 2.6.2 – Three-dimensional construct for the in vitro development of integrable arrays
of muscle fibers in patients. (A) A 3D scaffold is produced and coated with bioreactive
molecules that allow the attachment of muscle cell precursors. These cells propagate inside
each channel, aligning a differentiate into myotube fibers. Mature constructs are transferred
in damaged muscle to promote its regeneration. Once in vivo, HA matrix is progressively
degraded and promote the proliferation of silent cell both from the in vitro fibers and the
damaged muscle. When degradation is complete both cell type can interact each other in
a regenerated muscle. (B) As a proof of concept, these constructs have been successfully
integrated in mice with damaged-tibial muscle.
transferred inside an ablated muscle in a mice’s leg (Figure 2.6.3G). The construct
perfectly integrated with the host muscle promoting its regeneration (Figure 2.6.3H).
Again, in vivo we experienced a lower degradation than expected and the in vitro
muscle fibers remained isolated.
In parallel, we tried a Fidia’s proprietary new HA formulation. In this case, the
hydrogel had fast degradability botj in vitro and in vivo (Figure 2.6.3I), but not
enough to allow proper development of in vitro muscle fibers. In the next future, we
aim at integrating both hydrogels: MeHA will constitute the core shell to support the
proper formation of in vitro fibers and the bulk will be formed by the fast degradable
formulation (Figure 2.6.2B).
These results evidence the potential of HA in promoting controlled maturation of
in vitro tissues and in allowing the in vivo integration to promote tissue regeneration.
Exhancement of available chemistry protocols allowed the generation of 3D hydrogel
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Figure 2.6.3 – 3D biodegradable hydrogel constructs. (A) Different chemical functional-
izations were performed in order to obtain an optimal scaffold for in vitro differentiation
of muscle cell precursors. Methacrylated HA and gelatin were used to produce the hydro-
gel and the permanent ECM coating, respectively. HA was bind to a glass slide with a
methacrylic terminated silane. (B) An hydrogel prototype with channels filled with a green
fluorescent tracer. (C) Transversal section of a 100-µm-wide channel and the detection of
ECM protein on the walls with fluorescent-tagged antibody. (D) Evolution of cell culture,
from cell injection to maturation in myotubes. Immunofluorescent analysis shows expression
of mature muscular markers MHC-II and a-actinin (right). (E) One fiber extracted from the
hydrogel after 10 days and (F) MHC-II immunofluorescence of an extracted fiber. (G) In
vivo implants of 3D constructs with fibers on mice with ablated muscles. (H) Section of a
muscle 2 weeks after implant. Hydrogel is degrading and favoring muscle regeneration. (I)
Section of a muscle 2 weeks after implant using a the commercial hyaluronic acid derivate.
Hydrogel was completely degraded with concurrent muscle regeneration.
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scaffolds and the control of cell adhesion and maturation. Engineered muscle fibers
can support the host regeneration together with a stimulating biomimetic scaffold.
The chemical control of native biomolecules here presented will be used for the
microscale substrate enginering in microfluidic environments in Chapter 4.
2.7 Topological control
Previous sections depicted how substrate mechanics can influence and drive cell be-
havior, transducing signals from mechanical to soluble biochemical intermediates.
As reported in Appendix A and [129], mechanotransduction pathways also sense
cell morphology and spreading over the substrate. topological control of adhesive
substrates can complete the tools in out hands to control cell behavior in vitro.
Substrate topology has been controlled in many ways [108, 129–138] and detailed
experience in micro-contact printing (mCP) was gained during this thesis. However,
mCP results an unpractical way to topologically define a large number of samples.
Thanks to the experience achieved in this thesis, UV-activatable surfaces can be
exposed for few seconds to transfer geometric patterns from a photomask. In section
2.2, the poly-acrylamide surface was described problematic for the repellent action
versus proteins and cells. To topologically control cell adhesion, we turned in favor
this property saturating selected regions for cell-exclusion and leaving pro-adhesive
areas free for cell landing (Figure 2.7.1).
Instead of using a branched polymer as previously described, linear chains of
poly-acrylamide can be produced as well; in the first case, cell-exclusion is based
both on the chemical nature of the polymer and on the physical discontinuity of a
wall with defined height. In the second case, one side of poly-acrylamide chain is
anchored leaving the other fluctuate: the length of polymer is affected by the rate
of radical catalysis, the faster is catalysis the shorter will be the chain lenght, and
viceversa.
Since radical polymerization of acrylamide can be actuated either by the well
established chemical initiation/catalysis of APS/TEMED (see Appendix 2.2) or by
UV photo-activation different strategies can be followed. Stamps or other relief have
to be placed in conformal contact with a flat surface to guide patterned chemical
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Figure 2.7.1 – Techniques for topological control of cell cultures. (A) Indirect micropat-
terning. Glass is functionalized with an methacrylic-terminated silane and thin film of
positive photoresist is spinned on the entire surface. A defined pattern is transferred to
the photoresist thanks to the UV light passing through a mask. Acrylamide is then poly-
merized passivating resist-free regions. Resist is then solubilized to unmask regions for cell
adhesion. (B) Direct micropatterning. Silanized glass can be directly patterned using UV-
activated polymerization of acrylamide. Non exposed areas are free of acrylamide and allow
cell adhesion and patterned growth.
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polymerization, while photomasks can exclude regions from light exposure and photo-
polymerization. Techniques to topologically control cell cultures are reported in
Figure 2.7.1. Geometric constrains down to the single-cell isolation were realized
(Figure 2.7.2).
In Chapter 6, a concept of direct topological control inside finalized microfluidic
platforms is presented. Thanks to this advantage, soluble environment, substrate
Figure 2.7.2 – Topologically controlled cell cultures. (A-C) Indirect patterning. (A)
Crossilinked poly-acrylamide gels can be patterned on glass surfaces to obtain micrometric
wells. Cells (here stained with blue nuclei) adhere at the bottom ad are confined by non-
adhesive walls ( 100 height). (B) Linear poly-acrylamide has been used to pattern cells in
different geometries. Adhesive lanes 500 µm wide are separated by 200 µm. Muscle pre-
cursor cells align along the major axis, promoting cell fusion and myogenesis. (C) Large
areas can be patterned with linear poly-acrylamide. Here a merged image shows a pattern
obtained by after the removal of a spindle-shaped microfluidic stamp. Pre-polymer solution
was injected ad exposed prior to the detatcment of the sticky rubber above. (D) Result
of a high-resolution indirect patterning. Cells adhere on small adhesive areas aligned in a
matrix. Two magnifications show how it is possible to have single-cell patterns. At higher
magnification (bottom-right) it is possible to apprecciate the cell nucleus (bright spot at the
center).
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mechanics, chemistry and topology can be tailored and combined in an unique plat-
form to mimic human physiology and pathology to improve research discovery and
industrial valuable products.
2.8 Functionalization of PDMS based devices
Poly-dimethysiloxane (PDMS) is a commercially available silicon rubber mostly used
for micro-engineering applications. Although the precise chemical composition is
unknown, many aspects of PDMS are characterized [85, 139].
Cured blocks of the polymer can be activated via a plasma oxidation treatment
and permanently sealed together or with glass [140]. However, an effective and sta-
ble functionalization of cured PDMS is hard to achieve: inertness and evolution of
exposed polymer chains to water environment are the major obstacles [141].
In order to perform substrate development also on materials commonly used in
microfluidic applications, we explored the possibility to integrate previously described
techniques on PDMS. Compliant hydrogel films could cover stretchable PDMS mem-
branes and acrylamide surface chemistry may reduce adsorption of hydrophobic
molecules and topographically pattern silicone surface.
To provide an easy and stable functionalization, we thought of doping the base
pre-polymer of PDMS before the curing process (Figure 2.8.1).
Since the monomeric unit is based on a dimethyl-silane we introduced a 2.5% v/v
methacryl-terminated silane to co-polymerize with the PDMS backbone. Early tri-
als, evidenced that direct acrylamide polymerization occurs on methacrylate-doped
PDMS and geometric patterns can be realized. Further investigation will complete
the implementation PDMS modification for comprehensive control of surfaces in
micro-engineered devices.
2.9 Conclusions
Conventional culture substrates offer simple but chaotic cell distribution and grow,
and are not able to fully reproduce defined peculiarities such a biological valuable
stiffness, complex physical and biochemical architectures and geometric controlled
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Figure 2.8.1 – Functionalization of PDMS. (A) Commercial PDMS can be thermally cured
and oxidized through plasma activation. Oxidized species generated on the surface can be
used to react with functional silanes. (B) Uncured PDMS is obtained by mixing a two-
component kit. Since the monomeric unit is based on a siloxane, silanes can be included
during the polymerization by heating the doped PDMS. (C) BJ fibroblasts seeded on func-
tionalized PDMS with an array of adhesive lanes. Bars 500, 300, 100 µm from left to right
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patterns. Emerging examples of body-on-a-chip studies underline the importance of
controlling spatial, chemical and physical organization of cell culture environment in
order to resemble in vitro architecture and functionality of human tissues.
In this chapter, the achievements obtained in substrate development at different
levels were described. Starting from previously reported protocols, we extend the
potential and applicability of substrate control for cell culture studies, achieving
important research results and the possible scalability to commercialization.
The large adoption of synthetic biocompatible substrates with tunable stiffness
evidence brand-new biological dynamics and implications in the biomedical field.
Chemical activation and doping of hydrogels generated supports for long-term cell
adhesion of contracting cells and compliant biosensors with the possibility of real-
time measurements of metabolic activity. Looking at a clinical approach, we designed
a 3D biodegradable hydrogel prototype for in vitro cell and tissue production and
its straightforward delivery in vivo for muscular reconstruction and rehabilitation.
Acrylamide chemistry was then redefined in order to provide topological control of
cell culture down to the single-cell level and to modify PDMS rubber, a principal
component of micro-scaled engineered devices.
The expertise gained with substrate development will be translated in microflu-
idics to provide substrates for long-term cultures, a key requirement for the repro-
gramming and programming of human cells at the microscale.

Chapter 3
Cell cultures in microfluidics
This chapter introduces to the cell culture in microfluidic systems. As a proof of
concept, a first reversible integration of mammalian cell cultures with defined sti-
muli is proposed. A dissertation on the robust long-term cultivation in microfluics
follows. Long-term cultivation will be evidenced as a fundamental prerequisite for
reprogramming and programming studies at the microscale.
3.1 Motivation
Cells in our tissues are surrounded by an interstitial fluid that support the diffusion of
metabolites and connects to the blood vessels network for their delivery throughout
the body. Thanks to the low volume of these fluids, small changes in a solute secretion
or withdrawal can result in fast and effective signals directed to cells of the local tissue
or towards the periphery of our body [5].
In order to reproduce these advantages in an in vitro system, a miniaturized
environment at the cell-level must be designed together with the use of semi-synthetic
or synthetic media. Conventional culture systems based on plastic dishes result in
macroscopic vessels that can be used when 105   106 cells are required to grow
as a monolayer in few milliliters of medium. When a massive production of cells
is necessary, these culture surfaces can be extended in piles or cylindrical vessels
requiring liters of growth medium.
Since the in vivo cellular dynamics are exerted in a tiny soluble environment, the
previous examples can not provide a tool to screen and mimic biological processes
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which can take down to seconds [5]. Reducing the working volumes down to the
microscale, it is possible to perform a real-time control over the entire culture system
and obtain reproducible conditions [25]. Second, the use of large amounts of media
and of biochemical supplements needed for certain cellular activities dramatically
increase the costs for the maintenance and the stimulation of the cell layer.
Microfluidics can potentially drive low amounts of compounds over a cell culture
with high-efficiency and in an automated and parallelized manner [83, 91, 96, 142].
Moreover, microfluidics platforms can be designed as an open or closed system, with
the latter one a key characteristic for Good Manufacturing Process (GMP) directives
of Food and Drug Administration (FDA) [143].
All combined, these aspects are crucial for a next-generation cell culture platform
that can permit the control of new variables and make feasible new studies at an
affordable cost.
3.2 State of the art of microfluidic cell culture
Microfluidics is aimed at being utilized in various fields and for multiple purposes
(e.g. chemical reactions, detection of biochemical species, cell sorting, etc.) [79,
144–146] and microfluidic components has also been used in commercial apparatuses
(e.g. Agilent Technologies, Inc., USA; Affymetrix, Inc., USA; Fluidigm Corp., USA).
Working at the microscale, microfluidics has the potential to control the process
in time and space in real-time [147]. Thanks to the laminar flow regime, the use of
multiple inlets allow to perform multi-parametric analyses on the same sample, to
create gradients of soluble species and the design of fluidic channel can significantly
impact over the system behavior.
Cell cultures and living tissues have been integrated in microfluidics in the past
decade, with the aim of controlling the microenvironment for higher reproducibility
and higher throughput compared to conventional cell cultures [80, 82, 84, 142, 148].
Microfluidics has the potential to resemble the environmental conditions at the same
scale of in vivo tissues and can be tailored both to 2D or 3D architectures for a better
approximation of human organs.
Since microfluidic devices can be built in transparent materials (e.g. glass, plastic,
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resins, rubbers, etc.) cull culture progression, real-time experimental behaviors or
the analysis at a later stage are easy to monitor. Release of unwanted compounds and
uptake of essential components for cell culture by any material can compromise the
stability and healthy of cell cultures both at short and long term [85, 139]. In many
cases, glass and poly-dimethylsiloxane (PDMS) were chosen as elective materials for
their stability, low cytotoxicity, low price and easiness to assembly.
3.2.1 Materials for microfluidic cell cultures
In the development of microfluidic devices for cell cultures, some materials have raised
among others for their superior biocompatibility. This aspect includes different issues
referring the properties of a biomaterial. Any materials of the platform should not
release toxic compounds into the cell culture environment:
• attention have to be placed not only to the surfaces where cells are directly
growing but also to all materials exposed to the culture medium (i.e. upstream
reservoirs, tubings, connectors, bulk and structural components of the device);
• the interaction between materials, cells and culture medium should not trigger
any physical interaction or chemical reaction, leading to nutrients depletion or
release of unwanted substances.
Oxidized poly-styrene plates have being used for decades as the elective culture
surfaces in biology for in vitro cell and tissue cultures. Since microfluidic devices
rely on the three-dimensional confinement of micrometric channels, gas-permeable
materials have been adopted instead of plastic, which in turn can also result difficult
to integrate with other materials.
Hybrid devices of glass and PDMS or PDMS alone have been extensively used
in biological applications. While both show optimal optical properties and glass is
totally inert, PDMS presents some issues that must be considered with cell cultures:
• different formulation of PDMS are commercialized (e.g. RTV-615, Sylgard
184, etc.), offer different approaches and may impact differently on cell culture
quality;
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• PDMS is a silicone rubber which is commonly polymerized through the catal-
ysis of two-components (base and curing agent); uneven mixing can result
in defects of chip fabrication and in monomers dispersion in the cell culture
system. Additionally, a 5% of the initial monomer is estimated to always be un-
cured at the end of chip fabrication [85]; some solvents may be used to extract
low molecular weight species, which are in part responsible for the unstable
functionalization of PDMS surfaces [77].
• adsorption of lipophilic species and absorption of small non-polar molecules
[139];
• while diffusivity of oxygen and carbon dioxide in PDMS is not a limiting factor,
water evaporation from the tiny fluid circuit results in biased osmolarity that
strongly affect cell culture healthy.
Glass slides are commonly used in standard cultures when a thin support is required
for a later analysis. To improve the adhesion properties and the spreading capacity
of seeded cells, the glass surface is often coated with extracellular matrix (ECM)
proteins (e.g. fibronectin, lamin, collagen, gelatin, etc.) which normally support cell
adhesion in vivo. The physical adsorption of these proteins to the glass surface can
support cell culture for various days. Once cells have colonized the entire culture
surface, cell-cell interaction can become prominent over the cell-substrate interaction.
In this period, duplicating cells also rearrange the composition of the initial protein
layer, synthesizing a more complex network which can eventually not interact with
the glass surface [149]. For these reasons, a compact cell layer can laminate from the
support compromising the sample.
Due to the particular characteristics of microfluidic chips, this and other issue
must be addressed when culturing mammalian cells. A brief argumentation of current
limititations follows.
3.2.2 Current limitations and perspectives
Despite various efforts, the integration of cell culture in microfluidics always revealed
problematic since cells require multiple aspects to be solved at once [25]. Here are
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reported some of the main challenges to culture mammalian cells in microfluidics:
• the biocompatibility of the materials directly or indirectly exposed to the cells;
• adsorption/absorption of crucial molecules;
• the adhesion properties of the substrate for cell culture and its long-term sta-
bility;
• sterility;
• culture medium management and evaporation;
• limited operability at 37 °C and permeability to oxygen and carbon dioxide.
In many studies, once the cells were integrated within microfluidic chambers they
were not maintained for more than few hours or days and reflected abnormal pheno-
types [68, 82, 86, 87]. Human cells can reveal more demanding compared to animal
cells and specific cell type can be extremely sensitive to the variations of the mi-
croenvironment requiring ad hoc design and management of the microfluidic system
[86].
Another important aspect is the simplicity in using microfluidic devices. Behind
new built-in functionalities in a same chip, these devices must be both user-friendly
and simple to integrate with delicate biological samples. The need of a complex
apparatus and skilled operators in both biology and engineering limit the broadening
of this technology [150].
The integration of miniaturized add-ons to the microfluidic core is a powerful fea-
ture that can not be straightforward and present with the same packaging in standard
plastic culture plates. Biosensors upstream and downstream the culture chamber can
reveal many biological processes in real-time (e.g. metabolites, secreted factors, etc.)
[151]. At this time, no sensor has been successfully integrated in microfluidic devices.
Such fully integrated microfluidic chips would outperform existing biological and
biomedical devices providing real high-throughput performance and un-precedented
cost reduction and efficiency. Moreover, miniaturized accurate human in vitro mod-
els will substitute animal models that can not fulfill the entire human biology and
46 CHAPTER 3. CELL CULTURES IN MICROFLUIDICS
physiology [81]. Dangerous pre-clinical trials will be avoided for human testers, and
personalized drug compounds would be easier to develop.
3.3 Culture approaches in microfluidics
In the following sections, the main issues of microfluidic cell culture referred in the
3.2.2 are addressed. The research and results achieved during this thesis are focused
on various strategies to obtain a robust long-term cell culture platform over several
weeks. The cultivation over this timespan will be fundamental in order to perform
the reprogramming and programming processes at the microscale; a minimum of 2
weeks for each step is required in standard protocols.
The achievements obtained in this section have been obtained thanks to an inter-
disciplinary development across chemistry, biology and engineering. The long-term
integration of cell cultures in microfluidics required a comprehensive knowledge span-
ning from chemical bonds in biomaterial development to the physics of the microflu-
idic liquid environment. Especially regarding complex and delicate cell cultures such
hPSC, additional parameters fulfilling the biological requirements of these cells must
be taken into account. The accumulation of secreted factors by the cells or the their
washout with sustained exogenous stimuli carried by the medium can significantly
alter the homeostasis of hPSC [86].
In the following sections we report the results obtained integrating cell cultures
in microfluidic devices:
• in section 3.4, we report a first integration of conventional cell cultures in an
ad hoc microfluidic platform.
• in section 3.5, we extend the knowledge gained with substrates development
(Chapter 2) in microfluidic devices for long-term cell cultures.
• in section 3.6, we report the technical improvement for the definition a liquid
handling platform serving microfluidic chips.
• in section 3.7, we report the study of optimal strategies for medium delivery
on microfluidic cell cultures.
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3.4 Conventional cell cultures integrated in microfluidics
An early step to respond to some of the issues in 3.2.2 was performed by integrat-
ing cells grown in a conventional culture system into a microfluidic platform. The
work reported in Appendix D shows how starting from a conventional glass dish, we
integrated a defined cell culture in a microfluidic device with reversible sealing.
Briefly, starting from the expertise in structured cell cultures gained in the lab, we
integrated cells cultured in well defined static conditions in a fluidic chamber (Figure
3.4.1A,C). Three layers of PDMS were combined together: (i) at the bottom, a glass
(75x50 mm) support with a thin silicone membrane carved to accommodate the cell
culture glass slide; (ii) in the middle, a PDMS membrane permits the sealing on
the chip with a vacuum ring system and the communication between the sample
and the microfluidic layer above; (iii) at the top, the microfluidic channels provide
inlet and outlet support to the common culture chamber. Middle and top layer were
irreversibly bonded by plasma treatment (Figure 3.4.1A). After the prototyping of
different geometries and flow operative conditions, we achieved a platform to perform
multi-parametric experiments within a single sample with an accurate control of the
delivered species (Figure 3.4.1B). Since the platform serves as a temporary solution
for the selective delivery of factors above cells, the culture glass slides were transferred
back in the conventional dishes after the infection process. This platform has proved
that microfluidics, delivering a thin layer of viral suspension above the cell layer,
can increase the efficiency of infection (Figure 3.4.1D-E). Experimental validations
have also been confirmed by mathematical modeling in our laboratory. Moreover,
defined area of cell culture subjected to viral exposition were also detectable in static
condition 24 hours after the perfusion (data not shown), indicating that microfluidics
can optimally regulate stimuli in time and space over a cell culture.
This work represented a first approach on microfluidic cell cultures aimed at un-
derstanding the limits and the potential of the technology when coupled to biologial
systems. Since chip fabrication has been routinely adopted in our lab, we next fo-
cused on the permanent integration of cells directly in the fluidic circuits (section
3.5).
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Figure 3.4.1 – Conventional cell culture integration in microfluidics. (A) Schematic rep-
resentation of chip assembly, with (i) base for culture coverslip, (ii) sealing system with
common chamber and (iii) microfluidic layer. (B) Assembled chip with inlets and outlets
connected and perfusing either saline solution or fluorescein tracer. (C) Platform overview.
The microfluidic chip is integrated in a climatic chamber with an automatized fluorescent mi-
croscope for data acquisition. Syringe pumps and a vacuum system serve the chip for liquid
handling and temporary sealing. (D) Controlled viral infections in microfluidics. Once viral
particles above cells have been internalized in the cells, the delivery of the same amount of
virus per cell results in higher infection efficiency using the microfluidic integration with con-
tinuous perfusion (> 6 h). (E) Since infections performed in static vessels and microfluidics
rely on extremely different amounts o media, infection efficiency was determined using the
effective number of viral particles perfused over cells (effective MOI). Microfluidics results
significantly more efficient that static infection. Detailed material is reported in Appendix
D.
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3.5 Substrate development in microfluidic devices for long-
term cultures
The knowledge and practice achieved with the first platform were transferred in
microfluidic chips where cell can be directly seeded and cultured. When glass and
PDMS are permanently sealed together the chip offers inlet and outlet ports for the
cell seeding and medium perfusion. This permit a stable and and more robust device
compared to previous one (section (3.4)). On one side, this solution do not need any
sealing control, a two-step process (seeding and culturing separated by the stimulus)
is avoided and the chip is ready to use after the sterilization process; on the other
side cell culture on the surfaces of microfluidic channels require the development of
surfaces and protocols adapted to the micrometric scale.
Normally, PDMS layers are plasma bonded on mounting glass slides (1 mm thick)
to support the rubber layer with a rigid one. Coverslips normally used in cell cul-
turing (⇠100-130 µm thick) have a different composition based on borosilicate. This
aspect can impact on cell culturing since one cell type can behave differently on naive
surfaces with different compositions.
In order to understand how cell cultures behave in microfluidic channels, we first
applied the standard coating procedures injecting each solution form the inlet. Before
cell seeding, ECM proteins are adsorbed on the glass at the bottom of each channel.
Cells start adhering to the ECM protein and spread in few hours. Lack of adhesion
proteins results in lower and retarded attachment and can affect cell growth rate and
overall behavior at a later stage.
Despite the hydrophobicity of PDMS, ECM proteins may also adsorb to its ex-
posed surfaces in the channel. Proteins commonly have different aminoacids and
oligomers that interact in different manners depending on the side group chain; apo-
lar groups and aliphatic chains can weakly interact with PDMS, anchoring proteins
to the surface; proteins themselves may also recruit others and stack together. Due
to the tiny height of a microfluidic channel (e.g. 50-200 µm), the injected cells are
preferentially dispersed at the mid-height of the channel with few cells at the roof and
floor level; once the flow is interrupted, cells are subjected to gravity and concentrate
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at the bottom of the channel, with almost no cells on the PDMS roof.
When cells reached confluence and cover the entire glass at the bottom, the
cell-cell interaction becomes predominant. In particular:
• the initial provided substrate is dynamically rearranged during the culture
period by the cells.
• each cell is surrounded and in direct contact with various cells;
• the more the culture area is crowed the more the cell reduce their spreading
and contact area with the substrate;
• at confluence, cells stop growing and can than behave differently according to
the cell type.
• microfluidic channels have a discontinuity of materials (i.e. glass/PDMS) and
surfaces (i.e. edges) that can interfere with the homogeneity of the initial
coating and forces exerted by the cell layer.
When cell cultures remain confluent for various days, a tight cell monolayer is formed
and can eventually laminate where a discontinuity is present. In Figure 3.5.1, a
typical case is presented on the left. Cell layer laminates at the edges of glass/PDMS
interface and rolls for the cell-cell interaction with the progression of the culture until
a complete detachment of the cell layer.
The concentration of ECM proteins and their interaction with the surface at
the initial stage, thus, were found to be critical for the long-term stability of cell
cultures. In order to provide a stable culture surface for long-term studies various
functionalizations were explored, both absorption-based or with chemical immobi-
lization (Table 3.5.1). The work on substrate development (Chapter 2) revealed
particularly important and previous techniques were transferred inside microfluidic
channels.
Glass surface can be easily activated for the generation of chemical groups that
can stabilize the adsorbed proteins or can serve as bonding site for covalent immobi-
lization of ECM proteins. We stabilized the internal surface of microfluidic channels
by chemical bonding of ECM. Using previously functionalizations either based on
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Table 3.5.1 – ECM protein functionalization of microfluidic channels. Conventional ad-
sorption methods or cross-linking strategie are reported. Eventual cell layer lamination was
reported at 25 days of culture within microfluidic channels. Silanes were used to functionalize
the glass.
method cell layer lamination
gelatin 0.6% w/v adsorption yes, ⇠7 days
gelatin 0.1% w/v adsorption yes, ⇠10 days
fibronection 0.05 mg/ml adsorption yes, ⇠15 days
gelatin 0.1% w/v + aminated silane adsorption yes, ⇠10-15 days
fibronection 0.05 mg/ml + aminated
silane adsorption yes, ⇠15-20 days
gelatin + aminated silane +
glutaraldehyde bridging cross-link no, not fully tested
methacrylated gelatin 0.1% w/v +
methacrylic silane cross-link no
oxidized fibronectin + aminated silane cross-link no
Figure 3.5.1 – Substrate development for microfluidic cell cultures. Adsorption of ECM
molecules on the surfaces inside a channel (left) leads to the detachment of confluent cell
layers, starting at the edges. When a covalent attachment of ECM proteins was performed
(right), cultures resulted in stable cell layers for weeks.
methacrylation or oxidation (section 2.6 and 2.4, respectively), we bonded proteins
on glass surfaces via methacrylic- or amine-terminated silanes. Cells were stably
cultured for various weeks on chemically engineered surfaces (Figure 3.5.1).
Thanks to the know how acquired in Chapter 2, we were able to apport chemically
enginered biomolecules at the microscale. Since reprogramming and programming
procedures require various weeks of culture, the individuation of stable substrates
that allow a prolonged cell culturing is a fundamental step.
3.6 Liquid handling
Once we stabilized the cell substrate for cell cultures at the microscale, we focused
on the soluble microenvironment.
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Figure 3.6.1 – Schematic representation of a microfluidic platform. A microfluidic chip
composed by various parallel channels with indipendent reservoirs is connected with ta
bundle of tubings to a syringe pump. Controlled withdrawal is actuated by a LabVIEW
interface developed in the lab. A finalized chip with a glass as sealing and cell culture surface
is modeled on the right.
Since each microfluidic channel relies on few microliters of liquid volume and cells
need fresh nutrients before their depletion and waste products accumulation, new
fresh culture medium must be supplemented in the microfluidic system with a refresh
rate higher than conventional culture systems with lower culture surface/medium
volume ratios.
Depending on the cell requirements and microfluidic design, refresh rates of cul-
ture medium may not be possible to perform by an operator. Especially when the
number of similar operations is too frequent, a liquid handling automation is required
and can reduce possible errors by a human being (e.g. vehicle of contamination, re-
moval of chip from incubators and loss of temperature and gases, etc.).
Two liquid handling systems available in the laboratory were converted and in-
terfaced with a software in order to perform scheduled operations of culture medium
delivery. Syringe pumps and then step motor pumps (components of a previous-
generation DNA sequencer) were connected via serial ports to a computer and two
applications were written in LABVIEW software accommodating the machine own
language. LABVIEW offers an intuitive graphical interface to build applications as
a block diagram and basic templates serve a starting point to build your own appli-
cation. For each pump type, instructions can be either sent as command string or
by pressing a sequence of buttons. Further software implementation will be required
if pumps, micro-valves inside the microfluidic chip and an external medium source
have to work in synergy in a unique system.
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3.7 Medium delivery strategies in microfluidics
Having developed a cell substrate for a durable integration of cell layers in microflu-
idics and a tool for automated medium delivery, we explored the best strategy of
medium management to perform robust long-term microfluidic cell cultures and to
maintain optimal phenotype and biological functions of cultured cells.
In our body, a few cell types are exposed to a continuous flow. Endothelial
cells on the inner surface of blood vessels are continuously exposed to the flow at
least on one side [5]. The rest of our cells exchange nutrients and waste products
thanks a diffusion gradient between the tissue and the capillary bed. This gradient
can be subjected to fluctuations: for example, during digestion, glucose is delivered
throughout the circulating system to restore and support cell metabolism of tissues
and organs after a resting period [115].
Many studies reported to sustain cell cultures in microfluidics for prolonged time
[152] and either continuous or periodic medium delivery has been used [68, 82, 83,
87–93, 153]. Although the complexity of microfluidic architecture has been exten-
sively explored, and the effect of some operative variables has been analyzed, the
identification of an optimal strategy for medium delivery is still an open issue .
Microfluidics offers an efficient system in terms of medium consumption and
delivery but showed some drawbacks when coupled with cell culture systems: due to
the high surface/volume ratio, frequent accumulation or washout of extrinsic factors
can result in a long-term toxicity effect [68, 82, 91]. Even using the same overall
amount of medium in a time interval, it should be considered that different delivery
strategies imply different spatio-temporal profiles of metabolites and growth factors,
which may significantly influence overall cell behavior and long-term culture stability
(Figure 3.7.1A-B).
In the publication reported in Appendix E we reported that a periodic flow,
resulting in a fast perfusion pulse followed by a prolonged resting period is the best
strategy to:
• avoid downstream effects due to upstream consumption and release of species
(Figure 3.7.1C);
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• sustain grow by the accumulation of cell-secreted species for sufficient time
(Figure 3.7.1C and 3.7.1A-B);
• grow cells at normal rates and maintain their overall phenotype (Figure 3.7.2A-
B);
• optimize medium consumption.
These results were obtained using either mouse or human cells, and different cell types
and differentiation stages. Even though operative parameters of medium manage-
ment may be defined for each cell type, a common strategy emerged when integrating
cells in microfluidics channels. The model provided by E. Magrofuoco confirms that
continuous perfusion favours heterogeneous conditions along the culture chamber
and periodic pulses of fresh medium can restore optimal culture conditions (Figure
3.7.2C).
3.8 Conclusions
Microfluidics has the potential to improve current techniques in many fields thanks
to unique properties of a high surface/volume ratio and a small amount of fluid at the
microliter scale. Although this technology has been proposed in various studies cou-
pled with cell cultures and has found some biology-related commercial applications,
it has never been fully characterized for the integration of long-term cell cultures.
Since the phenomena at the microscale are unique, the adoption of proper substrate
and medium delivery strategy are key aspect for a successful cell culture.
In this chapter, substrate development via biochemistry and periodic medium
management are reported as powerful tools for the integration of long-term cell cul-
ture in microfluidics. Conventional cultures have been first integrated in ad hoc
microfluidic reversible chambers to evidence in our hand the potential and limits
of microfluidics. The infection process perfomed on integrated conventional samples
evidenced that microfluidics can efficiently and selectively deliver biochemical species
at the cell layer. Substrate development was integrated in microfluidics in order to
extend the lifespan of microscaled cell cultures. ECM cross-linking methods revealed
as the most reliable for culturing cell for several weeks. Medium delivery strategies
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Figure 3.7.1 – Medium delivery strategies for cell cultures. (A) The same amount of
medium can be perfused in a defined period with different strategies. Continuous or per-
diodic perfusion with different flow rates can be applyied and the same total perfused medium
equals to the rectangular area under a hyperbolic curve. (B) Transversal section of a mi-
crofluidic channel with fluxes of metabolites. Below, steady state behaviour of the system
(i.e. metabolites concentration) as a function of medium flow rate (at 80% of cell culture
confluence). (C) Microfluidic C2C12 cell line cultures at 4 days. Three different regions of
microfluidic channel were analysed, the upstream, the middle-section, and the downstream.
Upstream and downstream conditions are reported for continuous (up) and periodic perfu-
sion (down). Continuous flow presented marked heterogeneous growth (a – b) and cellular
death especially downstream. Altered morphologies resulted all along the channel with
marked perinuclear vesiculation (c). Applying a fast pulse with a periodic flow of medium
delivery, cells grew uniformly along the channel (g and h) and did not present alterations (i).
Microfluidic C2C12 cultures at 5 days. Continuouslly perfused cultures reached confluence
even with abnormalities but an antithetic situation followed downstream (j), compared to
the downstream channel of periodic flow where the culture was over-confluent (l). Insets
were taken at half-length of each channel.
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Figure 3.7.2 – Microfluidic mouse embryonic stem cell (mESC) cultures at 6 days. (A)
Bright field and immunofluorescence (IF) analysis for pluripotency marker SSEA-1 are illus-
trated. Continuouslly perfused channel presented marked heterogeneous up-/downstream
growth and marked differentiation with SSEA-1 negative flattened cells. Periodic condition
resulted in homogeneous and pluripotent compact colonies. Scale bars 250 µm. The same
amount of medium was used either in periodic or continuous regime. (B) Image analysis
of the pluripotency marker Nanog indicate that a fast pulsed periodic flow (P2’) is opti-
mal for mESC cultures. (C) Model of concentration profiles of glucose in the medium and
cell-produced factors (endogenous factors, EnF). Periodic perfusions result in oscillating
concentration while continuous perfusion generates two different microenviroment up and
downstream.
3.8. CONCLUSIONS 57
evidenced that the soluble control in microfluidic cell culture is a fundamental aspect
for cell culture grow and long-term maintenance. Periodic flow was found as the best
strategy to culture a variety of cell types.
A comprehensive, fine and tunable control of microfluidic environment for weeks
is a fundamental prerequisite to maintain human PSC and direct human pluripotent
stem cells fate in vitro. Achivements both on substrate development and microfluidic
cell cultures were fundamental for the development of a reprogramming strategy
at the microscale: cell behavior control, defined delivery of exogenous factors and
reduced requirements and reagents will be evidenced in Chapter 4 as key components
for a next generation reprogramming platform.

Chapter 4
Human reprogramming in a
substrate-defined microfluidics
This chapter describes the technological integration of substrate and microfluidics
development for the reprogramming of human cells at the microscale. The downscale
of the reprogramming process would introduce a fundamental tool to substantially
extend the actual capabilities and unleash the potential of human pluripotent stem
cells for screening assays and drug development from a population scale to individual
needs. Detailed methods of this chapter are available in Appendix F.
4.1 Introduction
Human pluripotent cells can provide insights on human development and generate
differentiated cells of our body for in vitro investigations on biological processes,
drug development and tissue regeneration [97]. Besides some limits of embryonic
stem cells, mostly ethical and relative to abundance, induced pluripotent stem cells
can be derived without these problems and expanded in large quantities.
The major limit regarding hiPSC is the generation phase: despite various avail-
able systems, these products still retain a considerable cost for every sample to be
reprogrammed. When looking forward for a large number of patients with differ-
ent clinical profiles, genetics, habits, etc., that reflects a population, the derivation
of at least one single clone per person becomes unsustainable in terms of material
expenses, skilled operators, facilities and required time [4].
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Scaling down the cost for each reprogramming sample would make possible the
realization of a platform for the reprogramming of a multitude of people and the
screening of human biodiversity at various level. With the difficulty in developing
new drugs for pharmaceutical industries, the scalability of reprogramming process
would provide unlimited in vitro human cells of different tissues [81]. Improvements
would span from the understanding of the variety of human biotypes to the ad hoc
solutions for unique people and rare diseases.
Thanks to the new achievements on cell culture substrates and microfluidics
gained in this thesis, it would be possible to generate a new platform for the mi-
croscaled and extended derivation of hiPSC. A significant cost and material reduction
would also allow to avoid the expansion process of hiPSC, realizing a straightforward
one-step process for derivation of human tissues on-a-chip.
4.2 Delivery of reprogramming factors at the microscale
In order to understand the practical aspects of the reprogramming process, we first
tried available conventional reprogramming systems. Early efforts to introduce repro-
gramming factors inside cells in conventional and microfluidic environments focused
on the adoption of viral constructs, the most used and efficient system known at that
time.
Since we wanted a system that relies on a transient expression of exogenous
reprogramming factors, we decided to adopt non-integrating viruses such as aden-
ovectors and Sendai (data not shown). The use of repeated infections of transient
adenovectors produced at the Dept. of Molecular Medicine resulted in a long-term
toxicity and some of the vectors had also production issues. The commercially avail-
able Sendai virus (Life technolgies, USA) was adopted in conventional systems to
understand the implications of delivering four different variants of the virus carrying
OCT4, SOX2, KLF-4 and c-MYC human genes. As stated in the official protocol,
a single series of viral transfections had a substantial toxicity on reprogramming
cultures with a cell death up to 60% in the first 4 days. After 7 days cells were
replated on non-replicating murine cells that support reprogramming process. Three
samples of 105 cells each were cultivated for at least 5 weeks in hiPSC media and
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10-cm-wide dishes, resulting in 0, 1, 13 stable clones. Efficiency is calculated as
the number of hiPSC clones over the initial cell number (0, 0.001%, 0.013%, respec-
tively). Transfection process performed in microfluidics resulted extremely cytotoxic
with cell cultures collapsing before 5 days, even with a 1/10 of the concentration used
in standard systems.
Despite the various problems emerged with the previous techniques, the stan-
dard reprogramming revealed the importance of transition steps from adult cell to
a pluripotent phenotype. Cell density, transfection efficiency, morphological changes
were taken into account in order to design the microfluidic protocol.
Since these methods were not satisfactory in our hands we looked for new alter-
natives to be scaled in microfluidics. As proposed in the next paragraph 4.2.1, the
emerging technology of modified mRNAs was studied and implemented.
4.2.1 Emerging modified-mRNAs technology
The 2011 International ISSCR conference on stem cells (Yokohama, Japan. 2011.
isscr.org) offered the great opportunity to discover the emerging reprogramming tech-
nology based on modified RNA messengers (mmRNA) provided by Stemgent, Inc.
(USA). mmRNAs directly encode encode proteins of reprogramming factors and by
their nature are degraded in less then 48 hours from the delivery inside the cell
[9, 14]. A subsequent partnership with Miltenyi biotec, GmbH (Germany) provided
own-developed GMP-grade mmRNAs for reprogramming.
We first assessed the delivery of mmRNAs in microfluidics with a sequence pro-
moting a nuclear-localizing fluorescent protein (nGFP). A cell fraction, 24 hours after
transfection, evidenced fluorescent nuclei and, thus, the possibility of delivering re-
programming factors. We next explored how to increment the transfection efficiency
by altering the ratio of mmRNAs, transfection complex necessary for the delivery
inside cells medium and time of transfection, and by providing non-adsorbent surface
in a microfluidic system (see section 2.8). Transfections are performed by incapsu-
lating mmRNAs in solution within lipid vesicles that in turn are dispersed in an
ad hoc medium for reprogramming (see Appendix F). In order to provide all the
seven mmRNAs encoding the reprogramming factors in the provided kit in the 5 µl
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Table 4.2.1 – Delivery efficiency of nGFP mmRNA reported for various conditions tested.
Medium proportion was reduced from the conventional protocol (0% means pure transfection
complex without PL). An incubation for 4 h revealed optimal for higher nGFP delivery.
Average percentage of nGFP positive cells at 24 h from a single transfection are reported.
Conventional
PL amount
1X mmRNA
single
transfection
Transfection
time
1 h
Transfection
time
2 h
Transfection time
4 h
100% 12% - - -
50% 28% 6% 13% 28%
25% 31% 9% 24% 29%
0% 13% - - -
volume of each microfluidic chamber, we had to reduce the proportion of medium
(Pluriton, PL) of the transfection mix presented in the official protocol (Table 4.2.1).
A 25%-50% of PL volume - compared to standard transfections performed in static
vessels - resulted optimal for repeated delivery of mmRNAs. Starting from the first
transfection, microfluidic was significantly more efficient than standard static proce-
dures (Figure 4.2.1). Although the previous treatment of microfluidic surfaces with
2% w/v Pluronic F-127 for 1 hour gave an higher transfection efficiency, probably
due to the lower adsorption of lipophilic vesicles on PDMS, at this stage, we main-
tained the platform the as simple as possible. Since mmRNAs have an expression
peak after 18-24 hour from the transfection, daily subministration of reprogramming
factors must be performed. Daily transfection a evidenced complete delivery over
the cell population (Figure 4.2.1).
4.3 Strategies for reprogramming and programming at
the microscale
Once verified that it is possible to deliver mmRNAs in microfluidics for days following
a fluorescent reporter, we introduced in the transfection complex all the 7 available
mmRNAs for reprogramming (OCT4, SOX2, KLF-4, c-MYC, LIN-28, NANOG,
nGFP). A comprehensive scheme of the reprogramming apparatus is reported in
Figure 4.3.1.
Standard procedures performed on static vessels follow the following pattern:
(i) target cell isolation, (ii) expansion, (iii) reprogramming, (iv) hiPSC clone isola-
tion, (v) clonal expansion, (vi) characterization and (vii) differentiation in defined
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Figure 4.2.1 – (A) Daily complete reprogramming mmRNAs delivery on BJ cells in mi-
crofluidics with 25% PL. Acquisition was performed at 1, 5, 8 days after the first transfection.
nGFP positive cells increased during culture and morphological changes occured on cells.
(B) Even with a single transfection, microfluidics results more efficient with lower amounts
of mmRNAs compared to medium (MW6) and small (MW96) conventional culture plates.
Figure 4.3.1 – Reprogramming apparatus. Cells are taken from biopsies or established cell
lines and integrated in the microfluidic platform. Liquid handling pumps are controlled by
a LabVIEW software. A reprogramming sequence is proposed on the panel below. After
an initial seeding, repeated transfections were performed for 16 days followed by 15 days of
differentiation.
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cell types. Reducing the minimum requirements to perform a microfluidic repro-
gramming, it should be possible to reduce or eliminate expansion steps and perform
one-shot experiments. In order to recapitulate the standard pattern in microfluidics
and dissect and optimize procedures at the microscale, we planned three different
strategies.
Strategy A: reprogramming in microfluidics, clone isolation and standard expan-
sion and characterization, differentiation. This strategy would clarify the perfor-
mance of microfluidics in the generation of hiPSC. Eventually, clones would be iso-
lated from the chip and expanded with standard procedures to verify the stability of
clones and the differentiation potential.
Strategy B: reprogramming in microfluidics, collection and clones plating on new
chip for differentiation. This strategy avoid the need of clonal expansion. Different
clones are pooled in new chips with free available space to grow and differentiated.
Strategy C: one-step reprogramming with differentiation. This strategy represent
the best option to obtain new defined cell types from the cells of a patient. Patient
cells are reprogrammed in microfluidics and directly differentiated toward desired
cell types to perform assays.
In order to obtain the best performance from our microfluidic chip, we used the
substrates developed in section 3.2.1 and the whole expertise detailed in Chapter 3.
In the next section, the results of evaluated strategies are reported.
4.4 Strategy A: reprogramming at the microscale
Reprogramming. Starting from the basics of the Stemgent’s reprogramming pro-
tocol (available at stemgent.com) we daily transfected cells inside microfluidic chan-
nels. Using the BJ fibroblast cell line model, we evaluated their reprogramming
starting with different seeding densities. In the first five days, normally elongated
cells evolved in more round shapes as seen in standard protocols. At day 12, we
experienced the first bona fide hiPSC colony generated at the microscale (Figure
4.4.1).
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Figure 4.4.1 – hiPSC colony derived in microfluidics. (A) Colony present characteristic
morphological markers such as compact cells, defined edges, well formed-nucleoli. Colony
expanded progressively in 4 days before being processed. (B) Reprogramming efficiency
of BJ cells. Average efficiency in a chip is displayed in blue. Total number of colonies
per channel is displayed in red. Higher seeding densities of BJ cells were more efficient in
producing hiPSC.
Due to the enormous importance of this hallmark, we continued following the
evolution of reprogramming. Best results were obtained with higher cell density
tested. In fact, different other colonies appeared the days later. As evidence by the
plot in Figure 4.4.1, we obtained efficiencies up to 3.2%.
Isolation. We next evaluated how to isolate colonies from each microfluidic chan-
nel. Two strategies were adopted:
• using a biopsy punch, we generated a core through the PDMS rubber and
exposed colonies were dissected and aspirated;
• based on the recent published method [154], we applied a high flow rate in-
side the channels. hiPSC colonies detached preferentially leaving the non-
reprogrammed cell layer on the chip.
Expansion & characterization. hiPSC clones were expanded for several pas-
sages on conventional plates in the presence of non-proliferating murine fibroblasts.
All molecular markers tested proved the effective pluripotency of each clone. Both
random or specific differentiation protocols available in the lab were effective. It can
be argued if microfluidic-derived clones have same characteristics of hiPSC obtained
with conventional procedures.
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Figure 4.4.2 – Microfluidic-derived colonies extraction methods. PDMS rubber was cored
in order to have access to the colony on bottom of the channel (top). Some colonies were
also isolated by shear-stress leaving non reprogrammed cells on the channel (bottom).
Figure 4.4.3 – Characterization of isolated colonies for pluripotency. Immunofluorescence
analysis evidenced standard pluripotency markers (Oct-4, Nanog, SSEA-4, Tra-1-60). Ad-
ditional analysis were performed via RT-PCR, karyotype stability and alkaline phosphatase
assay (right).
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Figure 4.4.4 – Characterization of isolated colonies for differentiation potential. Colonies
cultured on non adhesive wells formed spheroidal clusters that differentiate spontaneously
in the three germ layers that form our body. RT-PCR analysis revealed typical markers
(b-III-tubulin, AFP, aSMA). Immunofluorescence analysis evidenced markers for all germ
layers ectoderm (Tuj-1), mesoderm (brachyury), endoderm (AFP).
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Figure 4.4.5 – HFF-derived hiPSC. Various in situ immunofluorescence assays reveal the
expression of pluripotency markers NANOG, OCT4 an SSEA-4 within compact cell colonies.
4.4.1 Reprogramming of other cells types in microfluidics
HFF fibroblasts were tested to prove the reliability of the microfluidic system. It is
worth to underline that HFF were used at higher passage (P18) compared to fresh
BJ cells. In fact, fresh isolated cells are usually preferred since they are more prone
to undergo a reprogramming process. Reprogramming of HFF in microfluidics gave
clones with efficiencies similar to BJ. In situ characterization of HFF hiPSC clones
is reported in Figure 4.4.5.
A step towards clinics. Since the goal of this thesis is the application of the
developed platform on cells freshly-derived patient’s cells, we studied a non-invasive
way to obtain cells. To obtain fresh fibroblasts, an invasive skin biopsy is normally
required. It has been shown that epithelial cells can be derived from patients by their
isolation from urine and subsequently reprogrammed [36]. Regenerating renal epithe-
lium normally lose few luminal cells that are washed out with urine. Collecting these
cells we were able to introduce and cultivate them in the microfluidic environment
(Figure 4.4.6A-B). Although these cells can be subdivided in two different categories
and one resulted somehow refractory to repeated mmRNA transfections, we were
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Figure 4.4.6 – hiPSC derived from urine cells. (A) Phase contrast of renal epithelial cell
cultured in microfluidics under reprogramming. (B) Relative fluorescence image of nGFP
positive cells carrying the other factors. (C) An emerging compact hiPSC colony from the
epithelial cell layer. (D) A small colony of four hiPSC under expansion and derived from
the dissection of the colony in panel C.
able to generate hiPSC clone freshly derived from a patient (Figure 4.4.6B-D).
The isolation of cells from urine in a totally non-invasive manner and their re-
programming in our microfluidic chip is a paramount milestone for the realization
on an integrated platform for a large-scale screening based on hiPSC derived tissues.
Feeder-free. Since mmRNA protocol requires a co-culture of non-proliferating
cells other than patient’s cells to sustain reprogramming (feeder-cells), we evaluated
the possibility to remove such external cells to simplify the system and to simulate
a clinical-like approach. BJ fibroblasts were solely seeded at higher density in mi-
crofluidic platforms. With a dose-ramping of 100%-75%-50%-25% of conventional
static medium in the first 4 days we allowed cells to sustain factors uptake with a
tolerable stress before applying a full dose. Feeder-free hiPSC colonies were obtained
and showed expression of pluripotency markers.
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Figure 4.5.1 – In situ characterization of hiPSC. Fresh derived colonies inside each channel
have been analyzed for the expression of pluripotency markers after three days from the
latest transfection. A live staining for alkaline phosphatase (AP, Life technologies) was
performed (left). Once AP signal disappeared, cells were fixed (center) and processed for
immunofluorescent analysis (right). The colony in the middle of the channels is positive for
NANOG and OCT-4, nuclei are stained with Hoechst 33342.
4.5 Strategy B: pooling colonies for optimal differentia-
tion
In situ characterization. Once verified that microfluidic-derived hiPSC resulted
in stable pluripotent clones for various expansion passages (at least 12), we verified
the presence of pluripotency factors in fresh derived colonies in situ. As reported in
Figure 4.5.1, it is possible to perform assays directly in the reprogramming channels
and freshly obtained hiPSC express characteristic markers.
Pooling. Since our hiPSC directly express the pluripotent genes, we next isolated
and pooled freshly obtained colonies in new chips without a subclonal expansion
process. This was an required steo since a minimum cell density is required by
available protocols in order to properly induce defined differentiated cell types.
Differentiation. Since mmRNAs reprogramming technique relies on fast (24-48
hours) transient expression of exogenous factors, emerged clones have to express a
stabilized endogenous hiPSC pattern (namely, transcriptome) to proliferate. With
this strategy, we verified that non-expanded colonies are able to generate differen-
tiated cell types. It is possible that the full transcriptome of the same fresh and
expanded clone slightly varies due to the selection process made on the clonal expan-
sion. We are analyzing the actual transcriptome of clones before and after expansion.
If no significant chances are detected, expansion process could be considered if a cell
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Figure 4.5.2 – Specific differentiation of freshly generated hiPSC. Immunofluorescence
assay on chip with red-labeled proteins of terminally differentiated cells, nuclei are stained
in blue. On the left, cardiomyocytes expressing functional troponin proteins, sarcomeric
striatures are present evidencing contractile capabilities. On the right, functional hepatocite-
like cells expressing cytokeratin CK18, actin fibers in green evidence characteristic poligonal
shape of hepatocytes.
bank is required.
In hour hands, freshly derived hiPSC were able to differentiate as much as stan-
dard expanded clones.
4.6 Strategy C: one-step process for reprogramming and
programming
Strategy B was required since the density of rising hiPSC was not enough to perform
a differentiation protocol. We next investigated to increase the reprogramming effi-
ciency and perform differentiation protocols without clonal isolation. This strategy
would allow to obtain particular differentiated cells from a patient’s starting cells in
one-step without isolation or subculturing.
Substrate study. When microfluidic reprogramming was performed, we noticed
that reprogramming efficiency was lower that experienced with a conventional pro-
tocol. Delivered liposomal vesicles used to deliver mmRNAs normally fall by gravity
until they coalesce with cellular membranes. Due to an intrinsic toxic effect of trans-
fections, efficient delivery performed by microfluidics resulted in a high selective
pressure and stress on cells at the bottom. Since chemical functionalization of cul-
ture surface in microfluidics are performed in a finalized chip, adsorption of modified
proteins occured on PDMS. Cells that were able to escape the glass surface tended to
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Figure 4.6.1 – Enhanced reprogramming efficiency in microfluidics. (A) Favoring the cell
interaction with the glass against the PDMS surfaces, transfection efficiency was enhanced
(blue data) and reprogramming yieled up to 44 hiPSC colonies per channel, that equals to
a 16.3% (more than 5 times higher than the standard protocol). (B) Constrast phase image
of a fixed chip after reprogramming. Overimposed image of immunofluorescence analysis for
NANOG positive hiPSC (bynary image in green).
travel side walls and transfer on the roof where mild conditions and low transfection
efficiency can be found. This resulted in a partial and continuous loss of cells that
limited sustained delivery on cell at the bottom.
Substrate optimization/high reprogramming effciency. At this stage, we
reduced the concentration of protein for the long-term functionalization in order to
reduce the adsorption on PDMS and make this surface less appealable for cell growth.
As a remarkable result, we generated up to 44 single colonies in a single channel,
equivalent to a 16.3% of reprogramming efficiency (Figure 4.6.1). This efficiency was
never obtained with the induction of only Yamanaka-like factors and is more than
5-times higher than commercially proposed values (up to 3%).
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Figure 4.6.2 – One-step derivation of adult-like cells from patient’s cells. (A) Random
differentiation of fresh derived hiPSC with aspecific media and protocols. Different cell types
with various morphologies are present in the field. At the bottom, biomolecular RT-PCR
analysis revealed the presence of markers of the three germ layers, indicating the possibility
to generate the entire cellular set of the adult body. (B) Specific cardiac differntiation
at 15 days from the end of reprogramming. Dark and bright culture areas enriched in
cardiomyocyte cells. RT-PCR reveald prominent differentiation in the cardiogenic pathway
with the presence of FLK-1, NKX2.5, cTNT characteristic markers.
Differentiation. After canonical 16 days of daily transfection we cultured emerg-
ing clones for additional 3 days in order to growth against non reprogrammed cells.
Applying differentiation procedures, hiPSC were able to generate the three germ layer
in aspecific medium and matured in functional cardiac cells expressing troponin-T
using a specific protocol (Figure 4.6.2).
4.7 Conclusions
Advantages in substrate development and long-term microfluidic cell culture were
fundamental to approach the reprogramming of human cells at the microscale. The
transition from viral vectors to mmRNA offered a safe and defined approach to deliver
Yamanaka-like factors without the need of forced removal of exogenous material with
a subclonal expansion.
To describe at best the work performed to obtain such result, a list of key features
that has been implemented can be listed:
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Figure 4.7.1 – Scale down of minimum requirements in microfludics. Device area, cells and
reagents needed have been significantly reduced compared to standard procedures.
• defined substrates,
• robust microfluidics,
• clinical-grade mmRNA,
• patient’s non-invasive isolation,
• feeder-free reprogramming,
• scale-down of minimum requirements (Figure 4.7.1),
• increased efficiency,
• one-step reprogramming-programming process,
• fulfilling integration.
Thanks to these a charateristic, our platform has the potential to serve as new tool
for the extended reprogramming of cells derived from hundreds of patients. hiPSC
derived at a population scale can serve the study of both common and rare diseases.
Moreover, the cost reduction of the entire process (Figure 4.7.1) can attract the
pharmaceutical industry in discovery and developing drugs with more cost effective
procedures and avoid non fully predictive animal models before the clinical trials.
Chapter 5
Role of substrates on
reprogramming and hPSC
maintenance.
5.1 Mechanotransduction in reprogramming
In chapter 2, the interplay between cells and their substrate was described. Hydrogels
were optimized for large studies, clinical applications and biosensoring. Moreover,
in chapter 4, substrates and microfluidics were combined for the realization of a
breakthrough reprogramming approach at the microscale.
When the research focus on the study or the production of large quantities of
cells larger systems can be adopter such as the one realized in section 2.5. Since we
are now able to produce hydrogel on large culture vessels the mechanical role of the
matrix in the reprogramming process can be investigated at the larger scale. It have
been evidenced that substrates can have a role in the reprogramming process[24]
and may help in producing large quantities of hiPSC with a reduction of factors,
transfections and time to complete the reprogramming. A matrix with soft stiffness
has been demonstrated to sustain a pluripotent phenotype in mouse embryonic stem
cells without the use of factors normally required on conventional culture system
[22].
Since this research is at the beginning we report in this chapter the early results
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Figure 5.1.1 – Pluripotency and substrate stiffness. (A-C,E) Human PSC lines are cul-
tured on hydrogels with various stiffness or compositions. (A) Functionalizzation of poly-
acrylamide hydrogel allow proper attachment of PSCs. (B) Reducing the substrate stiffness
(~1 kPa), PSCs grow in more compact colonies compared to stiff substrates. (C) Poly-
acrylamide hydrogel with same nominal stiffness are functionalized with hyaluronic acid
(left) and fibronectin (right). HA leads to significantly more dense cell colonies optimal for
PSCs maintenance. (D) Hydrogels of pure methacrylated hyaluronic acid allow isotropic
grow of hPSC.
on mechanotransduction implications of pluripotency. Before performing a repro-
gramming on substrates, we investigated the main differences between adult cells
and hPSC on soft substrates.
Mechanotransduction in hPSC. In order to assess any implication of mechano-
pathways on hPSC, we first seeded our hiPSC and hES on hydrogel at various stiff-
nesses (0.7-80 kPa) (Figure 5.1.1A). We did not not recognized any preferential
stiffness for hPSC to maintain the expression of pluripotency marker OCT-4 in the
presence of a poly-acrylamide substrate, a Matrigel coating and standard culture
media for hPSC (Figure 5.1.1B). In each case, OCT-4 and SOX2 were expressed
in the large majority (>95%) of cells after 6 days. Similar data were confirmed by
Schaffer and colleagues [69]. However, within each colony, cell density was lower on
stiff hydrogels (80 kPa) compared to softer ones (0.7 kPa) (Figure 5.1.1B). As evi-
denced in Chapter 1, compact colonies with defined edges are a key characteristics
of hPSC.
Matrigel (BD biosciences) is an extracellular matrix mixture extracted from mice
and therefore it is not defined and subjected to variability. Thus,we wanted to
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understand the role of the ECM coating comparing the morphology of hPSC cultured
on an poly-acrylamide substrate at 4 kPa. When we functionalized the gel with
hyaluronic acid described in Chapter 2, we obtained compact colonies compared to
the one cultured on fibronectin. Not surprisingly, when we adopted a hydrogel based
on pure methacrylated hyaluronic acid used in a 3D application (2.6) with a bona fide
stiffness of <10 kPa, we obtained well defined circular colonies with compact cells.
This result recapitulate the previous findings present in literature [98, 123–125].
Biochemical composition of the ECMmatrix is thus a key player of hPSC shaping.
Despite matrix stiffness has not evidenced a role in the expression of characteristic
pluripotency markers, it affects significantly the cell density within the colony. Since
a tight contact of hPSC is essential for theit survival an expansion as pluripotent cells,
matrix stiffness can have a role in pluripotency maintenance and reprogramming
process. As reported in Appendix B and A, higher cell density also affects the single
cell shape and its iternal architecture, leading to mechanotransduction pathways that
can trigger certain biological functions normally repressed.
Mechanotransduction in reprogramming. It has been recently shown in a
recent publicatio that substrate topology can affect the expression of certain DNA-
binding proteins (histones) through mechanotransduction pathways [8]. Histone ac-
tivity and the accessibilty of certain regions of the DNA are known fundamental
barriers in the reprogramming process [51, 52, 155].
Since we had the evidence that topology, stiffness and chemical composition of
the substrate can act in a common circuit acting on internal cellular components [156,
157], we wanted to perform a first experiment by reprogramming adult fibroblasts.
As shown in Figure 5.1.2A on the left, we recapitulated the mechano-associated
transition in cell shape of adult fibroblast comparing the shape of adapted single-cell
hES cultured in standard conditions. The normalized ratio between cell perimeter
and area (circularity) was used as a shape descriptor of cells. Fibroblasts cultured
on ⇠1 kPa poly-acrylamide hydrogels evidenced a circularity similar to hPSC. We
next performed a reprogramming experiment using poly-acrylamide hydrogels devel-
oped in standard poly-styrene culture vessels 2.5. We used a 1 kPa hydrogel, a 12
kPa (as a stiffness control) and murine fibroblasts (MEF) as standard support for
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Figure 5.1.2 – Reprogramming and substrate stiffness. (A) BJ fibroblast cells progres-
sively round on softer hydrogels (left image). Circularity is 4⇡(⇡r2)/(2⇡r)2 with r the cell
radius. Differentiated fibroblast on 1 kPa have a circularity similar to hPSC. Also, fibroblast
evidenced an high cell area / nucleos area ratio, similar to hPSC. Single cells are presented
at the bottom with nuclei stained in blue with Hoechst 33342. (B) BJ fibroblasts were
infected with a Sendai virus to promote the reprogramming process and transferred either
on conventional dishes (MEF) or on poly-acrylmaide hydrogels at different stiffness (1 and
12 kPa). Cell area was used as a shape descriptor and analyzed for 45 days. After 10 days,
BJs on MEF undergo a remarked reduction in cell area, which is readily observable during
the first days of culture on 1 kPa substrates.
reprogramming experiments with viral vectors. Yamanaka’s factors were delivered
using the commercially available Sendai virus. Cells on softer hydrogel evidenced
high circularity and reduced cell area, with a prominent high ratio between cell area
and nucleus area (Figure 5.1.2A-B). In particular cell area followed a common trend
for the three samples (Figure 5.1.2B). As expected in conventional reprogramming,
cells undergo a phenotypical and morphological transition (Mesenchymal-Epithelial
Transition, MET) with rounded and smaller cells. Ten days after the transfection,
cell reduce significantly their ashesion area. Cell cultured on 12 kPa hydrogels were
less spread from the beginning and followed the same trend on MEF during the 45
days of reprogramming. Cells cultured on 1 kPa hydrogel maintained a reduce and
round adhesion area throughout the whole experiment.
Although no hiPSCs were generated with soft hydrogels, it must be considered
that the reprogramming on MEF was not efficient, generating only 1 single stable
hiPSC clone (see also 4.2.1). Therfore, at this stage, we can not exclude that sub-
strates may enhance the reprogramming efficiency. A recent report has evidenced
that soft substrates can support the reprogramming process initiated by viral vectors
[23].
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Moreover, the maintenance of a high growth rate of adult stem cells on softer
hydrogels (⇠1 kPa or below) is still an open issue due to the inteference of newly
discovered mechanotranduction pathways (Appendix A, B).
These evidences indicate that soft hydrogel can readily promote a cell shape that
is required to complete the reprogramming process in standard conditions. Further
experiments have been planned to reveal new insights on the mechano-associated
reprogramming process. In order to improve the statistical analysis and experimental
throughput, we will adopt the mmRNA reprogramming technology seen in Chapter
4.
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5.2 Conclusions
Mechanotransduction behaviors have been extensively proved on adult cells espe-
cially when focusing on their differentiation and maturation process.
The role of mechano-associated phenomena in controlling hPSC biology is still
poorly understood. In this chapter we have described the early studies we performed
to understand the role of substrate mechanics on hPSC and especially on the repro-
gramming process. As evidendeced in Appendix A and B, since linage specific cells
can activate mechanotransduction processes, we wanted to dissect the role of sub-
strates in hPSC maintenance. Although ECM composition clearly proved to guide
hPSC phenotype, substrate stiffness had an impact at least on hPSC conformation
and colony organization. When we looked at the transition from an adult phenotype
towards a pluripotent target on different substrates, cell morphological descriptors
evidenced a common pattern compared to conventional reprogramming substrates.
In particular, softer hydrogel can istantly guide single-cells under reprogramming to
a defitive cell shape transition mimicking a late strandard reprogramming phase.
Since soft gels induce a mechano-responsive behavior reducing the replication ac-
tivity, cells under reprogramming with a reduced hPSC-like shape will be stimulated
in order to elicit an important reorganization of DNA activity in the early replication
stages.
Chapter 6
Perspectives for a human body on
a chip
The engineering of substrates for biological applications (Chapter 2) introduced to
new insights of biological pathways and offered new tools for the in vitro and in vivo
studies and applications. The development of cell culture in microfluidic channels
(Chapter 3) has reveald that a comprehensive reorganization of current culture pro-
tocols is necessary in order to take an advantage on the phenomena occurring at
the microscale. In order to accomplish sofisticated procedures for the reprogram-
ming process at the microscale, a deep integration of the achievements obtained in
substrate development and microfluidic cell cultures was fundamental.
Various groups are proposing micro-engineered systems that allow the realization
of challenging in vitro tissues and organoids [158]. Due to the extreme complexity in
reproducing organs on a chip, multidisciplinary knowledge and integration in biology,
chemistry, physics and engineering is indispensable.
In this perspective, we aim at developing in vitro tools for a better description of
biological phenomena and for the realization of biomimetic environments for func-
tional physiological and pathological tissues and organoids.
In the following paragraph, we propose a proof on concept that integrates some of
the techniques developed in this thesis for the development of an analytical device in
diabetes studies. Muscles are a major tissue implicated in diabetes[115] and healthy
and disease tissues can respond in different ways to physiological stimuli or drugs.
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The generation of highly differentiated muscle fibers in a microfluidic chip can result
in a platform with high temporal and spatial resolution for stimuli delivery. Since we
demonstrated that optimal myotube differentiation occurs on aligned cell patterns
[108], it is crucial to transfer topological feautures in finalized microfluidic platfrorms.
Here we propose an effective and simple method to promote the differentiation
of muscle precursors in patterned areas within a microfluidic culture chamber.
In situ tolopological control of microfluidic environments. When cells are
chaotically distributed, overall population is normally investigated to individuate a
biological behavior and it can be extremely difficult to dissect different phenomena
occurring in various sub-populations.
Topological control of cell cultures reported in section 2.7 can offer advantages
to screen the biodiversity over a common cell line and distill biological analysis from
biased phenomena. Open systems such as a glass coverslip or hydrogel film offer
an easy access to physically print the surface with adhesive patterns or introduce
repellent features. Sealed systems such microfluidic chips only allow an indirect
access to the main chamber through inlet and outlet ports, making impossible any
selective geometrical treatment.
Thanks to the optical transparency and limited thickness of of the platform it can
be possible to selectively photo-activate the surface with UV-light and a photomask.
Adjusting the dose of UV, we were able to selectively attach linear poly-acrylamide
chains on the silanized glass. Cells adhered on non-exposed areas presenting the
acryl terminus of the silane, eventually coated with ECM proteins.
Since defined geometries can alter cell behavior, we analyzed the efficacy of mi-
cropatterned aligned lanes in promoting myogenesis. When myoblasts were seeded
in micropatterned chips, they distributed and adhered in non-repellent areas. When
they reached confluence after few days, packed cells aligned along the major axis of
each lane and differentiated in mature myotubes.
These system are being used to analyzed the expression profiles of engineered
myotubes subjected to conditioned media from healthy and diabetic patients.
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Figure 6.0.1 – Cell patterns inside a microfluidic chip. (A) Adhesive/repellent patterns
were obtained through direct patterning technique reported in 2.7. Myoblast cells adhere
on 300 µm wide lanes and progressively align along the major axis and differentiate in
myotubes. (B) Each channel can be fixed and stained to perform assays. Here it is reported
the expression of myosin protein (MHC), a major functional cytoskeletal component of the
muscle. The immunofluorescent assay (left magnifications) reveals a defined sarcomeric
architecture with repeated bands of MHC.

Conclusions
This work focused on the development of a reprogramming platform for the high-
throughput derivation of human induced pluripotent stem cells (hiPSC).
Since hiPSC are highly sensitive cells and their derivation is subject to various
intrinsic and extrinsic factors, the regulation of internal pathways and cell behav-
ior, and the tight control of environmental culture conditions are crucial aspects.
Substrates and microfluidic technology were used in order to provide a microscaled
integrated solution for the reprogramming process.
Substrate development focused on the realization of cell culture supports with
tunable properties such as stiffness, chemistry and topology. First, we optimized cur-
rent available protocols to produce biocompatible hydrogels based on poly-acrylamide
with a tunable stiffness mimicking the physiological range of in vivo tissues. Consis-
tent large-scale experiments with over 5000 used samples served for the identification
of new cell behaviors associated with the mechanical properties of the culture sub-
strate. By changing the stiffness of the hydrogel, cell can dramatically change its
shape and internal architecture. Crucial proliferation-associated factors YAP/TAZ
were either blocked or activated overriding previously known biochemical pathways.
The same high-throughput technology was applied to a subsequent study in order
to investigate the mechano-associated players that transduce the environmental me-
chanical cues into internal biochemical regulations and cell behaviors. Structural
and enzymatic mediators were found to be responsible of the mechanical checkpoint
of YAP/TAZ. Altogether, these studies evidenced a fundamental role of the extra-
cellular matrix in determining the cell behavior and fate.
Poly-acrylamide hydrogels have also been used to realized biosensors within a
soft compliant cell culture substrate optimal for muscle cell differentiation. Chemical
85
86 CHAPTER 6. PERSPECTIVES FOR A HUMAN BODY ON A CHIP
functionalization of poly-styrene cell culture vessels was performed to integrate soft
hydrogels for large-scale studies and analysis.
Biodegradable hydrogels based on hyaluronic acid were developed in order to pro-
vide a biomimetic environment for in vivo applications. Micro-engineered bundles
of aligned muscle fibers were generated in vitro on functionalized gelatin surfaces.
The hydrogel construct was integrated in ablated mice muscles to evaluate its re-
generation capability. Although a faster degradation was necessary to allow the full
viability and integration of engineered fibers, muscle regeneration was elicited by the
biodegradable hydrogel construct and further improvements are being applied.
The knowledge on substrate development and control of cell behavior were trans-
ferred on microfluidic cell culture environments. First, cell cultures on standard
supports were integrated in an ad hoc microfluidic platform to prove in our hand
the potential of an efficient delivery of biological species inside cells. Second, cell
cultures were directly integrated in microfluidic channels providing a stable adhesive
surface treatment for long-term cell cultures.
In order to provide also a favorable soluble environment, a liquid handling ma-
nagement software was realized to allow automated delivery of culture medium over
cells. The study of an optimal strategy to perform robust long-term microfluidic
cultures revealed that a periodic fast pulse of fresh media followed by a prolonged
pause allows the homogeneous culture of different cell types with correct phenotype.
Having developed a substrate-integrated microfluidic technology for long-term
cell cultures, we delivered on human cells modified messenger RNAs (mmRNA) trans-
lating for the reprogramming factors. The delivery of a mRNA encoding a fluorescent
protein revealed that microfluidic can efficiently introduce exogenous material in cells
to be reprogrammed.
hiPSC were obtained at the microscale from different human biopsies and their
characterization revealed the full potential to derive all somatic cell type present in
our body. Since our platform dramatically reduces the minimum requirements for a
single reprogramming, fresh hiPSC can be directly and effectively differentiated in
a one-step process towards functional adult cell types valuable to perform in vitro
screenings on human tissues. This results open new research perspectives extendible
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at a hundreds of people. New drugs could be developed with a cost-effective approach
for both common and rare diseases.
Concluding, the research on substrates and microfluidic cell culture technology
led to the definition of an integrated platform to control the behavior of adult human
cells. Passing through the efficient generation of hiPSC at the microscale, we gen-
erated new functional cell types in a one-step process usable for high-value human
assays at the population scale.
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Role of YAP/TAZ in
mechanotransduction
Sirio Dupont1, Leonardo Morsut1, Mariaceleste Aragona1, Elena Enzo1, Stefano
Giulitti2, Michelangelo Cordenonsi1, Francesca Zanconato1, Jimmy Le Digabel3,
Mattia Forcato4, Silvio Bicciato4, Nicola Elvassore2 and Stefano Piccolo1
1. Department of Histology, Microbiology and Medical Biotechnologies, University
of Padua School of Medicine, viale Colombo 3, 35131 Padua, Italy.
2. Department of Chemical Engineering (DIPIC), University of Padua, via Marzolo
9, 35131 Padua, Italy.
3. Laboratoire Matière et Systèmes Complexes (MSC), Université Paris Diderot,
and CNRS, UMR 7057, Paris, France.
4. Center for Genome Research, Department of Biomedical Sciences, University of
Modena and Reggio Emilia, via G. Campi 287, 41100 Modena, Italy.
Nature
Volume 474(7350): 179–183
10.1038/nature10137
105
106 APPENDIX A. ROLE OF YAP/TAZ IN MECHANOTRANSDUCTION
A.1 Summary
Cells perceive their microenvironment not only through soluble signals but also in
term of physical and mechanical cues, such as extracellular matrix (ECM) stiffness
or confined adhesiveness. By mechanotransduction systems, cells translate these
stimuli into biochemical signals controlling multiple aspects of cell behavior, in-
cluding growth, differentiation and cancer malignant progression; but how rigidity
mechanosensing is ultimately linked to activity of nuclear transcription factors re-
mains poorly understood. Here we report the identification of the Yorkie-homologues
YAP and TAZ as nuclear relays of mechanical signals exerted by ECM rigidity and
cell-shape. This regulation requires Rho activity and tension of the acto-myosin cy-
toskeleton but is independent from the Hippo/LATS cascade. Crucially, YAP/TAZ
are functionally required for differentiation of mesenchymal stem cells induced by
ECM stiffness and for survival of endothelial cells regulated by cell geometry; con-
versely, expression of activated YAP overrules physical constraints in dictating cell
behavior. These findings identify YAP/TAZ as sensors and mediators of mechanical
cues instructed by the cellular microenvironment.
A.2 Introduction
Physical properties of the extracellular matrix (ECM) and mechanical forces are
integral to morphogenetic processes in embryonic development, defining tissue ar-
chitecture and driving specific cell differentiation programs [1]. In adulthood, tissue
homeostasis remains dependent on physical cues, such that perturbations of ECM
stiffness - or mutations affecting its perception - are causal to pathological condi-
tions of multiple organs, contributes to aging and cancer malignant progression [2].
Mechanotransduction enables cells to sense and adapt to external forces and phys-
ical constraints [3,4]; these mechanoresponses involve the rapid remodeling of the
cytoskeleton, but also require the activation of specific genetic programs. In partic-
ular, variations of ECM stiffness or changes in cell shape caused by confining the
cell’s adhesive area have profound impact on cell behavior across multiple cell types,
such as mesenchymal stem cells [5,6], muscle stem cells [7] and endothelial cells [8].
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The nuclear factors mediating the biological response to these physical inputs remain
incompletely understood.
A.3 Results
A.3.1 ECM stiffness regulates YAP/TAZ activity
To gain insight into these issues, we asked if physical/mechanical stimuli conveyed
by ECM stiffness actually signal through known signaling pathways. For this, we
performed a bioinformatic analysis on genes differentially expressed in mammary ep-
ithelial cells (MEC) cultivated on ECM of high vs. low stiffness [9]. Specifically, we
searched for statistical associations between genes regulated by stiffness and gene sig-
natures denoting the activation of specific signaling pathways (Supplementary Fig. 2,
Supplementary Table 1 and see Methods). We included signatures of MAL/SRF and
NF-kB as these factors translocate in the nucleus in response to changes in F-actin
polymerization and cell stretching [10]. Strikingly, only signatures revealing activa-
tion of YAP/TAZ transcriptional regulators emerged as significantly overrepresented
in the set of genes regulated by high stiffness (Supplementary Fig. 2). To test if YAP
(Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding mo-
tif, also known as WWTR1) activity is regulated by ECM stiffness, we monitored
YAP/TAZ transcriptional activity in human MEC cultured on fibronectin-coated
acrylamide hydrogels of varying stiffness (elastic modulus ranging from 0.7 to 40
kPa, matching the physiological elasticities of natural tissues6). For this, we assayed
by real-time PCR two of the best YAP/TAZ regulated genes from our signature,
CTGF and ANKRD1. The activity of YAP/TAZ in cells cultured on stiff hydrogels
(15-40 kPa) was comparable to that of cells grown on plastics, whereas culturing cells
on soft matrices (in the range of 0.7-1 kPa) inhibited YAP/TAZ activity, to levels
comparable to siRNA-mediated YAP/TAZ depletion (Fig.1a and data not shown).
We confirmed this finding in other cellular systems, such as MDA-MB-231 and HeLa
cells, where we used a synthetic YAP/TAZ-responsive luciferase reporter (4xGTIIC-
lux) as direct read-out of their activity (Fig. 1a and Supplementary Fig. 4). Next,
we assayed endogenous YAP/TAZ subcellular localization; indeed, their cytoplas-
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mic relocalization has been extensively used as primary read-out of their inhibition
by the Hippo pathway or by cell-cell contact (Supplementary Fig. 5 and Ref [11]).
By immunofluorescence on MEC and human mesenchymal stem cells (hMSC, an
established non-epithelial cellular model for mechanoresponses5,6), YAP/TAZ were
clearly nuclear on hard substrates but became predominantly cytoplasmic on softer
substrates (Fig. 1b, Supplementary Fig. 6 and 7). Collectively, these data indicate
that YAP/TAZ activity and subcellular localization are regulated by ECM stiffness.
A.3.2 YAP/TAZ are regulated by cell geometry
It is recognized that changes in ECM stiffness impose different degrees of cell spread-
ing [6,12]. We thus asked whether cell spreading is sufficient to regulate YAP/TAZ.
To this end, we used micropatterned fibronectin islands of defined size, on which cells
can spread to different degrees depending on the available adhesive area8. On these
micropatterns, the localization of YAP/TAZ changed from predominantly nuclear in
spread hMSC cells, to predominantly cytoplasmic in cells on smaller islands (Fig.
1c). Of note, the use of single-cell adhesive islands rules out the possibility that
cell-cell contacts could be involved in YAP/TAZ relocalization. We confirmed these
results using human lung microvascular endothelial cells (HMVEC, Fig. 1d), that
are well known to regulate their growth according to cell shape8. Cells seeded on stiff
hydrogels or large islands display an increased cell spreading but, at the same time,
experience a broader cell-ECM contact area. To test if YAP/TAZ are regulated by
cell spreading irrespectively of the total amount of ECM, we visualized YAP/TAZ
localization in hMSC grown on the tip of closely arrayed fibronectin-coated micropil-
lars [12]: on these arrays, cells stretch from one micropillar to another, and assume
a projected cell area comparable to cells plated on big islands (3200 µm2 on average,
Fig. 1e); however, in these conditions, the actual area available for cell/ECM inter-
action is only about 10% of their projected area (300 µm2 on average, corresponding
to the smallest islands used in Fig. 1c). YAP/TAZ remained nuclear on micropil-
lars (Fig. 1e), indicating that YAP/TAZ are primarily regulated by cell spreading
imposed by the ECM.
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Figure A.3.1 – YAP/TAZ are regulated by ECM stiffness and cell shape. a, Real-
time PCR analysis in MCF10A cells (CTGF and ANKRD1, coloured bars) and luciferase
reporter assay in MDA-MB-231 cells (43GTIIC-lux, black bars) to measure YAP/TAZ tran-
scriptional activity. Cells were transfected with the indicated siRNAs (siCo., control siRNA;
siYZ1 and siYZ2, two YAP/TAZ siRNAs; see Supplementary Fig. 3) and grown on plastic,
or plated on stiff (elastic modulus of 40 kPa) and soft (0.7 kPa) fibronectin-coated hydrogels.
Data are normalized to lane 1. n = 4. b, Confocal immunofluorescence images of YAP/TAZ
and nuclei (TOTO3) in human mesenchymal stem cells (MSC) plated on hydrogels. Scale
bars, 15 µm. Graphs indicate the percentage of cells with nuclear YAP/TAZ. (n = 3). c,
On top: grey patterns show the relative size of microprinted fibronectin islands on which
cells were plated. Outline of a cell is shown superimposed to the leftmost unpatterned area
(Unpatt.). Below: confocal immunofluorescence images of MSC plated on fibronectin islands
of decreasing sizes (mm2). Scale bars, 15 µm. Graph provides quantifications. (n = 8).
See also Supplementary Fig. 8. d, Confocal immunofluorescence images of YAP/TAZ in
HMVEC plated as in c. Scale bars, 15µm. See also Supplementary Fig. 9. e, On top: grey
dots exemplify the distribution of fibronectin on micropillar arrays, shown superimposed
with the outline of a cell. Below: representative immunofluorescence of YAP/TAZ in MSC
plated on rigid micropillars. Scale bars, 15µm. Graphs, quantification of the projected
cell area, total ECM contact area, and nuclear YAP/TAZ in MSC plated on unpatterned
fibronectin, micropillars and 300 mm2 islands. (n = 4). All error bars are s.d. (*P < 0.05;
**P < 0.01; Student’s t-test is used throughout). Experiments were repeated n times with
duplicate biological replicates.
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A.3.3 YAP/TAZ sense cytoskeletal tension
We then considered that cell spreading entails activation of the small GTPase Rho
that, in turn, regulates the formation of actin bundles, stress fibers and tensile ac-
tomyosin structures [2,3]. Indeed, cells on stiff ECM or big islands displayed more
prominent stress fibers compared to those plated on soft ECM or small islands (Sup-
plementary Fig. 9 and 10). As shown in Figure 2a, we found that Rho and the actin
cytoskeleton are required to maintain nuclear YAP/TAZ in hMSC. As a control,
inhibition of Rac1-GEFs, or disruption of microtubules, did not alter YAP/TAZ
localization (Fig. 2a). Similar results were obtained also in HMVEC and MEC
(not shown). Crucially, inhibition of Rho and of the actin cytoskeleton also in-
hibited YAP/TAZ transcriptional activity, as assayed by expression of endogenous
target genes (Fig. 2b) and by luciferase reporter assays (Fig. 2c). Conversely,
triggering F-actin polymerization and stress fibers formation by overexpression of
activated Diaphanous promoted YAP/TAZ activity (Supplementary Fig. 12). We
then asked whether YAP/TAZ are regulated by the ratio of monomeric/filamentous
actin, as others observed for MAL/SRF13. To increase monomeric G-actin, we over-
expressed the R62D mutant actin13, but this was insufficient to inhibit YAP/TAZ
(Fig. 2c). Moreover, increasing the amount of F-actin either by overexpressing the
F-actin stabilizing V159N actin mutant or by serum stimulation [13] had no effect
on YAP/TAZ activity (Supplementary Fig. 13) or nuclear localization (data not
shown). As a control, in the same experimental set-up, MAL/SRF activity was
instead clearly modulated (Supplementary Fig. 14). Taken altogether, these data
indicate that Rho and stress fibers, but not F-actin polymerization per se, are re-
quired for YAP/TAZ activity. Cells respond to the rigidity of the ECM by adjusting
the tension and organization of their stress fibers, such that cell spreading is accom-
panied by increased pulling forces against the ECM3,6,12. By inhibition of ROCK
and non-muscle myosin (NMM-II)4,6, we found that cytoskeletal tension is required
for YAP/TAZ nuclear localization (Fig. 2d) and activity (Fig. 2e and Supplementary
Fig. 16). Of note, YAP/TAZ exclusion caused by these inhibitions is an early event
(occurring within 2 hours) that can be uncoupled from destabilization of stress fibers
(see Supplementary Fig. 17). By comparison, the activity of MAL/SRF was only
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marginally affected by the same treatments (Supplementary Fig. 18). To address
more directly the relevance of cell-generated mechanical force without using small-
molecule inhibitors and irrespectively of the surface properties of the hydrogels, we
compared rigid vs highly elastic micropillars [12]; on the elastic substrate, cytoplas-
mic localization of YAP/TAZ was clearly increased (Fig. 2f). Collectively, the data
indicate that YAP/TAZ respond to cytoskeletal tension. We also tested if inhibition
of YAP/TAZ occurs by entrapping YAP/TAZ in the cytoplasm or by promoting their
nuclear exclusion. As shown in Supplementary Fig. 20a, blockade of nuclear export
with LeptomycinB rescued nuclear localization of YAP/TAZ in hMSC treated with
cytoskeletal inhibitors, suggesting that YAP/TAZ keeps shuttling between cytoplasm
and nucleus irrespectively of cell tension, and that the presence of a tense cytoskele-
ton promotes their nuclear retention. Moreover, YAP/TAZ relocalization was rapid
(occurring in as little as 30 min with LatrunculinA), reversible after small-molecule
washout (Supplementary Fig. 20b), and insensitive to inhibition of protein synthesis
with cycloheximide (data not shown), suggesting a direct biochemical mechanism.
A.3.4 Mechanical cues act independently from Hippo
YAP and TAZ are the nuclear transducers of the Hippo pathway [14]. In several
organisms and cellular set-ups, activation of the Hippo pathway leads to YAP/TAZ
phosphorylation on specific serine residues; in turn, these phosphorylations inhibit
YAP/TAZ activity through multiple mechanisms, including proteasomal degrada-
tion [14]. Intriguingly, similar to Hippo activation by cell-cell contacts (Fig. 3a),
TAZ protein was also degraded by culturing MEC cells on soft matrices (Fig. 3b) or
by treatment with inhibitors of Rho, F-actin and actomyosin tension (Fig. 3c and
Supplementary Fig. 21). Similar results were obtained with hMSC and HMVEC
(Supplementary Fig. 22 and data not shown). Is then the Hippo cascade responsible
for YAP/TAZ inhibition by mechanical cues? Several evidences indicate this is not
the case. First, we noted that phosphorylation of YAP on serine 127, a key target
of the LATS kinase downstream of the Hippo pathway [15], was not increased upon
treatment of hMEC and hMSC with cytoskeletal inhibitors (Fig. 3c and Supple-
mentary Fig. 22), at difference with its regulation by high confluence (see Fig. 3a).
112 APPENDIX A. ROLE OF YAP/TAZ IN MECHANOTRANSDUCTION
Figure A.3.2 – YAP/TAZ activity requires Rho and tension of the actin cy-
toskeleton. a, Confocal immunofluorescence images of YAP/TAZ in MSC treated with
the Rho inhibitor C3 (3 µgml 1), the F-actin inhibitor latrunculin A (Lat.A, 0.5 µgml 1),
the Rac1-GEFs inhibitor NSC23766 (100 µgml 1) or the microtubule inhibitor nocoda-
zole (Noco., 30 µgml 1). Scale bars, 15 mm. Graph provides quantifications (n = 10).
See also Supplementary Fig. 11. b, Real-time PCR of MCF10A treated with cytoskeletal
inhibitors as in a. Data are normalized to untreated cells (Co.) (n = 4). c, Luciferase as-
say for YAP/TAZ activity in HeLa cells transfected with the indicated expression plasmids
(Co. is empty vector, actin R62D encodes for a mutant unable to polymerize into F-actin)
and treated with latrunculin A (n = 4). Similar effects were observed in MDA-MB-231
(not shown). d, Confocal immunofluorescence images of MSC treated with the ROCK in-
hibitor Y27632 (50 µgml 1), or the non-muscle myosin inhibitor blebbistatin (Blebbist., 50
µgml 1). Scale bars, 15 µm. Graph provides quantifications (n = 9). See also Supple-
mentary Fig. 15. e, Luciferase activity of the YAP/TAZ reporter in HeLa treated as in d.
(n = 4). f, Confocal immunofluorescence images of MSC plated on arrays of micropillars
of different rigidities. On rigid micropillars (black lines) cells develop cytoskeletal tension
(blue arrow) by pulling against the ECM (orange arrow); cells bend elastic micropillars
and develop reduced tension exemplified by reduced size of the arrows. Scale bars, 15 µm.
Graph provides quantifications (n = 2). See also Supplementary Fig. 19. All error bars are
s.d. (*P < 0.05; **P < 0.01). Experiments were repeated n times with duplicate biological
replicates.
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Second, depletion of LATS1 and LATS2 (see Fig. 3f and Supplementary Fig. 23 for
positive controls) had marginal effect on YAP/TAZ inactivation by mechanical cues,
as judged by: i) YAP/TAZ nuclear exit induced by micropatterns or cytoskeletal in-
hibition in hMEC, hMSC or HMVEC (Fig. 3d, Supplementary Fig. 24, 25 and data
not shown); ii) TAZ degradation (Fig. 3e); iii) endogenous target gene expression in
cells plated on soft hydrogels (Fig. 3f) or treated with LatrunculinA (Supplemen-
tary Fig. 26). Finally, we compared wild-type or LATS-insensitive 4SA [16] TAZ
in MDA-MB-231 depleted of endogenous YAP/TAZ and reconstituted at near-to-
endogenous YAP/TAZ activity levels with siRNA-insensitive mouse TAZ (mTAZ)
vectors. As shown in Fig. 3g, both wild-type (WT) and 4SA mTAZ remain sensitive
to mechanical cues. Further supporting these results, we found that MDA-MB-231
cells are homozygous mutant for NF2/merlin (Supplementary Fig. 27), an essential
component of the Hippo cascade [14]. Collectively, these data suggest that LATS
phosphorylation downstream of the Hippo cascade is not the primary mediator of
mechanical/physical cues in regulating YAP/TAZ activity. We then asked if me-
chanical cues regulate YAP/TAZ not only in isolated cells, but also in confluent
monolayers, when cells reorganize their shape and structure and engage in cell-cell
contacts, leading to activation of Hippo/LATS signaling11. We first explored the
effects of cell confluence in a simplified experimental set-up, namely in MCF10A
cells rendered insensitive to Hippo activation by depletion of LATS1/2; in these con-
ditions, Rho and the cytoskeleton remain relevant inputs to support TAZ stability
(Supplementary Fig. 28). Moreover, in parental MCF10A, plating cells at high
confluence cooperate with soft hydrogels in inhibiting YAP/TAZ activity (Fig. 3h).
Thus, mechanical cues and Hippo signaling represent two parallel inputs converging
on YAP/TAZ regulation.
A.3.5 YAP/TAZ mediate cellular mechanoresponses
Data presented so far indicate YAP and TAZ as molecular “readers” of ECM elasticity
and cell geometry; but are YAP/TAZ relevant to mediate the biological responses to
these mechanical inputs? An appropriate cellular model to address this question are
hMSC, that can differentiate into osteoblasts when cultured on stiff ECM, mimicking
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Figure A.3.3 – ECM stiffness and cell spreading regulate YAP/TAZ indepen-
dently of the Hippo pathway. a–c, Immunoblotting for the indicated proteins in
MCF10A under the following conditions: a, plating on plastic at low (sparse) or high (dense)
confluence; b, plating on stiff (40 kPa) or soft (0.7 kPa) hydrogels; c, untreated (Co.) or
treated with C3 and latrunculin A (Lat.A). P-S127 is phospho-YAP. d, Quantification of
nuclear YAP/TAZ in MSC transfected with control or LATS1/2 siRNA A (siLATS A) and
plated on microprinted islands of different size (n = 4). Similar results were obtained with
HMVEC (not shown). e, Immunoblotting from MSC cells transfected with the indicated
siRNAs (Co., control siRNA; L, LATS1/2 siRNA A), plated on plastic and treated with C3
(0.5 or 3 µgml 1). Similar results were obtained by using blebbistatin or latrunculin A,
or by treating HMVEC and MCF10A (not shown). f, Real-time PCR analysis of MCF10A
transfected with the indicated siRNAs and cultured on hydrogels. Data are normalized to
the first lane (n = 3). g, Luciferase assay in MDA-MB-231 transfected as indicated and
treated with latrunculin A (Lat.A) or replated on soft hydrogels. (n = 8). h, RT– PCR
of MCF10A grown under sparse or confluent (dense) conditions on the indicated hydrogels.
Data are normalized to the first lane (n = 2). All error bars are s.d. (*P < 0.05; **P <
0.01). Experiments were repeated n times with duplicate biological replicates.
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the natural bone environment, while on soft ECM - or small islands - they differenti-
ate into other lineages, such as adipocytes [5,6]. A similar case applies to endothelial
cells, that respond differently to the same soluble growth factor by proliferating,
differentiating or involuting according to the degree of cell spreading against the
surrounding ECM8. We hypothesized that cell fates induced by stiff ECM and large
islands (i.e. where YAP/TAZ are active) should require YAP/TAZ function and,
conversely, cell fates associated to soft ECM and small islands (where YAP/TAZ are
inhibited) should require their inactivation. In line with this hypothesis, osteogenic
differentiation induced in hMSC on stiff ECM was inhibited upon depletion of YAP
and TAZ, and a similar inhibition was achieved either by culturing cells on soft ECM
or by incubation with C3 (Fig. 4a, b). We also monitored adipogenic differentiation,
a fate normally not allowed on stiff ECM; strikingly, YAP/TAZ knockdown enabled
adipogenic differentiation on stiff substrates, thus mimicking a soft environment (Fig.
4c and Supplementary Fig. 30). In the case of HMVEC, cells plated on small islands
undergo apoptosis, while cells on bigger islands proliferate, as assayed by TUNEL
staining and BrdU incorporation, respectively8. Upon YAP/TAZ depletion, cells on
bigger islands behaved as if they were on small islands; this is overlapping with the
biological effects of Rho inhibition (Fig. 4d). In line with the Hippo independency of
this regulation, knockdown of LATS1/2 was not sufficient to rescue osteogenesis upon
C3 treatment, or endothelial cell proliferation on small islands (Supplementary Fig.
32). Collectively, these data suggest that YAP/TAZ are required for cell differentia-
tion triggered by changes in ECM stiffness and for geometric control of cell survival.
We next tested if the sole YAP/TAZ activity can re-direct the biological responses
elicited by soft/confined ECM. Overexpression of activated 5SA-YAP with lentiviral
infection (to at least ten fold the endogenous levels, data not shown) remarkably
overruled the geometric control over proliferation and apoptosis in HMVEC (Fig.
4e), and rescued osteogenic differentiation of hMSC treated with C3 or plated on
soft ECM (Fig. 4f, g). Thus, cells on soft matrices or on small adhesive areas can be
tricked to behave as if they were adhering on harder/larger substrates by sustaining
YAP/TAZ function.
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Figure A.3.4 – YAP/TAZ are required mediators of the biological effects con-
trolled by ECM elasticity and cell geometry. a–c, MSC were transfected with the
indicated siRNA (control, siCo.; YAP/TAZ, siYZ1 and siYZ2), plated on stiff (40 kPa) or
soft (1 kPa) substrates and induced to differentiate into osteoblasts (a, b) or adipocytes (c).
C3 (0.5 mg ml21) was added and renewed with differentiation medium. a, Representative
alkaline phosphatase stainings and b, quantifications of osteogenic differentiation (n = 4).
c, Quantification of adipogenesis based on oil-red stainings (n = 2) (A.U., arbitrary units,
see methods). See Supplementary Figs 29 and 30 for controls. These results are consistent
with ref. 23. d, Proliferation (BrdU, upper panel) and apoptosis (TUNEL, lower panel)
of HMVEC plated on adhesive islands of different size; where indicated, cells were treated
overnight with C3 (2.5 µgml 1), or transfected with the indicated siRNAs (n = 5). Similar
results were obtained with siYZ2 (not shown). Representative stainings in Supplementary
Fig. 31. e, Proliferation (upper panel) and apoptosis (lower panel) of control and 5SA-
YAP-expressing HMVEC, plated on adhesive islands. f, g, Quantifications of osteogenesis
in MSC transduced with 5SA-YAP, and treated with C3 (50 and 150 ngml 1) (n = 3) (f)
or plated on hydrogels (n = 2) (g). Representative stainings in Supplementary Fig. 33. All
error bars are s.d. (*P < 0.05; **P < 0.01; n.s., not significant). Experiments were repeated
n times with duplicate biological replicates.
A.4. DISCUSSION 117
A.4 Discussion
In sum, our findings indicate a fundamental role of the transcriptional regulators
YAP and TAZ as downstream elements in how cells perceive their physical microen-
vironment (Supplementary Fig. 1). Our data define an unprecedented modality of
YAP/TAZ regulation, that acts in parallel to the NF2/Hippo/LATS pathway and
instead requires Rho activity and the acto-myosin cytoskeleton. Interestingly, this
recapitulates aspects of MAL/SRF regulation13, but also entails profound differ-
ences: YAP/TAZ activity requires stress fibers and cytoskeletal tension induced by
ECM stiffness and cell spreading, but is not directly regulated by G-actin levels. The
detailed biochemical mechanisms by which cytoskeletal tension regulates YAP/TAZ
awaits further characterization, but it is tempting to speculate that stress-fibers
inhibit an unidentified YAP/TAZ-interacting molecule that, when released, would
promote their inactivation. Functionally, we showed that different cellular models
read ECM elasticity, cell shape and cytoskeletal forces as levels of YAP/TAZ activity,
such that experimental manipulations of YAP/TAZ levels can dictate cell behavior,
overruling mechanical inputs. This identifies a new widespread transcriptional mech-
anism by which the mechanical properties of the ECM and cell geometry instruct cell
behavior. This may now shed light on how physical forces shape tissue morphogen-
esis and homeostasis, for example in tissues undergoing constant remodeling upon
variation of their mechanical environmnent; indeed, alterations of YAP/TAZ signal-
ing have been genetically linked in animal models to the emergence of cystic kidney,
pulmonary emphysema, heart and vascular defects [17-20]. In cancer, changes in the
ECM composition and mechanical properties is the focus of intense interest, as these
have been correlated with progression and build-up of the metastatic niche [2]; in
light of their powerful oncogenic activities [14], YAP/TAZ might serve as executers
of these malignant programs. Genetically, YAP and TAZ have been linked to a uni-
versal system that control organ size14. The current view implicates Hippo signaling
as the sole determinant of YAP/TAZ regulation in tissues. However, our results sug-
gest physical/mechanical inputs as alternative determinant of YAP/TAZ activity.
Supporting our model, it has been observed that growth of epithelial tissues entails
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posed that these serve as positive feedback to homogenize cell growth, compensating
for uneven activity of soluble growth factors [22]. It is tempting to speculate that
proliferative tissue homeostasis may be achieved by a combination of growth fac-
tor signaling and localized control of YAP/TAZ activation by cell-cell contacts and
mechanical cues.
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B.1 Summary
Key cellular decisions, such as proliferation or growth arrest, typically occur at
spatially-defined locations within tissues. Loss of this spatial control is a hallmark
of many diseases, including cancer. Yet, how these patterns are established is in-
completely understood. Here we report that physical and architectural features of a
multicellular sheet inform cells about their proliferative capacity through mechanical
regulation of YAP and TAZ, known mediators of Hippo signaling and organ growth.
YAP/TAZ activity is confined to cells exposed to mechanical stresses, such as stretch-
ing, location at edges/curvatures contouring an epithelial sheet, or stiffness of the
surrounding extracellular matrix. We identify the F-actin capping/severing proteins
Cofilin, CapZ and Gelsolin as essential gatekeepers that limit YAP/TAZ activity in
cells experiencing low mechanical stresses, including contact inhibition of prolifera-
tion. We propose that mechanical forces are overarching regulators of YAP/TAZ in
multicellular contexts, setting responsiveness to Hippo, WNT and GPCR signaling.
B.2 Introduction
Spatially restricted patterns of cell proliferation shape embryonic development and
maintain adult epithelial tissues. How these local growth patterns are established
remains unclear. In the past decades, major emphasis has been placed on graded dis-
tribution of soluble growth factors or their restricted activity in “niches”. This view,
however, does not fully explain how the microenvironment can robustly template cell
behavior in time and space, with micrometer accuracy [1,2]. Moreover, soluble factors
alone can hardly account for some remarkable examples of ordered proliferation, dif-
ferentiation and self-organization of entire organs emerging in vitro from naïve cells
cultured in media saturated of mitogens and growth factors [3]. This suggests that
tissues are somehow endowed with the capacity to inform individual cells on their pro-
liferative competence, likely including the responsiveness to soluble cues. Although
the molecular nature of these informational systems is uncertain, an intriguing model
is that the architectural form of the tissue - its shape and three-dimensional geometry
- serves as template to initiate and self-sustain asymmetric patterns of cell prolifer-
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ation [4,5]. Key elements of such architectural signal are cell shape, cell geometry
and deformation generated by the pulling forces of the extracellular matrix (ECM)
and of neighboring cells, and the associated changes in cytoskeletal organization
and tension [6-9]. In this model, a specific tissue conformation would translate into
a pattern of mechanical forces potentially targeting individual cells with exquisite
detail. Supporting this “biomechanical” perspective, the physical properties of the
microenvironment are increasingly recognized as potent and pervasive regulators of
cell behavior, such as proliferation and differentiation [10]. A critical step forward
in understanding these processes has been the discovery that mechanical signals are
transduced by two related transcriptional coactivators, YAP and TAZ [11]. These
are powerful regulators of cell proliferation and survival, playing critical roles in or-
gan growth [12,13]. A number of human cancers hijack these properties to foster
their own growth, including induction of cancer stem cells and metastatic coloniza-
tion [14,15]. YAP and TAZ shuttle between the cytoplasm and the nucleus, where
they interact with TEAD transcription factors to regulate transcription. Classically,
the Hippo cascade has been regarded as the major regulatory input upstream of
YAP/TAZ [12]. Very recently, WNT and GPCR signaling pathways have also been
recognized as important regulators of YAP/TAZ [16,17]. Thinking along the connec-
tions between tissue architecture, cell mechanics and YAP/TAZ biology, we asked:
is the mechanical regulation of YAP and TAZ translating spatial force distribution
into patterned growth within multicellular layers? If so, how is positional informa-
tion transmitted to YAP/TAZ? Are the different inputs feeding on YAP/TAZ (e.g.
mechanical stimulation, Hippo, WNT or GPCR signaling) parallel or interdependent
regulations? Here we started to shed light on these issues by discovering that cell
proliferation in an epithelial monolayer is profoundly influenced by a mechanical and
cytoskeletal checkpoint that regulates YAP and TAZ. This tissue-level checkpoint is
enforced by the F-actin capping and severing proteins CapZ, Cofilin and Gelsolin.
These factors inhibit YAP and TAZ in cells that, within a monolayer, are located at
sites of low mechanical stress. Conversely, YAP/TAZ-mediated proliferative compe-
tence occurs in cells that exhibit higher contractility in response to stretching forces,
depending on the shape of the epithelial sheet or on the rigidity of the surrounding
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ECM. We propose that mechanical stresses are overarching regulators of YAP/TAZ
in multicellular contexts, also setting cell responsiveness to Hippo, WNT and GPCR
signaling.
B.3 Results
Mechanical regulation of cell proliferation through YAP/TAZ A classic paradigm
on the control of proliferation in multicellular aggregates is contact inhibition of
proliferation (CIP), a process by which cultured cells stop dividing when they become
confluent occupying the entire space allotted to them. This behavior recapitulates
the proliferative arrest of most epithelia typically leading to cell differentiation or
death. Interestingly, loss of CIP is considered a hallmark of cancer [18,13]. In CIP,
a unifying theme is the regulation of YAP and TAZ, that tend to remain nuclear in
cells growing at low density and relocate in the cytoplasm in confluent cultures [19].
CIP is associated with phosphorylation of YAP and TAZ, indicating the activation
of the Hippo pathway kinases [19]. However, the regulation of YAP/TAZ by contact
inhibition appears more complex. For example, recent data show that, at least in
MEFs or keratinocytes, the mammalian Hippo homologue MST1/2 and LATS1/2 are
dispensable for CIP [20]. Here we decided to explore a different scenario, in which
CIP incorporates a mechanical regulation of YAP and TAZ. To test this, we compared
immortalized human mammary epithelial cells (MEC) plated at different densities
(3000, 15000, 75000 cells/cm2) (Figure 1A). At the lowest plating density (hereafter
called “sparse”), cells exhibited no or minimal contact between neighboring cells. At
the intermediate plating density (“confluent”), cells were confluent with all-around
cell-cell contacts, while, at the highest density (“dense”), space constraints caused
cells to form a densely packed monolayer. Using anti-E-Cadherin immunofluorescence
to identify cell borders, we quantified that the projected cell area dropped more
than ten folds with increasing density, from 1400 µm2 in sparse cells, to 700 µm2
in confluent cells and down to 130 µm2 in dense cells (Figure 1A). As measured by
BrdU incorporation, confluent cultures displayed about a 30% reduction of S-phase
entry when compared to sparse cultures (Figure 1B). This degree of proliferative
inhibition is in agreement with the expected contribution of cell-cell contact and
B.3. RESULTS 127
E-Cadherin engagement to CIP [21], and was paralleled by a partial YAP/TAZ
cytoplasmic relocalization (Figure 1C). That said, both nuclear YAP/TAZ levels and
proliferation remained clearly evident in confluent cultures (Figures 1B and 1C), with
YAP/TAZ activity being causal for S-phase entry (Figure 1B). This suggests that
cell-cell contact per se is not sufficient to induce either post-confluence inhibition
of proliferation, or robust YAP/TAZ inactivation. This is in contrast to the cells
seeded at high density (dense), which are overtly growth arrested and exhibit largely
cytoplasmic, transcriptionally inactive YAP/TAZ (Figures 1B, 1C, S1A). CIP is
reversible, as inducing a “wound” in the monolayer by scraping away a stripe of
cells caused the cells lying within a few cell diameters from the edge of the wound
to stretch without losing cell-cell contacts, re-localize YAP/TAZ to the nuclei and
proliferate (Figure S1B and data not shown). Similar results were observed by using
immortalized human HaCaT keratinocytes (Figures S1C-F and data not shown).
YAP/TAZ inactivation in the course of CIP has been associated with activation
of cell-cell adhesion machinery and activation of the Hippo pathway (Zhao et al.,
2007). We thus asked if the distinct degrees of YAP/TAZ inactivation observed in
confluent and dense cultures, were dependent on catenins and LATS. Consistently
with previous reports [21,20], knockdown of ↵-catenin, p120-catenin or LATS1/2
rescued YAP/TAZ transcriptional activity in confluent cultures, as measured by the
expression of YAP/TAZ target genes CTGF, CYR61 and ANKRD1 (Figures S1G-
I and data not shown). Surprisingly, however, the same depletions had marginal
effects on YAP/TAZ signaling in dense cultures (Figures S1G-I). The above results
suggest that, beside cell-cell contacts, the main determinant for YAP/TAZ inhibition
and post-confluent growth arrest is actually to attain a small cell size - intended
as adhesion to a small ECM substrate area (Figure 1A). Indeed, cells attaching
to a small area are known to experience low mechanical stresses, as they display
decreased integrin-mediated focal adhesions, reduced actin stress fibers, and blunted
cell contractility [22,8,9]. Importantly, these mechanical cues have recently been
shown to be essential for YAP/TAZ nuclear localization and activity [11,23]. In
this perspective, CIP would represent the response to a mechanical constraint: as
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be subjected to the same YAP/TAZ-regulating mechanotransduction pathways that
affect isolated cells plated on small ECM islands. In line with this view, MEC
plated as single cells on micropatterned fibronectin islands of defined areas displayed
strong inhibition of YAP/TAZ nuclear levels and BrdU incorporation when individual
cell-size dropped below 300 µm2 (Figures 1D and 1E), independently of cell-cell
contacts. Similarly, decreasing mechanical cues by culturing cells on soft substrates
(i.e., fibronectin-coated acrylamide hydrogels) also caused cell rounding, YAP/TAZ
nuclear exclusion and proliferative inhibition (Figures 1F, 1G and S1J).
The remarkable phenotypic similarities between cells cultured in small, soft or
dense conditions clearly suggest that these apparently different modalities to regulate
YAP/TAZ may actually all correspond to the control of YAP/TAZ by mechanical
cues. To address more directly the notion that in a multicellular layer the control of
YAP/TAZ activity and cell proliferation occurs through mechanical cues, we devel-
oped a microdevice that reproduces some of the mechanical challenges experienced
by tissues, such as stretching (Figure 2A and S2A-C). This microdevice was built
by fabricating into polydimethylsiloxane silicone (PDMS) a microfluidic network of
hollow channels connecting larger “chambers” filled with saline solution. The surface
of PDMS was coated with ECM (fibronectin) to allow cell attachment. MECs were
seeded on this surface at high cell density causing cells to exclude YAP/TAZ from
nuclei and undergo CIP. Next, we slowly applied computer-controlled pressure to
the system, imposing cells to radially stretch as the PDMS membrane overlaying
each chamber inflated (Figure 2A). This applied strain increased the cell adhesive
surface to 150%, as quantified from measurements of the cell-projected area (Figure
2B). This was associated to a remodeling of the F-actin cytoskeleton with appear-
ance of phalloidin-positive actin bundles in stretched cells (Figure S2D). Remarkably,
stretched cells rapidly reactivated YAP/TAZ, as monitored by nuclear localization,
and re-entered S-phase (Figure 2C and 2D). Based on these experiments we con-
clude that mechanical forces acting on specific areas of an epithelial sheet reflect into
changes of shape and mechanics of the individual cells, and act as spatially localized
determinants of cell proliferation through YAP/TAZ regulation.
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Figure B.3.1 – High Cell Density, Small Cell Geometry, and Soft ECM All Lead
to Restriction of Cell Area, YAP/TAZ Relocalization, and Growth Arrest (A)
Cells plated at different densities display increasingly smaller cell-substrate adhesion areas.
MECs were seeded to obtain sparse cells and confluent or dense monolayers. After 2 days,
cells were fixed for immunofluorescence with anti- E-cadherin antibody (anti-E-CAD) to
visualize formation of cell-cell contacts by confocal microscopy. TOTO3 is a nuclear coun-
terstain. Scale bar, 20 mm. (Right) Average cell area in the three seeding conditions. Similar
results were obtained with HaCaT keratinocytes (Figure S1C). (B) MECs were plated as in
(A); after 2 days, cells were incubated for 1 hr with a pulse of BrdU to label cells undergo-
ing DNA duplication. Cells were fixed and processed for anti-BrdU immuno- fluorescence
(aBRDU). (Right) Quantitation of proliferation measured as the percentage of BrdU-positive
cells. Similar results were obtained with HaCaT keratinocytes (Figure S1D). Note minimal
residual proliferation in dense cells, even after YAP/TAZ depletion, suggesting that cell
proliferation in culture may not be totally dependent on YAP/TAZ. (C) MECs were plated
as in (A) and stained for immunofluorescence with anti-YAP/TAZ antibody (aYAP/TAZ).
TOTO3 is a nuclear counterstain. Scale bar, 20 µm. (Right) Proportion of cells dis- playing
preferential nuclear YAP/TAZ localization (N, black), even distribution of YAP/TAZ in
nucleus and cytoplasm (N/C, gray), or cytoplasmic YAP/ TAZ (C, white). Similar results
were obtained with HaCaT keratinocytes (Figure S1E) and with an in- dependent anti-YAP
antibody (not shown). (D and E). Restricting cell-substrate adhesion area to levels compara-
ble to those of dense cells is sufficient to cause YAP/TAZ nuclear exclusion and inhibition of
proliferation. MECs were seeded as individual cells plated on fibronectin-coated glass (large)
or on square microprinted fibronectin islands of 300 mm2 (small). In (D), cells were fixed
after 1 day for immunofluorescence with anti-YAP/ TAZ antibody (aYAP/TAZ). DAPI is a
nuclear counterstain. Scale bar, 20 µm. (Right) YAP/TAZ nucleo/cytoplasmic localization
was scored as in (C). In (E), cells were processed for BrdU incorporation as in (B). (F and
G) Effects of a soft ECM substrate on epithelial proliferation. Confocal immunofluorescence
images of YAP/TAZ of MECs plated on fibronectin-coated stiff (plastic) and soft (acry-
lamide hydrogels of 0.7 kPa) substrates. TOTO3 is a nuclear counterstain. Scale bar, 20
mm. On the right: YAP/TAZ nucleo/cytoplasmic localization was scored as in (C). In (G)
cells were processed for BrdU incorporation as in (B). Similar results were obtained using
acrylamide hydrogels of 40 kPa or plastics (Dupont et al., 2011 and data not shown). Data
are mean and SD. Experiments were per- formed at least three times with three biological
replicates each time. Quantitations were carried out by scoring at least 2,000 cells for each
sample. Pictures show representative results. See also Table S1 for siRNA sequences and
Figure S1.
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Figure B.3.2 – Stretching of an Epithelial Mono- layer Overcomes YAP/TAZ Inhibition
and Growth Arrest in Contact-Inhibited Cells (A) A monolayer stretching device. Cells
were seeded on the upper surface of a PDMS substrate to obtain a dense monolayer (see
also Figure S2A). Underneath the PDMS is a chamber filled of fluid (white space between
the PDMS and glass). At atmospheric pressure (dense, p = 0), the cell monolayer remains
flat; when pressure is applied to the fluid inside the chamber (stretched, p > 0), the increase
of the chamber volume causes a corresponding increase of the surface to which the monolayer
is attached. (B) MECs stably expressing membrane-bound EGFP (Mb-EGFP) and nuclear-
localized mCherry (NLS-Cherry) were seeded at dense conditions as in Figure 1A on top of
the stretching device. After 2 days, cells were imaged under the epifluorescent microscope
before (Co.) and immediately after stretching. Pressure was then maintained constant
during observation. Projected cell area was measured in the two conditions (dashed lines
in the lower pictures indicate the cell boundaries before and after stretching). The graph
shows the average quantitation of cell area. The ramping of pressure increase was set in
order to avoid destruction of cell-cell contacts (as monitored with Mb-EGFP; data not
shown). Scale bar, 20 mm. (C) MECs were plated on the stretching device as in (B).
After 2 days, cells were subjected to 6 hr of static stretching, fixed with the device still
under pressure, and then processed for immunofluorescence with anti-YAP/TAZ antibody
(aYAP/TAZ). DAPI is a nuclear counterstain. Scale bar, 20 mm. (Right) Proportion of
cells displaying preferential nuclear YAP/TAZ localization (N, black), even distribution of
YAP/TAZ between the nucleus and the cytoplasm (N/C, gray), or prevalently cytoplasmic
YAP/TAZ (C, white). Similar results were obtained after 3 hr of stretching (not shown).
(D) MECs were plated on the stretching device as described in (B). After 2 days, cells
were subjected to 6 hr of static stretching in the presence of BrdU to label cells undergoing
DNA duplication. Scale bar, 20 mm. (Right) Quantitation of proliferation measured as
the percentage of BrdU-positive cells. Throughout the panels, data are mean and SD.
Experiments were performed at least three times with at least three biological replicates
each time. Quantitations were carried out by scoring at least 2,000 cells for each sample.
Pictures show representative results. See also Figure S2.
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B.3.1 F-actin capping and severing proteins are YAP/TAZ inhibitors
We next sought to identify molecular players involved in YAP/TAZ regulation by
mechanical cues. F-actin regulatory proteins appeared as ideal candidates: treat-
ments that disrupt F-actin or cytoskeletal contractility oppose YAP/TAZ function
[11,23,19]; then, it is recognized that cells respond to external mechanical cues by
adjusting the tension and overall organization of their actin cytoskeleton by engag-
ing a plethora of actin-binding proteins [22]. Finally, cells plated on small ECM
islands, on soft ECM or in a dense monolayer are characterized by similar F-actin
organization, as they retain cortical F-actin, but all display reduced or absent F-
actin bundles (Figure S2D and data not shown). We thus reasoned that knockdown
of endogenous negative regulators of F-actin should restore cytoskeletal structures
required for YAP/TAZ activity in inhibitory mechanical conditions. We selected a
total of 62 genes identified as F-actin inhibitors in a genome-wide screen [24]. In
order to specifically identify genes relevant for YAP/TAZ regulation by mechanical
cues, we screened them using an unambiguous mechanotransduction assay, that is,
the rescue of YAP/TAZ-dependent transcription on soft ECM substrates. MECs
were transfected with two pairs of siRNAs for each F-actin inhibitor and seeded on
soft hydrogels (approximating an elastic modulus of 0.7 kPa). Cells were harvested
after 48 hours and analysed by qPCR for CTGF mRNA expression as read-out of
YAP/TAZ activity (Figure 3A). Although most siRNAs were ineffective, few siRNAs
reactivated CTGF expression to levels comparable to, or higher than, those of cells
growing on a stiff matrix (Figure 3B). These candidates were then validated by using
individual siRNAs and testing their effectiveness at activating multiple YAP/TAZ
endogenous targets (CTGF, ANKRD1, CYR61); among the candidates, Cofilin1/2,
Capzb and Gelsolin, well-established organizers of F-actin distribution and dynam-
ics [25], stood out as potent YAP/TAZ inhibitors (Figure 3C and S3A and data not
shown). Cofilin and Gelsolin (also known as Actin Depolymerizing Factors) increase
the turnover of F-actin by severing microfilaments; after severing, Gelsolin remains
attached to the newly formed barbed end, preventing filament annealing and poly-
merization. CapZ (also known as  -actinin or Capping Protein) shares with Gelsolin
such actin-capping function [25]. Most of what we know about Cofilin, Gelsolin
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and CapZ in mammalian cells is based on cell migration studies, particularly in the
context of dynamic cell protrusions, or from in vitro studies [25], while little data
is available on their role in other relevant biological processes. In sparse MECs,
depletion of Cofilin, CapZ and Gelsolin caused a general increase in F-actin stain-
ing, with particularly thickened stress-fibers, and increased peripheral protrusions
resembling filopodia and lamellipodia (Figure 3D and S3B). Supporting the notion
that F-actin capping and severing proteins do work through F-actin modification
to regulate YAP/TAZ, we found that CapZ depletion could not increase YAP/TAZ
activity in cells treated with LatrunculinA, an F-actin inhibitory drug (Figure S3C).
To further dissect which subset of the F-actin networks is relevant for YAP/TAZ
activity we treated cells with chemical inhibitors of formins (SMIFH2) or ARP2/3
(CK666; CK869; see Supplemental Information for details): these compounds pref-
erentially inhibit formation of F-actin bundles (formin-dependent), or of F-actin
branched networks that sustain lamellipodia formation (ARP-dependent). qPCR for
CTGF indicated that YAP/TAZ activity mostly depends on F-actin bundles (Fig-
ure 3E). Taken together, the results link mechanical regulation of YAP/TAZ activity
to F-actin capping/severing proteins and formation of stress fibers. We next used
F-actin capping/severing proteins as tools to further query the nature of YAP/TAZ
inhibition by cell density. Depletion of Cofilin, CapZ or Gelsolin rescued formation
of stress fibers as well as YAP/TAZ nuclear localization, TAZ protein stability and
YAP/TAZ-dependent gene expression in dense cells (Figures 4A-C, S4A and S4B).
These findings support the notion that control of YAP/TAZ by high cell density
entails a mechanical and cytoskeletal regulation.
B.3.2 Role of YAP/TAZ and F-actin inhibitors in mechanical pat-
terning of cell proliferation
Next, we wondered whether YAP/TAZ reactivation by depletion of F-actin capping
and severing proteins is also paralleled by a rescue of CIP. To address this ques-
tion, we employed microfabrication methods to stamp fibronectin-coated substrates
of defined shape and area. This set-up allows studying how patterns of mechanical
forces generate patterned growth within a monolayer: cells located at the borders
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Figure B.3.3 – CapZ, Cofilin, and Gelsolin Inhibit YAP/TAZ Activity (A and B) siRNA
screen for negative regulators of the F-actin cytoskeleton impinging on YAP/TAZ activ-
ity. (A) Schematic overview of the screening procedure. MECs were transfected with two
independent couples of siRNAs against each gene (siRNA 1+2 or siRNA 3+4). The day
after transfection, cells were replated as single cells on a soft ECM hydrogel (0.7 kPa) and
harvested after 2 more days for qPCR analysis. (B) Results of the screening, where each
point of the purple line corresponds to a single siRNA/gene. The orange diamonds indicate
the effects of controls and of selected siRNAs that were further validated (see text). Cfl,
Cofilin; Gsn, Gelsolin. The dotted line represents CTGF levels in cells transfected with
siControl (siCo.) but plated on a stiff ECM substrate. Here and throughout the figures,
CTGF levels are relative to GAPDH expression. (C) Loss of capping and severing proteins
rescues YAP/TAZ inhibition on soft ECM. CTGF (purple) and ANKRD1 (violet) expres-
sion in MECs are independent readouts of YAP/TAZ transcriptional activity. Cells were
transfected with single siRNA against each gene (A, B, or C). Stiff (white column) is a stiff
ECM substrate; soft (colored columns) is a 0.7 kPa ECM hydrogel. See Figure S3A for
knockdown efficiencies on endogenous proteins. (D) Loss of Capzb, Cfl1, and Gsn induces
formation of thicker actin bundles. Close-up confocal immunofluorescence of MECs trans-
fected with the indicated siRNA and stained for F-actin with phalloidin (green) and nuclei
(TOTO3, red). Scale bar, 20 µm. See Figure S3B for increased filopodia and lamellipodia
after Capzb, Cfl1, and Gsn knockdown. Consistent results were obtained with independent
siRNAs (not shown). (E) Regulation of F-actin dynamic and assembly by formin proteins is
required for YAP/TAZ activity. MECs were plated on a stiff ECM substrate and treated for
24 hr with increasing doses of the inhibitor of formin-homology 2 domains SMIFH2 (used
at 5, 15, 30 µM) or of the Arp2/3 inhibitors CK666 (5, 10, 50 mM) and CK869 (5, 10, 50
µM). Data are mean and SD. Experiments were performed three times with at least three
biological replicates each time. See also Figure S3 and Tables S1 and S2.
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of the island experience higher mechanical stress than cells located in the center
[26]. MECs were uniformly seeded at high density on circular islands and, after 48
hours, cell proliferation rate was assayed by BrdU incorporation (Figure S4C). As
shown in Figure 4D, the number of cells in S-phase greatly decreased in the center of
the island but persisted at the border, matching the distribution of physical forces
[26]. Knockdown of YAP and TAZ revealed that proliferation at the border was
YAP/TAZ dependent (Figure 4D). This growth pattern - as previously noticed [26]
- was driven by tensional forces, since inhibition of non-muscle myosin II with bleb-
bistatin, or of myosin light chain kinase with ML-7, greatly reduced proliferation at
the culture borders, phenocopying attenuation of YAP/TAZ (Figure 4D). Strikingly,
depletion of CapZ and Cofilin clearly prevented CIP in center cells. Importantly, this
occurred without increasing the growth of cells at the border, thus partially leveling
the growth differentials within the epithelial sheet (Figure 4D). The restoration of
proliferation by depletion of capping and severing proteins was dependent on YAP
and TAZ (Figure 4D). We obtained similar results by seeding cells on square-shaped
islands, where YAP/TAZ-dependent proliferation was concentrated at corners and
edges (Figures S4D, S4E and data not shown). The above results suggest that the
form of an epithelial monolayer generates patterns of tensional forces that trans-
late into differentials of YAP/TAZ activity, whose establishment requires F-actin
inhibitors. Yet, in vivo, distinct tissues not only exhibit specific shapes, but also
their ECM composition varies greatly, due to the content, crosslinking and topol-
ogy of collagen fibers [27]. To mimic such integration, we investigated the roles of
YAP/TAZ, and F-actin capping and severing proteins, on the behavior of MECs
growing in three dimensions (3D). For this, we used reconstituted ECM containing
a mix of basement membrane (BM; Matrigel) and collagenI (COL), whose concen-
tration can be changed to obtain soft and stiff BM/COL gels (COL 1.2 mg/ml or 3
mg/ml, respectively) [28] (see Figure S5A for validation of these gel compositions as
mechano-regulators of YAP/TAZ). After 8 days in culture, MECs growing embed-
ded in soft BM/COL gels formed growth-arrested acini (Figure 5A). When collagen
concentration was increased, we observed the formation of larger spheroids, actively
growing tubules and organoid-like structures (Figure 5A). By immunofluorescence,
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YAP/TAZ were predominantly evenly distributed in cells cultured in soft ECMs, but
were clearly nuclear in cells embedded in the stiffer ECM (Figure 5B). Transcriptional
activation of YAP/TAZ by increased ECM stiffness in 3D cultures was confirmed by
induction of endogenous markers, such as CTGF, CYR61 and ANKRD1 mRNAs
(Figure S5B). siRNA-mediated knockdown of YAP and TAZ caused severe reduc-
tion of the overall number and size of the 3D colonies, that in no case expanded
beyond small aggregates, regardless of substrate rigidity (data not shown). We next
sustained endogenous YAP/TAZ activity in cells embedded in the soft ECM through
siRNA-mediated knockdown of Cofilin or Gelsolin. Strikingly, this induced the for-
mation of bigger acini and caused the appearance of elongated or branched struc-
tures (Figure 5C) and was paralleled by YAP/TAZ-dependent induction of CTGF
and CYR61 mRNAs (Figure 5D). Using phospho-histone-3 as proliferation marker,
acini transfected with control-siRNA were mainly growth arrested, while Cofilin or
Gelsolin-depleted spheroids retained proliferative activity (Figure 5E). We conclude
that YAP/TAZ regulation by F-actin capping and severing proteins plays a critical
role in regulating the growth of epithelial cells in a 3D reconstituted ECM.
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Figure B.3.4 – Knockdown of F-Actin-Capping and -Severing Factors Rescues Contact
Inhibition of Proliferation (A) Loss of Capzb, Cfl1, or Gsn rescues YAP/TAZ nuclear lo-
calization in dense monolayers. MECs were transfected with the indicated siRNA and were
seeded to obtain sparse cells or a dense mono- layer. After 2 days, cells were fixed for
immunofluorescence with anti-YAP/TAZ antibody (aYAP/ TAZ). DAPI is a nuclear coun-
terstain. Scale bar, 20 µm. (Right) Proportion of cells displaying preferential nuclear
YAP/TAZ localization (N, black); even distribution of YAP/TAZ between the nucleus and
the cytoplasm (N/C, gray); or cytoplasmic YAP/ TAZ (C, white). Consistent results were
obtained with independent siRNAs (not shown). (B) CTGF expression in MECs transfected
and seeded as in (A). Loss of Capzb, Cfl1, and Gsn rescues YAP/TAZ transcriptional activ-
ity in dense monolayers. (C) Western blotting for TAZ and YAP in MECs transfected and
seeded as in (A). GAPDH is a loading control. (D) Panels show colorimetric stacked images
of BrdU incorporation, used to visualize spatial variations of proliferation in cell monolayers
of defined shape and dimensions. MECs were plated as monolayers on large microprinted
fibronectin islands (diameter, 350 µm ) and processed as described in the text and as in the
Figure S4C legend. The color scale indicates the extent of cell proliferation in a given posi-
tion of the monolayers. The proliferation rate decreases to nearly undetectable levels at the
center of the circle due to CIP (black/blue color), whereas cells continue proliferating along
the border of the cellular sheet (green/ red color). Cultures were treated with blebbistatin
(Blebbi, 50 µM) or myosin light-chain kinase inhibitor (ML-7, 10 µM) overnight before the
BrdU pulse. For experiments with siRNAs, cells were first transfected with the indicated
siRNA and were re- plated after 1 day. Similar results were obtained on islands of square
shape (Figures S4D and S4E). Data are mean and SD. Experiments were per- formed at
least twice with biological replicates each time. Quantitations were carried out by scoring
at least 2,000 cells for each sample. Pictures show representative results. See also Figure S4
and Table S1.
B.3.3 Cytoskeletal regulation of YAP/TAZ dominates over Hippo
signaling
We next sought to investigate the intersections between the control of YAP/TAZ ac-
tivity by cytoskeletal cues and the classical Hippo cascade, centered on the activity of
two kinases, MST1/2 (Hippo in Drosophila) and LATS1/2, the latter directly phos-
phorylating YAP/TAZ and causing their inhibition [12]. CIP has been associated to
increased YAP/TAZ phosphorylation mediated by LATS1/2 [19]; similar phosphory-
lation occurs in cells rounded after placing them in suspension, or upon disruption of
the F-actin cytoskeleton [29,23,19]. Fully confirming these associations, we also found
increased YAP/TAZ phosphorylation in cells treated with LatrunculinA, an F-actin
inhibitory drug (Figure 6A). YAP/TAZ phosphorylation, however, may not auto-
matically surrogate for biological function, and no previous studies supported this
biochemical observation with functional evidence [10]. To investigate the functional
role of LATS, we used independent pairs of validated siRNAs targeting both LATS1
and LATS2. We first controlled the efficacy of LATS-depletion by reconstituting
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Figure B.3.5 – 3D Matrix Stiffness Regulates Growth and Morphogenesis of Mammary
Epithelial Cells through YAP/TAZ (A) Mammary epithelial cells (MECs) were embedded
as a single cell in a matrix formed of a different mixture of Matrigel and CollagenI (see
Experimental Procedures). Soft matrix contained 1.2 mg/ml CollagenI, whereas stiff matrix
contained 3 mg/ml CollagenI [36]. After 8 days, cells were fixed and stained for phalloidin to
help visualize the morphology of multicellular structures. TOTO3 is a nuclear counterstain.
Scale bar, 100 µm. Bottom panels show bright fields at lower magnification. (B) 3D matrix
density regulates YAP/TAZ localization, as assayed by confocal immunofluorescence with
anti-YAP/TAZ antibody (aYAP/TAZ). MECs were plated as in (A) and were fixed after
6 days. TOTO3 is a nuclear counterstain. Scale bar, 100 µm. (C) Loss of Cfl1 and Gsn
promotes the formation of tubule-like structures in soft 3D matrix. MECs were transfected
with the indicated siRNAs and then embedded in soft matrix as in (A). After 8 days,
acini were fixed and stained for phalloidin. TOTO3 is a nuclear counterstain. Scale bar,
100 µm. (D) Loss of Cfl1 and Gsn increases YAP/TAZ transcriptional activity in soft
3D matrix. MECs were treated as in (C) and were harvested for qPCR of the YAP/TAZ
target genes CTGF and CYR61. (E) Loss of Cfl1 and Gsn promotes proliferation of cells
embedded in 3D soft matrix. MECs were treated as in (C) and were stained with anti-
pH3 antibody to mark mitotic cells. pH3 signal is shown merged with the TOTO3 nuclear
counterstaining. Scale bar, 100 µm. (Right) Quantitation of cell mitosis normalized to the
volume of the multicellular structures, as calculated from 3D z stacks reconstructions. Data
are mean and SD obtained from at least 20 structures per condition. Data are mean and
SD. Experiments were performed at least twice with biological replicates each time. Pictures
show representative results. See also Figure S5 and Table S1.
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NF2 expression, a bona fide upstream regulator of the Hippo cascade, in the NF2-
null breast cancer cell line MDA-MB-231 [11]. NF2 re-expression caused a dramatic
inhibition of TEAD luciferase reporter and LATS1/2 inactivation completely abol-
ished this effect, confirming the efficacy of our siRNAs (Figure 6B). Similarly, NF2
re-expression was completely ineffective in cells expressing only a LATS-insensitive,
phosphorylation mutant form of YAP or TAZ (Figure S6A and data not shown).
Next, we wondered if LATS1/2 were downstream of mechanical cues. If this were
the case, as in the above NF2 paradigm, loss-of-LATS1/2, or loss-of-YAP/TAZ phos-
phorylation, should also rescue YAP/TAZ activity in cells on soft ECM or dense
cultures. In stark contrast to this hypothesis, the results for mechanical regulation
were different: depletion of LATS1/2 could not rescue YAP/TAZ inhibition by a
soft environment (Figures 6C), indicating that F-actin and mechanical regulation
affect YAP/TAZ activity independently from their phosphorylation by LATS. In
line, cells expressing only LATS-insensitive YAP or TAZ mutants (5SA-YAP, 4SA-
TAZ) did not escape mechanical inhibition when cultured on soft hydrogels (Figure
S6B and S6C). Using CapZ inactivation as paradigm of cytoskeletal remodeling, we
also found that cells expressing 4SA-TAZ were still responding to depletion of CapZ
(Figure S6D). Finally, knockdown of CapZ left the YAP/TAZ phosphorylation lev-
els completely unchanged, as shown by Phos-TAG analysis (Figure 6D); collectively,
the results strongly suggest that YAP/TAZ control by the F-actin cytoskeleton and
Hippo signaling represent formally distinct regulations. An unexpected discovery
came when we simultaneously inactivated CapZ together with LATS1/2 in MECs
cultured in soft or dense conditions. The results actually showed that LATS1/2 are
effective inhibitors of YAP/TAZ only in the context of a mechanically competent
F-actin cytoskeleton. Several results support this conclusion: (i) combined depletion
of CapZ and LATS1/2 cooperated to fully induce nuclear localization of YAP and
TAZ in cells seeded on soft hydrogels and dense conditions (Figure 6E and 6F); (ii)
LATS1/2 depletion in either soft or dense MEC cultures was inconsequential per se
but potently synergized with CapZ depletion to maximize YAP/TAZ transcriptional
activity (Figure 6G and 6H); (iii) in large square (or round) fibronectin-coated is-
lands, LATS1/2 depletion alone could not rescue CIP (Figure 6I, S6E, S6F), and
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left proliferation of cells at the border still sensitive to inhibitors of cytoskeletal
tension (Figure S6E). However, combined depletion of CapZ and LATS1/2 fully
rescued the blockade of S-phase entry in cells located at the center of the epithe-
lial sheets triggering unabated proliferation evenly throughout the island (Figure
6I and S6F). We next tested how loss of YAP/TAZ regulation by the Hippo ki-
nases impacted on MECs growing in 3D within a soft or stiff ECM. To this end,
we compared MECs stably expressing near to endogenous levels of wild-type TAZ,
and LATS phosphorylation-insensitive 4SA-TAZ. As shown in Figure 6J, wild-type
TAZ expressing cells behaved similarly to their parental counterparts. 4SA-TAZ
expressing cells displayed increased protrusive activity in soft ECM, yet retained a
spheroid structure. Notably, in the more rigid ECM, 4SA-TAZ expressing cells did
not form tubular structures and invaded the matrix as single cells. As TAZ over-
expression has been shown to induce Epithelial-to-Mesenchymal Transition in cells
cultured on plastic in 2D [30], this 3D phenotype likely reflects fully unleashed TAZ
activity. Finally, we asked if the permissive effect of the cytoskeleton is specific for
the Hippo pathway or also applies to other regulatory inputs. To this end, we used
two inducers of YAP/TAZ, WNT and GPCR signaling [16,17], and monitored their
efficacy in soft vs. stiff extracellular conditions. As shown in Figure 6K, knockdown
of APC (mimicking WNT signaling by inactivation of the APC/Axin/GSK3 TAZ
destruction complex [16]) caused robust upregulation of YAP/TAZ-dependent tran-
scription in cells cultured on stiff substrates, but had minimal effect in cells seeded
on a soft matrix. Similarly, addition of TRAP6, a positive inducer of YAP/TAZ ac-
tivity through GPCR-signaling, could operate only in cells cultured on stiff, but not
on soft matrices (Figure 6L). Remarkably, depletion of capping and severing proteins
re-empowered YAP/TAZ activation by WNT and GPCR signaling (Figures 6K, 6L
and data not shown). Collectively, the results suggest that mechanical and physical
properties of the environment control not just Hippo signaling but also YAP/TAZ
responsiveness to signaling cascades initiated by soluble growth factors.
B.3. RESULTS 141
142 APPENDIX B. MECHANICAL CHECKPOINT OF CELL GROWTH
Figure B.3.6 – Cytoskeletal Mechanics Is a Dominant Input for YAP/TAZ Activity. (A)
Disruption of the F-actin cytoskeleton induces YAP phosphorylation. Phos-TAG SDS-PAGE
analysis of MECs plated as confluent monolayer and treated with LatrunculinA (Lat.A, 100
µM) for 3 hr. Black and white arrowheads indicate hyperphosphorylated or nonphosphory-
lated YAP, respectively. Identity of YAP isoforms was defined based on extracts from cells
transfected with YAP siRNA and on l-phosphatase treatment (not shown). (B) LATS1/2
knockdown completely rescues YAP/ TAZ inhibition by NF2/Merlin. Luciferase reporter
assay (8XGTIIC) in MDA-MB-231 transfected with the indicated siRNA and without (Co.)
or with NF2 expression plasmid. See Figure S6A for similar results obtained with LATS-
insensitive 5SA-YAP mutant. Similar results were obtained in HeLa cells (not shown). (C)
LATS1/2 knockdown does not rescue YAP/ TAZ inhibition by soft ECM. Luciferase re-
porter assay (8XGTIIC) in MDA-MB-231 cells transfected with the indicated siRNA and
replated on stiff or soft ECM substrates. See Figure S6B for similar results obtained with
LATS-insensitive 5SA-YAP mutant. Similar results were obtained in HeLa cells (not shown).
Of note, inhibition of LATS by constitutive-activation of PI3K or AKT (Fan et al., 2013),
known for being downstream of integrin signaling, could not rescue YAP/TAZ inhibition by
soft ECM; and inhibition of PI3K, AKT, and mTOR by small-molecule inhibitors had no
effect on a stiff ECM (data not shown). (D) Capzb knockdown does not result in a decrease
of YAP phosphorylation. Phos-TAG SDS-PAGE analysis of MECs transfected with the in-
dicated siRNAs and plated as confluent mono- layers. Black and white arrowheads indicate
hyperphosphorylated or nonphosphorylated YAP, respectively. (E) MECs were transfected
with the indicated siRNAs and were plated on soft ECM substrates. After 2 days, cells
were fixed for immunofluorescence with anti-YAP/TAZ antibody. Scale bar, 10 µm. (Below
the pictures) Proportion of cells displaying preferential nuclear YAP/TAZ localization (N,
black), even distribution of YAP/TAZ between the nucleus and the cytoplasm (N/C, gray),
or prevalently cytoplasmic YAP/TAZ (C, white). Transfection of LATS1/2 siRNA alone had
no significant effects on YAP localization (not shown). Consistent results were obtained with
independent siRNAs (not shown). (F) MECs were transfected with the indicated siRNAs
and were seeded to obtain a dense monolayer. After 2 days, cells were fixed for immunofluo-
rescence with anti-YAP/TAZ antibody. Scale bar, 20 µm. (Below the pictures) Proportion
of cells displaying preferential nuclear YAP/TAZ localization (N, black), even distribution of
YAP/ TAZ between the nucleus and the cytoplasm (N/C, gray), or prevalently cytoplasmic
YAP/TAZ (C, white). (G) MECs were transfected with the indicated siRNAs and were
plated on stiff (white column) or soft (colored columns) ECM substrates. After 2 days, cells
were harvested for qPCR analysis. LATS knockdown has no effects on a soft ECM but
potently enhances CTGF transcription upon combined depletion of Capzb. Similar results
were obtained with ANKRD1 and CYR61. (H) MECs were transfected with the indicated
siRNAs and plated as sparse cells (white column) or dense monolayers (colored columns).
After 2 days, cells were harvested for qPCR analysis. Similar results were obtained with
ANKRD1 and CYR61.
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(J) MECs were transfected with YAP/TAZ siRNA (to avoid interference from endogenous
proteins) and reconstituted with siRNA-insensitive mouse TAZ (mTAZ). TAZ add-back was
carried out with both WT and LATS-insensitive 4SA mTAZ. Cells expressing empty vector
and transfected with control siRNA serve as controls. Cells were embedded as a single cell
in a matrix formed of a different mixture of Matrigel and CollagenI to obtain softer and
stiffer gels (see legend to Figure 5A and Experimental Procedures). After 6 days, cells were
fixed and stained for phalloidin to help visualize the morphology of multicellular structures.
Scale bar, 100 µm. (K and L) WNT and GPRC signaling efficiently promote YAP/TAZ-
dependent transcription on soft substrates only after Capzb depletion. (K) MECs were
transfected with control siRNA (siCo.), APC siRNA (siAPC) to activate WNT signaling,
or with Capzb siRNA (siCapzb). Cells were plated on stiff or soft ECM substrates and
were harvested after 2 days for qPCR of YAP/TAZ target genes (CTGF and ANKRD1).
(L) MECs were transfected with the indicated siRNAs and were plated on stiff or soft
ECM substrates. After 1 day, cells were serum starved overnight and were subsequently left
untreated or treated with 2 µM TRAP6 for 3 hr. Data are mean and SD. Experiments were
performed at least twice with biological replicates each time. Quantitations were carried
out by scoring at least 2,000 cells for each sample. Pictures show representative results. See
also Figure S6 and Table S1.
B.4 Discussion
How cell shape and tissue form connect with tissue function, growth and pattern-
ing is one of the most fascinating and least understood aspects of biology. Here we
provide evidence that tissue shape and three-dimensional ECM compliance pattern
the proliferative competence of an epithelial sheet. These inputs localize YAP/TAZ
activity at sites of high mechanical stresses, and inhibit it where mechanical forces
are minimal. Thus, YAP and TAZ regulation serves as link between tissue architec-
ture and a key cellular function, that is, proliferation. YAP/TAZ inhibition entails
a remodeling of the F-actin cytoskeleton mediated by F-actin capping and sever-
ing proteins, for which we reveal an essential role as proliferative checkpoints in
mammalian epithelial sheets through YAP/TAZ regulation. The presently described
connections appear to hold a number of implications for the biology of epithelial cells.
For organ size control, tissue regeneration and homeostasis cells must be constantly
informed of the size and shape of the whole organ (Discher et al., 2009; Huang and
Ingber, 1999; Nelson and Bissell, 2006). This suggests that cells are able to per-
ceive what happens many cell diameters away and respond to it with great spatial
accuracy. Mechanical forces are ideally suited to serve as messenger of this global
control, as it has been recently shown that forces display long-range and broad scale
effects (Halder et al., 2012; Guo et al., 2012). Using monolayers of defined shape
and size, here we show that patterns of mechanical stresses locally control YAP/TAZ
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activity. At sites of low mechanical forces, that is, in contact-inhibited center cells,
YAP/TAZ are inhibited by F-actin capping and severing proteins, as loss-of-CapZ or
Cofilin potently rescues YAP/TAZ nuclear localization, transcriptional activity and
proliferation. In contrast, cells at edges and corners of the same multicellular sheets
display YAP/TAZ dependent proliferation induced by cytoskeletal contractility and,
here, loss-of-CapZ or Cofilin has marginal effects.
Inactivation of capping and severing proteins is accompanied by reappearance of
F-actin stress fibers. Conversely, YAP/TAZ inactivation is phenocopied by inhibit-
ing formin and myosin, which by themselves are essential for stress fibers formation
and cellular contractility. These data collectively suggest that mechanical forces
promote YAP/TAZ activity at least in part by inhibiting capping and severing pro-
teins. However, this does not exclude a different scenario, one in which YAP/TAZ
are regulated independently by mechanical forces and capping/severing proteins; the
latters may operate to unbalance the distribution of microfilaments to different, per-
haps competing, F-actin pools (e.g. cortical F-actin, stress fibers and nuclear actin)
endowed with different YAP/TAZ activating capacities. In other words, while this
study unambiguously identifies endogenous F-actin capping and severing proteins as
YAP/TAZ inhibitors, a more detailed picture of their function will necessarily re-
quire the unraveling of the precise mechanisms by which F-actin affects YAP/TAZ-
dependent transcription as well as a more comprehensive understanding of cellular
rigidity sensing. Classical experiments using transformed mammary epithelial cells
grown as spheroids in three-dimensional ECM of distinct rigidities and compositions
unequivocally showed that the physical properties of the matrix could lead to tu-
mor cells “reversion” to a near normal phenotype, overriding oncogenic aberrations
[5]. Conversely, ECM stiffening, and ensuing cytoskeletal tension, cooperate with
oncogenes, and may even initiate aberrant proliferation [27]. Yet, how the microen-
vironment intercepts the malignant phenotype at the level of gene-expression is a
major question in cancer biology. Here we show that transformed mammary epithe-
lial cells grown in low-collagen 3D environments display low levels of YAP/TAZ ac-
tivity, while collagen-rich matrices induce YAP/TAZ nuclear localization, YAP/TAZ
target genes and YAP/TAZ dependent proliferation. These observations are consis-
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tent with the positive correlations between collagen content and tissue stiffness (as
determined by mammographic density) with breast cancer risk and metastasis [27].
Here we show that F-actin capping and severing proteins are instrumental for the
effects of a soft ECM, as their depletion induces YAP/TAZ activation and prolifer-
ation, phenocopying the attributes of a more rigid ECM environment. This work
also provides a unifying principle for how contact inhibition of proliferation is real-
ized. We propose a two-step model of this classic phenomenon [18]. As cells engage
in cell-cell adhesion - starting from a situation of unrestricted adhesive areas with
fully nuclear YAP/TAZ - the E-cadherin/catenins system triggers LATS activation
and YAP/TAZ phosphorylation, as previously reported [21,32], but this is insuffi-
cient for overt growth arrest. Then, as proliferation continues, cell crowding causes
reduction of cell size and low mechanical stress, now leading to a more effective
contact inhibition. We show that the regulation of YAP/TAZ by cell mechanics is
not only distinct from Hippo pathway-induced YAP/TAZ phosphorylation and in-
hibition, but in fact dominates over it. Remarkably, LATS1/2 inactivation is per se
inconsequential in cells experiencing a low mechanical stress. Moreover, depletion of
F-actin capping/severing proteins sustains YAP/TAZ activity without affecting their
phosphorylation. In fact, LATS-mediated inhibition of YAP/TAZ requires a mechan-
ically competent cytoskeleton, as the effect of LATS knockdown becomes manifest
only in the absence of F-actin capping/severing proteins. Our finding that LATS
and F-actin organization act independently to regulate YAP/TAZ is also supported
by genetic evidence in Drosophila [33,34]. In fly wing development, inactivation of
the CapZ homologue induces organ overgrowth similarly to Hippo mutations, and
the extent of this phenotype can be either counteracted or amplified, respectively
by overexpression or inactivation of LATS, altogether making unlikely an epistatic
relationship between the two inputs. Our data further suggest that the scale of acti-
vation of YAP/TAZ may be particularly broad, depending on the relative intensity
and duration of cytoskeletal and Hippo controls. There is ample genetic evidence for
the Hippo pathway as an intrinsic regulator of organ size; for example, inactivation
of the upstream Hippo kinase MST1/2, or of its cofactor Salvador/WW45, causes re-
markable tissue overgrowth in several organs, including liver, intestine and skin [35].
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According to our findings, the effect of a Hippo pathway mutation should not indis-
criminately affect all cells, but preferentially expand the cell populations experiencing
a mechanical stress. The existence of a second control layer for YAP/TAZ activity
overseeing the effects of an Hippo mutation is supported by in vivo observations:
in the liver, YAP/TAZ hyperactivation by Hippo deficiencies generates a functional
and histologically well-organized organ [35], a finding incompatible with global and
uncontrolled cell proliferation. Similarly, in the ↵-catenin knockout mouse model,
YAP activation remains spatially restricted to the basal layer of the skin, where YAP
protein is normally confined [20], suggesting that cell attachment to the appropriate
ECM is instrumental to locally sustain normal as well as aberrant YAP activation.
Finally, the idea that the cytoskeleton is a key input for YAP/TAZ in vivo is sup-
ported by recent genetic evidence: kidney development requires YAP activation by
the CDC42 Rho-GTPase, well known promoter of F-actin polymerization.
Besides the Hippo pathway, mechanical cues also dominate the cellular response
to soluble cues positively affecting YAP and TAZ activity. We show that YAP/TAZ
activation by WNT or GPCR signaling requires a mechanically stressed cytoskeleton,
or, in cells experiencing a soft ECM, inactivation of F-actin capping and severing
proteins. In the same line of thought, the fact that YAP/TAZ are stabilized and
act in stem and progenitor cells, typically lodged in specific tissue-niches [35], is an
enticing argument that the status of the ECM, the cell’s cytoskeletal organization
and tension may impart a “physical” competence for stemness and differentiation.
B.5 Experimental procedures
Details are provided in the Extended Experimental Procedures
Plasmids siRNA-insensitive FLAG-hYAP1 WT and 5SA were generated by PCR
and subcloned in pcDNA3. pXJ40-HA-Merlin/NF2 S518A is Addgene# 19701.
8xGTIIC-lux [11] is Addgene# 34615.
Cell cultures and Transfections MCF10A and MII cells were used with equal re-
sults, except for experiments shown in Figure 3 and 5 where we used only MII cells.
Micropatterned glass slides were from Cytoo. Fibronectin-coated hydrogels were as
previously described [11]. The monolayer stretching-device was fabricated by using
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standard soft-lithography techniques. For 3D assays, cells were embedded into mixes
of Growth Factor Reduced Matrigel (BD Biosciences) and CollagenI (TREVIGEN
CULTUREX 3D Culture Matrix Rat CollagenI). For assays on large square and
circular fibronectin-coated islands, 1.000.000 cells were plated in a 35mm dish con-
taining a single Cytoo glass slide. siRNA transfections were done with Lipofectamine
RNAi-MAX (Life technologies). Sequences of siRNA are provided in Table S1 and
S2. DNA transfections were done with TransitLT1 (Mirus Bio). siRNA and DNA
transfection were performed on sparse cells plated on tissue culture plastics before
replating on the various ECM substrates and islands. For Retroviral infections see
(Azzolin et al., 2012).
Antibodies and Bioassays Antibodies: anti-YAP/TAZ (sc101199), anti-CAPZB
(sc81804), anti-COFILIN1 (Epitomics 6663-1), anti-GELSOLIN (sc57509), anti-GAPDH
(Millipore mAb374), anti-LATS1 (CST) and anti-LATS2 (Abcam), anti-E-Cadherin
(BD Biosciences). For microscopy, luciferase, proliferation and real-time PCR assays
see Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION Supplemental Information includes Extended
Experimental Procedures, Supplemental References, six Figures, two Tables.
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C.1 Summary
The development of smart biomaterials able to quantitatively analyse the dynamic
of biological systems with high temporal resolution in biomimetic environments is
of paramount importance in biophysics, biology and medicine. In this context, we
develop a biosensing water-based soft biomaterial with tunable mechanical proper-
ties through the generation of an electro-conductive nano-element network. As a
proof of concept, in order to detect glucose concentration, we fabricate an elec-
troconductive poly-acrylamide glucose-oxidase loaded hydrogel modified with a low
amount of Single-Walled Carbon Nanotubes (SWNTs) (up to 0.85 wt%). Micro-
Raman maps and optical analysis show nanotube distribution in the samples at
different mass fraction. Electrochemical impedance spectra and their fitting with
equivalent circuit models reveal an electron conduction in charged hydrogels in ad-
dition to ionic conductivity. The effective resulting resistance of the nanostructured
network is comparable to the gold electrode one. These findings are also confirmed
by cyclic voltammetries. Interestingly, heterogeneous clustering of SWNTs shows
double electric mechanisms and efficiencies. GOx-SWNT doped hydrogels show a
glucose-concentration linear response in the range between 0.1 mM to 1.6 mM; all
together these results show high detection limits for glucose (down to 15 µM) and a
sensitivity of 0.63 µA/mM. In the perspective of monitoring cell dynamics, hydrogel
functionalization allows cell adhesion and long-term cell culture whereas atomic force
microscope is used for mapping the doped hydrogel stiffness. Myoblasts, cell sensi-
tive to mechanical substrate properties, show proper differentiation and phenotype
in SWNT-HYs with nominal physiological stiffness.
C.2 Introduction
Soft biomaterials are nowadays of great interest in various field such as biophysics,
biotechnology, biology and medicine [1-4]. Among different biomaterials, their soft
nature provides an artificial bi-dimensional and tri-dimensional environment which
closely resembles both biochemical and biomechanical cues found in cell and tissue
interactions in vivo [5, 6]. These features are achieved by latest progresses in the
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development of biomimetic substrates that require a deep integration of material
and biological sciences. In this context, polymeric hydrogels (HYs) have already
reached a prominent position among the other water-based biomaterials because of
their peculiar chemical and physical properties, which can be easily tuned by adjust-
ing HY composition and crosslinking. Among other properties like biocompatibility,
biodegradability, high permeability and smart chemistry, mechanical ones are very
important because make HYs ideal to provide structural and biological support to
cells and tissues, controlling the delivery of medium components and enrichment
of autocrine and paracrine factors [7]. For this reason, HYs have been relevant for
mechanotransduction applications,[8] specific topological targeting of cell adhesion
and proliferation and biomimetic scaffold development for in vitro tissues [9-14].
Several works report the possibility of promoting a proper tissue specification and
functional properties by tuning mechanical properties of substrate [15-18]. In this
perspective, even if soft materials have been successfully applied to induce biological
or biophysical responses related to their mechanical or chemical properties, there are
no evidence about the possibility of recording biological activities through soft sub-
strates. However, continuous analysis of living system has been recently exploited
through the use of stiff materials. For instance, metallic nanowires [19, 20] and
nanoparticle arrays [21] were used for metabolic biosensing as conductive supports
for bioelectronic applications [22]. Moreover, examples in which glass or metallic
multi-electrode arrays were used for electrophysiological studies have been reported
[23-25]. This experimental effort underlines the importance of developing biomaterial
capable of continuously and quantitatively analyzing cell activity. The possibility of
combining compliant substrates with no-invasive continuous detection is extremely
relevant to develop biological studies without affecting cell functionality. For in-
stance, electrophysiological studies on contractile cell (such as, skeletal muscle cells
or cardiomyocytes) on stiff substrates could be difficult to perform because of cell
easily detach from the substrate. Thus, we aim at developing a biosensor integrated
into a biomimetic soft material in order to quantitatively analyze the cell dynamics
with high temporal resolution. In particular, as a proof of concept, we aim at tar-
geting a metabolite, glucose that is important for cellular activity. Among different
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mechanisms of detection, we used electrochemical methodologies because of the high
sensitivity and specificity of electrochemical based devices. In fact, the specificity can
be achieved using enzyme mediated biosensors: several works have been published
on electrochemical biosensing devices using catalytic enzymes [26-28]. The major
challenge that needs to be solved is to obtain an electronic flow within the biomate-
rial without affecting the biophysical and biological properties of HY. Although HYs
are ionic conductors, due to the strong ion permeability in aqueous media, electron
flow is actually forbidden and no electric charge can be collected when using HY-
based electrodes. There are a lot of electron carriers usually used as dopants in poly-
meric biomaterials: particular attention may be given to noble metallic nanoparticles
(NPs), such as Au, Ag, Pd and Pt [29-33] but strong limitations occur when used in
biological systems due to the toxic effect induced by the large amount of NPs needed
to obtain an effective electron current [34, 35]. Carbonaceous particles are also used,
such as graphite, fullerenes and single-walled carbon nanotubes (SWNTs) [36-38].
The latter are very interesting due to their intrinsic peculiar electronic properties:
high conductivities can be achieved with very low additions of particles (down to 4%
with respect to 50% for metallic NPs) thus allowing the realization of quasi unmod-
ified doped materials [39, 40]. In our knowledge, only a few works concerning the
bulk modification of HYs are reported [41-44], however, works reporting the effect
of dopant loading on mechanical properties of soft-materials together with biocom-
patibility and cell behaviour (in terms of both proliferation and differentiation) are
never been reported yet. It would be extremely relevant for biological, physiological
and pathophysiological studies to develop a soft-biosensor with minimal amount of
dopant in order to preserve biomechanical and biochemical properties of the soft-
materials and the cell biocompatibility while performing physiological measurements
of metabolites in the physiological range (for instance, glucose concentration between
1-5 mM). For these reasons, we realized an electroconductive biomimetic HY in which
the electroconductivity was achieved by the creation of a SWNT electronic network
that could allow an electroconductive percolation across the biomaterial. The wiring
effect of nanotubes would promote the electron jumps between the enzymatic core
where the reaction takes place to the underlying collecting electrode. The biophys-
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ical properties of the modified HYs are not altered because very low concentrations
(less than 1% in weight) were used, whereas the catalytic behavior was tested by
glucose detection, as a case of study, by specific loading of Glucose Oxidase (GOx).
Doping uniformity and distribution were characterized by optic microscopy and Ra-
man spectroscopy, whereas electronic conductivity was verified by electrochemical
impedance spectroscopy (EIS) and cyclic voltammetry (CV). Biophysical and bio-
logical properties were verified by AFM force-distance curve on doped and undoped
materials and by measuring the viability and the phenotype maintenance of cultured
cells on the HY surface.
C.3 Results and discussion
C.3.1 Developing the sensor
In Fig. 1 it is shown a schematic representation of the steps involved in the prepa-
ration of the glucose bionsensor. A gold electrode fabricated as referred in Experi-
mental Section is modified with an in situ polymerized polyacrylamide SWNT doped
HY. SWNT-sodium cholate aqueous suspensions at different concentrations are used
for doping HYs (Fig. 1A-1B). Then GOx is loaded into doped and undoped HYs
biasing the working electrode in three electrochemical cell configurations (Fig. 1C):
the charged enzyme can be drifted into the HY. Glucose is oxidized by the enzyme
and indirectly detected potentiostatically in the cell as in Fig. 1D; the byproduct of
the reaction is the hydrogen peroxide that oxidizes when a potential of +0.7V ref.
Ag/AgCl is applied as reported elsewhere [45].
C.3.2 Hydrogel characterization
Raman spectroscopy is often used for characterizing carbon nanotube through SWNT
scattering upon laser excitations in the near-IR range [46]. Fig. 2 shows histograms
related to the G-band Raman intensity (about 1600 cm-1) of samples at different
SWNT mass fractions. Qualitative increasing trend in the doping level was found.
More detailed description about Raman measurements are reported in the Support-
ing Information (Fig. S5).
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Figure C.3.1 – Schematic representation of the steps involved in the preparation of the
biomimetic glucose biosensor. A clean, insulated gold electrode (A) is modified with an in
situ polymerized SWNT doped HY at different SWNT concentrations (SWNT HYs) (B);
then the electrode is biased with a positive voltage and the enzyme is loaded into the HY,
forming a GOx-SWNT doped HY (GOx-SWNT HYs) (C). By means of a potentiostatic
measurement, glucose is converted by the enzyme into hydrogen peroxide which can be
electrochemically discharged by GOx-SWNT HYs (D).
Figure C.3.2 – The car-
bon nanotube distribu-
tion within the samples at
different concentrations.
The histogram refers to
the SWNT Raman G-
band intensity. Error
bars are described in the
ESI. The inset graph rep-
resents an example of
Raman scattering for a
SWNT HY sample used in
the paper.
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In order to collect information about the resistivity of the SWNT doped mate-
rial, electrochemical impedance spectroscopy (EIS) was used. Conventional 4-probe
conductivity measurements did not lead to reproducible analysis because weak elec-
tric contact on soft substrate. EIS gives information about the electric behavior of
the interface of an electrodic system by fitting the experimental data with specific
equivalent circuit models; polarization resistance for the interface can be derived.
A Randles cell was used for modeling equivalent circuits as reported in literature
for organic electrodic interfaces [47]. A constant phase element (CPE) was used for
replacing the ideal double layer capacitance (C). Fig. 3 summarizes EIS results. In
Fig. 3A-C Bode phase plot for the samples at different SWNT mass fraction are
shown, whereas, in Fig. 3D the polarization resistances obtained by fitting are re-
ported as a function of SWNT mass fraction. Fig. 3A and Fig. 3C show a maximum
in the frequency spectrum. On the other hand, two principal time constants for the
electrodic system (i.e. two maxima in the spectrum) are shown for samples in Fig.
3B. For this reason, two different equivalent circuit models (with one or two RC
systems) are required to fit all the data; Rs is the unsupported resistance solution,
RPij is the polarization resistance indexed by i and j related to equivalent circuit I
or II. Numerical outcomes for fitting and a more detailed description of circuits used
are provided in the Supporting Information (Fig. S7). The resulting resistances are
reported as a function of SWNT mass fraction in Fig. 3D-i, Fig. 3D-iii and Fig.
3D-v; for higher dopant concentration, lower RP value was observed only for lowest
and at highest SWNT mass fraction samples (0.25 wt% and  0.64 wt%). Inter-
estingly, at intermediate mass fraction range, RP1II shows similar behavior to RP1I
whereas RP2II is almost constant. The additional RP2II in intermediate SWNT
mass fraction samples suggests the existence of a double electric behavior with pecu-
liar electroconductive properties; this behavior could be associated to dopant phase
separation and non uniform SWNT dispersion within the HY as shown in Fig. 3E,
(black areas are likely to represent clustering zones of material). Uniform dispersion
of SWNT within HY are associated with simple Randles cell (sample in the range of
0.25 wt%-Fig3D and  0.64 wt%-Fig.3F). The existence of a peak at low frequency
value in the electrodic system may alter the time of response and the sensitivity of
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Figure C.3.3 – Electrochemical impedance spectroscopy and optical analysis of SWNT
doped HYs. (A)-(C) Bode phase plots for doped HYs at different dopant concentrations;
circles are experimental values, whereas the solid line is the fitting using the circuits in
scheme (D)ii for (A) and (C) and the circuit in scheme (D)iv for (B). (D)i, (D)iii and (D)v
show the fitted resistance versus SWNT doping percentage. Error bars and numerical values
are available in the ESI. Symbols are noted in the manuscript. (E)-(G) show different optical
images related to the three different regimes identified by varying the dopant concentration.
a SWNT-HY based biosensor.
A deeper analysis on electrochemical faradic response was required to identify the
optimal dopant mass fraction for realizing electroconductive nanotube based biosen-
sors. Cyclic voltammetry (CV) is a simple strategy for detecting faradic current from
the electrode immersed into a redox probe solution (0.5 mM ferrocenemethanol in
PBS 1x solution) for a specific time (Fig. 4). Fig. 4A shows faradic peak current
of several CVs as a function of redox loading time. In all samples, the peak current
increases reaching a plateau after few hours. Interestingly, the largest peak current
value has been observed for sample with 0.85 wt% and 0.1 wt% SWNT mass fraction;
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these samples also show an immediate increasing in the peak current. On the other
hand, the sample at 0.5 wt% shows a delay in peak current increasing, reaching a
plateau value lower than all other samples, including the control (SWNT HY 0 wt%).
Fig. 4B show two different time points, at 6 min (left) and 150 min (right), respec-
tively: the ohmic response and the high capacitive current of SWNT HY 0.5 wt%
with respect to other samples confirms the sensor low-conductive behavior. On the
other hand, SWNT HY 0.85 wt% provides highest currents. These data confirm that
SWNT dispersed in the HY form an effective network of conductive materials that
support electron flow. Redox probe detection in control HY without SWNT was only
possible after diffusion of the probe within the hydrogel on the underneath electrode
surface. Similar effect was observed for intermediate SWNT mass fraction samples.
It seems that phase separation and clustering of SWNT previously observed, could
limit the diffusion of redox probe leading to lower faradic current detection. This
outcome highlights the goodness of EIS analysis by confirming the high catalytic
feature for charge transfer reactions previously found (Fig. 3D-iii) for highly doped
samples.
Mechanical and biocompatibility measurements
Surface stiffness is one of the most important parameters in determining cell-substrate
interaction [49-51]. For this reason, we aim at studying the effect of SWNT doping
on mechanical properties of HY samples. AFM distance-curve technique was used
for characterizing the stiffness of the samples as reported in literature for low elastic
modulus substrates [52-54]. Three HY samples without SWNT with defined Young’s
modulus (4.5 kPa (A), 17 kPa (B) and 40 kPa (C)) were fabricated in order to be used
as reference [10]. The hydrogel that are mostly used in physiological study of soft
tissues (stiffness ranging from 4.5 to 17 kPa) were doped with SWNT at 0.85 wt%
(A  and B  samples respectively). Due to the uncertainty of Poisson’s coefficient for
such substrates and due to the difficulty of choosing the correct force-distance curve
fitting model [54], stiffness was established as the phenomenological parameter for
determining HY mechanical properties. In Fig. 5, force-distance curves are shown.
Sample stiffness, i.e. the slope of the curve in the contact region, linearly increases
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Figure C.3.4 – Cyclic
voltammetry analysis of
SWNT HYs. (A) Time
dependence of faradic
peak current in ferrocene
methanol redox probe at
different SWNT loadings.
(B) Cyclic voltammo-
grams at 6 minutes (left)
and 150 minutes (right).
All potentials are refer-
enced to the Ag/AgCl
reference electrode.
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Nominal Young’s modulus ratio Measured stiffness ratio
A to B 3.5 4
B to C 2.5 2.6
A to A  - 2.4
B to B  - 2
Table C.3.1 – Force distance curve analysis results.
Figure C.3.5 – Force-distance
curves for HY and SWNT-HY sam-
ples at different nominal Young’s
moduli. Stiffness is represented by
the slope in the contact region.
with the nominal Young’s modulus as reported in tab. 1. Comparison between con-
trol and doped hydrogel show that the hydrogels without SWNT show a reduction
of stiffness of about 50%.
From these findings the SWNT network within the hydrogel leads to stiffer ma-
terials even at low SWNT mass fraction. However, even if this variation is quite
significant, it is negligible if compared to stiffness variation required to elect any
biological responses [8,9]; for instance, one order of magnitude variation from 15 kPa
is required in order to depress functional maturation of skeletal muscle precursor
cells [9]. These results are very relevant for the development of effective biosensors
that fully recapitulates biomechanical properties of in vivo tissues. Other funda-
mental aspects required for interfacing biosensor with living biological systems are
the biocompatibility and the maintenance of proper phenotype during proliferation
and differentiation process. For this purpose, murine muscle cell line, C2C12, were
cultured on doped HYs; skeletal muscle cell line could provide information not only
to viability but also to cell response to mechanical substrate as we previously demon-
strated [9]. Polyacrylamide hydrogels doped with SWNTs with 0 wt%, 0.1 wt% and
0.85 wt% were tested. Cell adhesion was complete within 4 hours after seeding,
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Figure C.3.6 – C2C12
live and dead viability
test. (A) and (C) Cells
are deposited on SWNT-
HY 0.1 wt%; (B) and (D)
Cells cultured on SWNT-
HY 0.85 wt%. (E) C2C12
on SWNT-HY 0.1 wt% re-
tained the proper expres-
sion of desmin, marked
with a red-labelled an-
tibody. (F) Confluent
cells spontaneously diffe-
rentiated into myotubes
which expressed myosin-
II, in green. Nuclei are
stained with Hoechst dye
(blue).
both in non-doped and doped HYs. Cells on doped HYs evidenced the same mor-
phology and behavior compared to unmodified HYs. After three days of culture, a
LIVE/DEAD assay was performed to evaluate the percentage of live and dead cells
(Fig. 6). The green fluorescent dye calcein evidenced viable cells and red nuclei
showed damaged and dead cells with the membrane-impermeant dye Eth-D1. Cell
viability and proliferation were not altered on 0.1 and 0.85 wt% SWNT HYs. Cell
proliferated reaching confluence, confirming that the SWNTs embedded in the gel
did not altered cell behaviour. Moreover, on SWNT doped HYs, cells maintained
proper expression of desmin, a typical skeletal muscle marker (Fig. 6e) and spon-
taneously differentiated into mature myotubes, the functional unit of muscle fibers
expressing myosin-II (Fig. 6f).
C.3.3 Glucose monitoring
In order to give the proof of concept that metabolite concentration can be mea-
sured under cell culture in biomimetic stiffness, a glucose biosensor was developed
for analysing glucose in physiological range between 1 and 5 mM. The realization
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Results
Vmax 4.0 ± 0.2 µA
KM 2.0 ± 0.4 mM
Sensitivity 0.63 µA mM 1
Detection limit 15 mM
Table C.3.2 – Fitting outcomes for the GOx–SWNT–HY 0.85 wt% biosensor. Vmax repre-
sents the maximum current produced by the biosensor for high glucose additions, whereas
KM represents the concentration for which the current is Vmax/2. The detection limit is
calculated following the considerations outlined in ref. 57
of the biosensor is achieved by GOx loading as described in Experimental section.
First of all we show that GOx-doped HYs without SWNT do not exhibit any de-
tectable electrical signal increasing the glucose concentration up to 160 mM (Fig.
S9 of Supporting Information). Fig. 7A shows potentiostatic measurement of glu-
cose concentration using GOx-SWNT HY 0.85 wt%; sequential glucose additions
are highlighted with vertical arrows in the figure. Fig. 7B shows quantification of
plateau current values for each glucose addition as function of glucose concentration.
Michaelis-Menten enzymatic kinetic model can be used to fit these experimental data
(tab. 2); linearity is achieved in the range between 0.1 mM to 1.6 mM (inset graph).
All together, these data show that an effective glucose potentiostatic detection
can be achieved through SWNT doped hydrogel at 0.85 wt% mass fraction. More-
over, the detection limit of 15 µM and the sensitivity of 0.63 µA/mM. The detection
limit value is in total agreement with other biosensors fabricated for blood glucose
detection which values vary in mM concentration range [27, 56-58]. These findings
show that the enzyme bioactivity is well preserved within the three-dimensional hy-
drogel environment. The production of hydrogen peroxide, as mediator in glucose
oxidation, can be easily and quantitatively detected by the three-dimensional network
of SWNT within the biomaterial. This behavior suggests that the percolative pat-
tern through SWNT clusters allows electron flow from hydrogel bulk to gold surface
electrode. In addition, the lower dopant concentration (compared to those reported
previously for other materials) and the choice of starting material (polyacrylamide
HY) allows the biomaterial to preserve biophysical and biological properties letting
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Figure C.3.7 – Glucose
detection and biosensor
calibration. (A) Poten-
tiostatic measurements
of GOx-SWNT-HY 0.85
wt% in PBS 1 solution.
The arrows represent
points of glucose addi-
tion; (B) plateau current
values versus glucose
concentration. Circles are
experimental values of
the measurements given
in panel (A), and the
solid line represents the
fitting of the data with
the enzymatic Michaelis-
Menten kinetic equation.
Outcomes of the fitting
are shown in Table 1.
The inset graph shows
that linearity is achieved
in the range between 0.1
mM and 1.6 mM.
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Experimental
Chip preparation: Working electrode was realized by the patterned deposition of Au
nanometric thin film on clean glass slides through PECVD using a photosensitive
epoxidic mask (SU8, MicroChem, USA) that would be removed by Remover PG
(MicroChem, USA) after metallic deposition. In order to enhance gold adhesion, a
Ti nanometric seed layer was deposited before gold deposition. In order to ensure
a uniform and prolonged adhesion of hydrogel to glass, a specific functionalization
of the glass surface is necessary. The treatment protocol developed consists of glass
surface chemical modification with silane and glutaraldehyde (Sigma-Aldrich, Italy)
as reported in [48]. Supporting Methods are available. Electrochemical cleaning
procedure was used by performing repetitive scans to the working electrode from
0 V to 1.5 V vs Ag/AgCl in HSO at 0.1 V/s. Measurement was stopped when
reproducible scans have been obtained.
C.3.4 Water suspension of carbon nanotubes
100mg of CoMoCat SWCNTs (Sigma Aldrich, Italy) were added as received to 10mL
of milliQ water to form 1 wt% suspension of SWCNTs. Also 20mg/mL of Sodium
Cholate (SC, 99% Sigma-Aldrich, Italy) as surfactant agent were added to the mix-
ture. The suspension was then ultrasonicated for 30 min in ice bath and filtered to
remove clusters obtaining a dark black solution. The suspension was concentrated
by heating until a 1.33 wt% final concentration were reached.
C.3.5 HY Preparation
To realize SWNT HYs, acrylamide/Metilen-bis-acrylamide 29:1 solution (AA/BIS)
was used in addition to carbon nanotubes water mixtures at different final concen-
trations as reported in tab. 3.
C.3.6 Chemical polymerization
1/100 v/v Ammonium Persulfate, 5% solution (APS, Sigma-Aldrich, Italy) and
1/1000 v/v N,N,N,N-Tetramethylethylenediamine (TEMED, Sigma-Aldrich, Italy),
were added to the prepolymer solution. APS in water produces SO radicals that
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SWNT-HY 1.33 wt% SWNT in H2O AA-bis 100 wt% H2O
(wt%) (µL) (µL) (µL)
0.0 0.0 100 400.0
0.1 37.6 100 362.4
0.25 93.9 100 306.1
0.375 141.0 100 259.0
0.5 188.0 100 212.0
0.64 240.0 100 160.0
0.85 320.0 100 80.0
Table C.3.3 – Chemical compositions of SWNT–HY samples used in this work
start the reaction. TEMED catalyzes the reaction because it exists as free radical in
solution. The higher is the concentration of TEMED, the faster will be the polyme-
rization. The pre-polymer solution was degassed because oxygen could inhibit the
initiator. So the prepared solution was rapidly transferred to a silicon mold and then
covered with a coverslip. It takes about 15 min to reach the complete polymerization
of 0.5 mm tall cylindrical HY at room temperature.
C.3.7 Optical and Raman characterization
HY micrographs were taken with an inverted stereomicroscope (Olympus, Italy)
coupled with a photo camera, at a magnification of 10X. A Raman/SNOM confocal
spectrometer (Alpha 300S, WITec, Germany) equipped with a He-Ne laser (  =
633 nm) and a 10X lens was used to perform scans over a 15x15 µm area on three
humid hydrogels at three different SWNT concentrations (0.1 wt%, 0.5 wt% and 0.85
wt%). Spectra were integrated 10 times for each point in the G-band peak interval
(between 1585 cm 1 and 1597 cm 1). Then data were normalized on the maximum
peak intensity collected throughout the three HYs and plotted as a function of x-y
spatial coordinates obtaining three comparable microRaman maps of the surface of
the HYs. The measurement was repeated four times to obtain statistical analysis.
C.3.8 Electrochemical characterization
Electrochemical impedance spectroscopy measurements were performed using a po-
tentiostat/galvanostat (Autolab PGSTAT302N, Metrohm, EcoChemie, The Nether-
lands) managed by software NOVA 1.8 and equipped with a FRA2 module for fre-
quency analyzer. The classic three electrodes cell scheme was used: gold electrode
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acts as working electrode, a Ag/AgCl electrode (Amel Instruments, Italy) as the
reference electrode and a Mettler Toledo Pt cylindrical electrode is used as counter
electrode. Frequency scan range was established between 0.1 Hz to 100 kHz. Fit-
ting of data were performed using NOVA 1.8 software. Cyclic voltammetries were
conducted between 0 V and 0.5 V referred to the reference. Redox probe used was
ferrocene methanol (Sigma-Aldrich, Italy) at 0.5 mM concentration. Electrolytic
supporting solution was KNO 10 mM (Sigma-Aldrich, Italy). Potentiostatic mea-
surements were performed at +0.7 V vs Ag/AgCl electrode in PBS 1x (Invitrogen,
Italy). Concentrations from 0.1 mM to 160 mM of commercial sterilized glucose
(Glucosata solution) were used.
C.3.9 Biocompatibility tests - Seeding and Culture of C2C12 cells
Biocompatibility tests were done. Live/Dead and immunochemical assays were con-
ducted to assess viability and proper functionality of cell culture on doped HYs. (see
Supporting Information for further details). Polyacrylamide hydrogels doped with
SWNTs with 0 wt%, 0.1 wt% and 0.85 wt% were tested. To promote cell adhesion,
the surface was coated with a 0.1 mg/ml solution of laminin-collagen. Cells were
seeded at a density of 3x10 cell/mm and monitored with a phase-contrast micro-
scope for three days.
C.3.10 AFM analysis
AFM studies were performed with a commercial SPM (XE-Bio, Park Systems Corp.,
Suwon, Korea). The instrument has AFM and SICM systems on the stage of an
inverted optical microscope (Eclipse Ti, Nikon Corp., Tokyo, Japan). Manipulating
Park XEP data acquisition software, force-distance spectroscopy was performed on
HYs. The cantilever used for the force-distance spectroscopy was Biotools PNP-TR
(triangle cantilevers with a spring constant of 0.32 N/m and resonance frequency of
about 67 kHz, Nanotools, Germany). The cantilever was calibrated by measuring
the thermally induced motion of the sample free cantilever in Park XEP software.
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Conclusions
An electron conductive network is required to allow electron flow within soft bio-
material because of the insulating nature of polymeric hydrogels. In our work, we
show that a proper electron network could be successfully used to acquire electrons
from a redox enzymatic reaction that takes place within soft biomaterial. Loading of
highly conductive species like carbonaceous nanoparticles within soft hydrogel is the
easiest and the most effective approach to induce the formation of electron conduc-
tive percolative patterns. In particular, we developed an electrochemical biosensor
with good quality using single-walled carbon nanotubes as dopants. We also opti-
mize dopant percentage mass (up to 0.85 wt%) for high detecting efficiency (glucose
detection limit of 15 µM, linearity in the range between 0.1 mM to 1.6 mM and a
sensitivity of 0.63 µM/mM), consequently opening the range of potential interest-
ing applications as quantitative analysis on cell dynamics through the non invasive
direct measurement of metabolites. However, heterogeneous clustering of SWCNT,
which compromise overall biosensor quality, was observed within the material when
the mass fraction is varied in the intermediate range (0.25  wt%   0.5) by optical
imaging and verified by EI spectra. It is worth to underline that, since optical images
and Raman spectroscopy can give qualitative and quantitative information about the
homogeneity of the doping, electrochemical impedance spectroscopy can be used to
monitor the efficiency of nanotube doping in terms of interface resistance by fitting
experimental data with simple equivalent circuit models. This strategy is compatible
with samples varying in size, compositions and structure and thus greatly extends
the range of potential applications that soft materials based devices could be used.
In the perspective of integrating the soft biosensor within cell culture technology
for dynamically monitoring metabolic activity of living systems under physiological
conditions, we show the biomechanical properties and the biocompatibility of doped
and undoped materials.
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D.1 Abstract
Advanced cell culture systems creating a controlled and predictable microenviron-
ment together with computational modeling may be useful tools to optimize the
efficiency of cell infections. In this paper, we will present a phenomenological study
of a virus- host infection system, and the development of a multilayered microfluidic
platform used to accurately tune the virus delivery from a diffusive-limited regime
to a convective- dominated regime. Mathematical models predicted the convective-
diffusive regimes developed within the system itself and determined the dominating
mass transport phenomena. Adenoviral vectors carrying the enhanced green fluo-
rescent protein (EGFP) transgene were used at different multiplicities of infection
(MOI) to infect multiple cell types, both in standard static and in perfused condi-
tions. Our results validate the mathematical models and demonstrate how the in-
fection processes through perfusion via microfluidic platform led to an enhancement
of adenoviral infection efficiency even at low MOIs. This was particularly evident
at the longer time points, since the establishment of steady-state condition guaran-
teed a constant viral concentration close to cells, thus strengthening the efficiency
of infection. Finally, we introduced the concept of effective MOI, a more appropri-
ate variable for microfluidic infections that considers the number of adenoviruses in
solution per cells for a certain time.
D.2 Introduction
The importance of performing efficient and controlled viral infections on mammalian
cell cultures has long been crucial to optimize the gene transfer procedures for basic
research and gene therapy [1-4]. The common denominator is the necessity of increas-
ing viral infection efficiency while preserving viability and biological processes of the
cultured cells. The use of adenoviruses, non-integrating viruses, preserve genomic
integrity and offer reduced risks for human safety. Moreover, process automatiza-
tion, low volumes of reagents, and reduced costs are desirable. Standard procedures
for culture infection involve virus dilution in the media to defined concentrations,
usually quantified by the multiplicities of infection (MOI), representing the number
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of viral particles per cell. Efficiency of transfection of some cell types may be low,
thus requiring high MOIs potentially resulting in toxic side effects on the cells. In
parallel, the advent and ever-increasing use of microscaled technologies and microflu-
idic devices for lab-on- a-chip applications has led to relevant improvements in the
study of complex biological systems [5-10]. Examples of applications of microflu-
idic platforms have been extensively reviewed [11,12] and point at the advantages
deriving from the miniaturization, integration, and automation of biochemical as-
says. Recent literature reflects increased interest in adopting microfluidic devices in
drug discovery process [13,14], molecular detection [15], and in clinical and medical
research [16]. In order to efficaciously control and exploit their potential, it is funda-
mental to understand the physics of mass- transport phenomena and of fluid flows at
the microscale [17,18] and the fabrication processes, and properties of typically used
materials [19-21] Despite the advantages and versatile applications deriving from mi-
crofluidic platforms, only few studies combining these devices and viral infections of
cultured cells can be found in the literature. Examples include some applications of
microfluidic bioreactors for the continuous production of retroviral vectors [22], or
the dielectrophoretic capture and imaging of viral particles on microelectrodes [23].
A microscale platform was developed to detect and quantify virus growth and spread
[24] and micropatterning has been used to characterize the in vitro propagation of
viruses in cell arrays [25] Cells were infected using virus gradients [26], but the bi-
ological readout showed a low number of cells within the microchannels, and virus
replication studies were performed on hepatocytes seeded within micro cell-culture
chambers [27]. However, neither rational studies on the influence of perfusion nor a
screening of the infection parameters were performed. Finally, most of these systems
suffered some of the major limitations deriving from culturing cells within standard
microfluidic channels such as lower growth rates, and the need for frequent changes of
media during the preliminary phases. Here, we develop a microfluidic platform that
can be easily and reversibly coupled to cell cultures, that allows performing multi-
parametric experiments and exerting a precise control over the soluble extracellular
microenvironment, thus increasing the efficiency of infection. Our microfluidic de-
vice is used for the optimization of the process of cell infection through an approach
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that combines mathematical modeling with the experimental validation. On one
hand, mathematical models evaluate the transport phenomena and the dominating
regimes within a defined system, while experiments, on the other, analyze static and
perfused microfluidic-driven infection processes, validating the modeled conditions
and demonstrating that our microfluidic platform allows increasing the infection ef-
ficiency when compared to static conditions, even at the lowest MOIs. Infections
are usually carried out in standard culture plates at defined MOIs and since the ef-
ficiency of infection is proportional to the virus adsorbed on the cellular membrane,
the minimization of the total volume of viral suspension is crucial to favor the contact
between viral particles and adhering cells. Viral particles are uniformly dispersed in
the solvent, and their transport from the bulk of the liquid to the cell surface is purely
driven by brownian-like diffusion. However, in microfluidic experimental setup, mass
transport of particles is driven by both diffusion and convection phenomena. In
particular, diffusion has a driving force represented by a difference in concentration
( c), while convection results from a bulk velocity of the fluid. Consequently, con-
vection gives an additional contribution enhancing the transport of viral particles
to the cells, thus increasing the efficiency of infection. It will be crucial to define a
method to compare the results of static and microfluidicperfused conditions in terms
of infection efficiency. In order to have fair comparison between static and perfused
conditions, a proper experimental design has been proposed to maintain the same
concentration, MOI, and total volume of medium. This experimental design will
allow to highlight the influence of different intrinsic properties of the hydrodynamic
regimes (static and perfused) on infection efficiency. Mathematical modeling will
allow to analyze the theoretical variations of the ratio of virus fluxes in static and
perfused conditions and derives the optimal operative variables such as flow rates
and infection times.
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D.3 Materials and Methods
D.3.1 Cell culture
Mouse embryonic fibroblasts (MEFs) were purchased from Chemicon and were cul-
tured in 79% Iscove’s modified Dulbecco’s medium (IMDM, Invitrogen), 20% foetal
bovine serume (FBS, Invitrogen), and 1% penicillin/streptomycin (Invitrogen). Hu-
man foreskin fibroblasts (HFFs) were supplied by Dr. L. Barzon from the University
of Padova and were cultured in 89% Dulbecco’s modified eagles medium (DMEM,
Sigma-Aldrich), 10% FBS (Invitrogen), and 1% penicillin/streptomycin (Invitrogen).
Passaging of both cultures was performed with Trypsin 0.025%-EDTA (Invitrogen)
and cells were either re -plated on culture flasks for further expansion or seeded on
glass coverslips, both coated with 0.66% A-type pork gelatin (Sigma-Aldrich).
D.3.2 Microfluidic platform
The multilayered microfluidic platform (overall dimensions: 75 x50 mm) was de-
signed for an easy interface with the cell system, and fabricated using lithographic
techniques and molded in poly-dimethylsiloxane (PDMS)[28].The platform (Figure
1(A)) comprised: (i) a supporting glass slide with a PDMS slab carved to accommo-
date the cell culture coverslip, (ii) a membrane-based vacuum system for its reversible
sealing, and (iii) the microfluidic channels (width x height 0.2 x 0.1 mm) delivering
fluids to the cultured cells. The circular channel creating the suction sealing the two
layers, faces the PDMS slab in (i) and is thermally (and irreversibly) bonded to the
upper microfluidic layer (iii). The assembled platform formed a 16x16mm culture
chamber, area in which the cultured cells were exposed to the fluid streams from the
microfluidic channels. The height of the chamber could be varied as needed; for all
the experiments presented here we used 0.5mm high membranes. The platform was
entirely optically transparent, allowing in-line observations of the cultures by easy
interface with standard microscopes (Figure 1(B)). The micro-perfusion apparatus
(Figure 1(C)) was composed of the multilayered microfluidic platform, two syringe
pumps (PHD, Harvard Apparatus, Holliston, MA), and a vacuum control system
(membrane pump H35M and digital vacuum sensor, Vuototecnica, Italy). All con-
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Figure D.3.1 – Platform design and experimental setup. Panel A. The platform comprised:
i) a supporting glass slide with a PDMS slab carved to accommodate the cell culture cov-
erslip (f), ii) a membrane-based vacuum system for the reversible sealing of i, and iii) the
microfluidic channels delivering flu- ids to the cultured cells (inlets in (a) and exits in (b)).
The assembled platform formed a 12x12 mm culture chamber (c) where cells were exposed
to the fluid streams. The top layer embedded connections to the vacuum system (d) and to
a pressure-monitoring auxiliary service (e). Panel B reports an image of the assembled plat-
form, which was entirely optically transparent, operated flowing a color tracer (fluorescein)
in 2 of the 8 channels. Panel C. The micro-perfusion appara- tus was essentially composed
by the multilayered microfluidic platform, two syringe pumps, and a vacuum control system.
The interface with a fluorescence microscope equipped with an environmental chamber is
shown.
nections between components were made using Tygon tubings (0.5mm ID, 1.5mm
OD, Cole Palmer, USA).
A brief description of the experimental procedures follows. Before assembling and
coupling to the cell cultures, all components, connections, and tubings were rinsed
with water and then sterilized via autoclave treatment. Tubings were then rinsed
with sterile culture medium and incubated for at least 1 h prior to the platform
assembly. This preconditioning of the tubings’ walls reduced the potential loss of
viral particles due to undesired adsorption. Sterile 3 ml syringes to be connected to
the platforms outlets were filled with 500 µl of sterile PBS, to avoid the elastic effect
of air, and connected to the microtubes exiting the platform. Sterile 3 ml syringes to
be connected to the platforms inlets were filled with culture medium. The open cell
chamber was covered with 1 ml of culture medium and the syringe-pumps activated to
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Figure D.3.2 – Model validation. Panel A reports representative results of the mathe-
matical modeling showing concentration maps within the culture chamber. For a defined
molecular species with its diffusion coefficient and fixed systems geo- metrical specifications,
increases in the fluid flow rate change the shape of the compartment. Transport phenomena
span from diffusion- to convection-dominated regimes following increases in flow rate. Panel
B shows merged fluorescent images reconstructing the entire culture chamber, acquired dur-
ing the experimental runs performed using parameters equal to the modeled ones.
stabilize the fluid flow and eliminate any residual bubble. Finally, the glass coverslip
with the cultured cells was coupled to the lower layer, the entire platform assembled
and the vacuum system ensuring hydraulic sealing activated. The multiple inlet and
outlet channels allowed creating highly compartmentalized fluid regions within the
culture chamber, thus increasing the throughput of the system potentially consenting
to test several levels for a variable (i.e., virus MOIs) at a single time (Figure 2).
D.3.3 Fluid dynamics modeling
The Navier-Stokes equations for incompressible fluids were numerically solved us-
ing the finite elements method implemented in COMSOL Multiphysics (Burlington,
MA). The 2D domain of the culture chamber was geometrically modeled and a non-
structured mesh was automatically generated with triangular elements. Subsequent
grid refinements were required to ensure independency of the solution from the spatial
discretization. No-slip boundary conditions were used for the chamber and microflu-
idic conduits walls, a fixed velocity for the inlet channel and finally zero pressure
for the outlet. The fluid properties viscosity and density were taken from the liter-
ature [29]. To obtain concentration profiles within the chambers, the mass balance
equations for a convective-diffusive regime were solved again using COMSOL Multi-
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physics software (Burlington, MA, USA). Fluid velocity profiles were obtained from
the Navier-Stokes solutions. Defined concentrations were used as boundary condi-
tions at the different inlets, convective flux at the outlets and insulation/symmetry
elsewhere. The diffusion coefficient for the adenoviral vector (AdV) was calculated
from the Stokes-Einstein equation [30]. The diffusion coefficient of a virus particle,
approximated by a 90 nm hydrodinamic diameter, was assumed to be 6·10 12 m2s 1.
Fundamental assumptions of our modeling approach follows. Focusing on the resis-
tances within the media compartment, we assumed that the virus adsorption was
much faster (steady state assumption) than the mass transport. We also assumed
that all intracellular phenomena related to viral protein expression such as virus in-
ternalization, virus decay, and protein production, were not affected by the velocity
profile in the media compartment. Within these assumptions, the calculated virus
molar flux at cell membrane could be considered directly related to the efficiency of
infection. The ratio between virus molar fluxes of dynamic and static conditions is
defined as the theoretical relative efficiency, \phi_r. In this work, we compared  r as
a function of different parameters such as MOI, time of infection, and hydrodynamic
regime. In particular, hydrodynamic regime was described through the dimensional
Peclet number defined as Pe = ⌫H/D, where ⌫ is the velocity, H is a characteristic
length (chamber height in our case), and D is the diffusion coefficient. This dimen-
sionless variable identifies flow rate conditions at defined geometrical constraints into
specific diffusional or convective transport regimes. Empirical calculations were also
performed (fluxes were evaluated as a function of time, diffusion coefficient, volumes)
and used as a comparison to validate the mathematical modeling (data not shown).
Cell densities, MOIs, viral concentrations, and infection times were kept constant at
their optimized values. In addition, during the preliminary design and development
phases, experimental validation of the modeled fluid compartmentalization in multi-
channel platform was performed using fluorescein dye as a tracer. Figure 2 shows the
good agreement between model prediction and experimental analysis allowing model
prediction of small diffusing particles. Supplementary Figure AS1 reports additional
data quantifying the fluorescence levels of the experimental images (directly corre-
lated to concentration values) [31]. These plots can be compared to the analogous
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concentration curves obtained by the modeled concentration maps.
D.3.4 Infection protocols
D.3.4.1 Static condition
AdVs carrying the EGFP transgene were used at different MOI to infect multiple
cell lines, both in static or in perfused conditions. Briefly, AdV is based on the
Ad5 genome and lacking the E1 and E3 regions was constructed by homologous
recombination in E. coli using AdEasy vector system (Qbiogene, Carlsbad, CA). In
this vector, human cytomegalovirus promoter was used to drive expression of green
fluorescent protein. AdEGFP was propagated in E1- complementing HEK 293 cells,
purified by cesium chloride density centrifugation, and titrated by TCID50 endpoint
assay according to the AdEasy production protocol. Viral vector stocks were stored
at 5.0 · 109 pfu/ml concentration in 10% glycerol at -80 °C until use. The infection
efficiency was evaluated at different time-points post-infection quantifying the EGFP
expression on the live samples via image analysis. Cells were seeded on gelatin coated
coverslips 24 h before infection; the volume of the viral high-titer stock solution to
be used was calculated for any given cell density and experimental MOIs. The viral
stock solution was thawed and aliquots prepared and diluted to the final volume
with the required culture medium. Cell cultures were then incubated (37 °C, 5%
CO2, 95% humidity) with the viral solutions for defined times. Cells were rinsed
with warm PBS without Ca2+/Mg2+ (Gibco) and reincubated with culture medium.
Post-infection incubation time varied depending on the experiment. In time-course
runs, cells were re-incubated for up to 3 days. Images were acquired 48 h post
infection.
D.3.4.2 Microfluidic perfused conditions
All of the above described procedures were followed, with the sole difference that
the viral suspension was loaded in 3ml syringes and connected to the assigned inlet
channels. Particular attention had to be paid at calculating the exact viral par-
ticles number which would ensure correspondence between the static and perfused
infections.
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D.3.4.3 Measurement of the infection efficiency
At the established time points, cell cultures were incubated with Hoechst 33342 (In-
vitrogen) nuclear dye. After this assay, images of randomly chosen positions were
acquired (microscope Leica DMI 6000-B) on both fluorescence channels: blue for
Hoechst marking all cell nuclei and green for the cytoplasmic EGFP signal expressed
by the infected cells only. In order to obtain comparable set of data, the exposure,
gain, and intensity values should be the same in every image. Quantification of these
results was performed via image analysis on paired fluorescence pictures (blue and
green channels). A custom developed script listing the command lines was imple-
mented and run in MATLAB. Briefly, this script organized images in pairs, converted
them in grayscale, enhanced contrast and finally converted them in binary format.
Further processing allowed removing cell-debris, a potential source of quantification
errors. The binary image of the nuclei was used to automatically count the total
number of cells. After that, a pixel by pixel subtraction between the two binary
images produced a new matrix creating the final image showing only the nuclei of
successfully infected cells. Automated counting led to the obtainment of the number
of infected cells and of the global efficiency of infection (number of infected cells over
total number of cells).
D.4 Results
D.4.1 Model validation
The capability of the platform to generate well-defined concentration compartments
was first modeled and then validated using fluorescein as a dye tracer. The results of
the mathematical modeling are shown in Figure 2(a), where the sole culture chamber
is represented for ease of visualization. The shape of the compartment can be pre-
cisely defined by simply tuning the fluid flow rate. At the lowest flow rates, transport
by diffusion and convection competes determining a feather-like shaped concentra-
tion pattern. For increasing flow rates, convection becomes the dominant transport
phenomena and leads to the formation of sharp compartments. Figure 2(b) reports
the results of the experimental validation, performed using the same coefficients and
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geometrical specifications applied for the mathematical modeling. The extremely
close resemblance between the experimental concentration patterns and the modeled
ones validated the model predictions and the systems performance. A quantification
of this observation is available in supplementary Fig. AS1 [31].
D.4.2 Modeling of the cell infection process
Figure A3 summarizes representative results of the computational modeling of the
infection process. Again, is the theoretical relative efficiency of microfluidic perfused
versus static infection. The curves in panel A3(a) are parametric in Pe and reported
as a function of the square root of time. The horizontal line at  r =1 highlights
the threshold at which molar fluxes (and thus infection efficiencies) of perfused and
static processes are equal, thus allowing to identify the parameters characterizing
the variables-space where perfused-microfluidic ( r > 1) or standard static ( r < 1)
infection conditions are favored. For example, given the systems geometrical con-
straints and the duration of the infection process, increases in fluid flow rate (which
directly translate into increases in Pe number), will favor perfused-microfluidic pro-
cesses, which will result in higher infection efficiencies. Vice versa, at the lowest flow
rates where convection gives no significant contribution to the overall transport of
viral particles from the bulk of the liquid to the cell surface, standard static infections
prove to be more efficient. Panel 3(b) plots the values of  r as a function of Pe for a
fixed time (t = 90 min) of infection. Again, it is evident how for increasing flow rates,
perfused-microfluidic infections lead to higher yields with a trend plateauing for Pe
higher than 200 (corresponding to a 1 µl/min flow rate and 8 µm/s linear velocity).
Finally, panel 3(c) plots the times at which  r = 1 for Pe   100, showing again how
for increasing Pe perfused-microfluidic infections could lead to higher yields than
standard static processes exposing the cells to potentially harmful viruses for shorter
times.
D.4.3 Cell infection
Several experiments have been performed in order to optimize the procedures and
parameters characterizing the infection process, both in static and microfluidic cul-
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Figure D.4.1 – Computational
modeling of the infection process.
 r is the theoretical relative effi-
ciency of microfluidic perfused ver-
sus static infection. Panel A re-
ports  r curves parametric in Pe
and as a function of the square
root of time. The horizontal line
at  r = 1 (equality of perfused
and static molar fluxes) separates
the variables space where perfused-
microfluidic ( r > 1) or standard
static ( r < 1) infection conditions
are favored. Panel B plots  r as
a function of Pe at a defined time
(t=90 min) of infection. Finally,
panel C plots the times at wich  r
= 1 for P > 100.
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ture. Cell line, cell density, cell passage, virus MOI, duration of the exposure to the
viral solution (incubation time), and Pe number, were among the screened variables.
From these preliminary experiments, we established optimal values and ranges: cell
seeding density was kept constant at 100 cells/mm2, MOI was varied from 10 to 100,
Pe levels for microfluidic cultures were 10 and 100, and infection times spanned from
90 min to 12 h. In reporting some of the most significant findings on HFF cells,
we highlight how: (a) increases in the incubation time led to increases in the infec-
tion efficiency (Figure A4(a)) (further discussion will be presented in the following
sections). (b) An inverse-relationship correlation was established between viral sus-
pension volume (at a given MOI) and infection efficiency: increases in the first led to
decreases in the latter (Figure A4(b)); however, no changes in infection efficiencies
were measured for increases in the viral suspension volume at constant viral particles
concentration (Figure A4(c)). (c) For a given infection time, observation of the cell
cultures over 3 days demonstrated how the efficiency increased over the first two days
and reached a plateau by day 3 (data not shown). Additional material is presented
in supplementary FigureA S2 [31]. Fundamental relations were established between
variables, to allow comparisons between the different culture and infection condi-
tions. In particular, to ensure constant virus concentration in static and microfluidic
infections, MOIs must be translated into concentrations as follows:
cv =
MOI ·NCellsStat
V olStat
=
MOI ·MCellsµFl
V olµFl
(D.4.1)
and
V olµFl = Q · t (D.4.2)
where cv is the virus concentration in culture medium, MOI is the number of
viral particles per cell, NCells is the total number of cells exposed to the viruses,
and Vol is the total volume of fluid used in the experiment. Q is the fluid flow rate
and t is the duration of the infection process. Subscripts Stat and Fl refer to static
and perfused-microfluidic infections, respectively. It is important to underline how
the possibility of compartmentalizing fluids within the microfluidic platform would
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divide the culture area in 4 sections, each containing 1/4 of the total number of cells
and exposing them to different MOIs; this thus need to be taken into account in
evaluating virus concentrations and other variables.
Rearranging the above equations, we can calculate the volume of the viral sus-
pension to be used in standard conditions as a function of the fluid flow rate, corre-
sponding to the chosen Pe value, of the microfluidic process:
V olStat =
NCellStat
NCellµFl
·Q · t (D.4.3)
We planned the experimental runs following these variables constraints and ob-
tained the results shown in Figure 5. Cell seeding density was constant at 100
cells/mm2. Experiments were performed at Pe=10 and Pe=100. Panels 5(a) and
5(c) refer to HFF cultures, 5(b) and 5(d) to MEF. Image acquisition was performed
48 h post infections on cells treated at MOI 100 for 90 min. At lower Peclet, static
infections led to significantly higher infection efficiencies when compared to the corre-
sponding microfluidic perfused ones for both cell lines, while differences were strongly
reduced at the highest Pe value. This is an expected trend described by our model,
as can be seen in the bottom graphs of Figure 5 (panels C and D), where the relative
efficiency of microfluidic perfused versus static infection is reported as a function of
the square root of time. Here,  r resulted in significant higher values at Pe=100
when compared to the ones at Pe=10 for both cell lines. In particular, the highest
 r values were detected on MEFs, a result that led us to the use of MEFs for the
following experiments. The relative infection efficiencies are in very good agreement
with the theoretical ones. Higher Pe always led to higher infection efficiencies (mea-
sured by the theoretical relative efficiency factor) and, under the same conditions,
MEFs showed higher infection efficiencies if compared to HFF. Regarding HFF, the
value at higher Pe is overestimated by the model. It is worth to remind that the
model describes the ideal case in which the delivery of viral particle is mainly limited
by the transport phenomena within the liquid domain. If our hypothesis fails, an
additional step normally faster than transport phenomena, such as virus adsorption
or internalization, could negatively affect the overall infection efficiency.
To further explore this issue we performed additional experiments, whose results
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Figure D.4.2 – Static infections
on HFF cultures. HFF were plated
at a 100 cells/mm2 density, and
all infections started 24 h after
seeding. MOIs were: 50 in panel
A, 100 in panel B, and 100, 200,
400 respectively for the data points
in panel C. In panel A, the plot-
ted data points demonstrate how
longer incubation times of cell cul-
tures with the viral suspension led
to increases in the infection effi-
ciency. In panel B, increases in
the viral suspension volume (at a
given MOI) led to reduced infec-
tion efficiencies; in parallel, panel
C demonstrates that no signifi-
cant changes in infection efficien-
cies were measured for increases in
the viral suspension volume at con-
stant viral particles concentration.
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Figure D.4.3 – Comparison between static and microfluidic infec- tions at different Peclet
numbers for two cell types. Cell density was kept constant at 100 cells/mm2; MOI was 100,
and infection time 90 min. Experiments were performed at Pe = 10 and Pe = 100. Panels
A and C refers to HFF cultures, B and D to MEF. Data were obtained via image analysis of
cell cul- tures 48 hours post infection. Panels C and D graph the mod- eled profiles for  r
(the theoretical relative efficiency of microfluidic perfused versus static infection) and allow
comparison with representative experimental results. Empty markers are for Pe = 10 and
filled markers for Pe = 100.
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are presented in Figure 6. First of all, we analyzed the effect of increasing infection
times at low MOIs. Panel 6A shows infection efficiencies measured following exposure
of cell cultures (MEFs) to adenoviruses at MOI 10 for times ranging from 90 min to 12
h, both in static and microfluidic perfused culture. Additional material is available in
Figure S3 [31]. The results highlighted how the use of microfluidics allowed obtaining
higher efficiencies for longer incubation times. This is due to the fact that, while in
static infections the concentration of viral particles surrounding a cell decreased
with time, resulting in plateauing efficiencies, the steady state that was established
perfusing the cultures ensured the maintenance of a constant concentration of viruses
around cells and further increases in the infection efficiency. Finally, we introduced
the new concept of “effective MOI”: as the standard MOI is the total number of
viral particles per cell which varies with time as viruses are transported to cells, the
effective MOI was defined as the number of viral particles surrounding a cell at a
certain time. This value is considered constant in perfused conditions, according to
the establishment of the steady state. Now, the two MOIs are related through the
fluid volumes used for the experiment (in turn determined by the chosen Pe number):
MOItotal =MOIeffective
Vi
Vch
(D.4.4)
where Vi is the viral suspension volume used for cell infection during a single exper-
iment and Vch is the volume of the cell chamber. The total and effective MOI are
equal in static conditions, where Vi corresponds to Vch, and different in experiments
with perfusion, where V iVch. Experiments performed using the effective MOI pro-
duced the results shown in Figure 6(b). Exposing cells to the viral suspension at an
effective MOI of 100 for 12 h led to favored efficiencies for the microfluidic perfused
processes, resulting in significantly higher infection efficiencies than those reached in
static conditions.
D.5 Discussion and conclusions
In this study, we present a rational approach to the issue of viral infection of cell
cultures, comparing theoretical modeling and experimental evidence. An accurate
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Figure D.4.4 – Comparison between static and microfluidic infec- tions for different infec-
tion times and at effective MOI. In Panel A the cells were exposed to the viral suspension
at MOI 10 for times ranging from 90 minutes to 12 hours, both in static and microfluidic
perfused culture. The use of mi- crofluidics allowed obtaining higher efficiencies for longer
in- cubation times. In Panel B, infections were performed at an effective MOI of 100 for
12 hours and led to significantly higher efficiencies in microfluidic infections compared with
those reached in static conditions.
analysis of the phenomenological behavior of an infection process on a cell culture, ex-
plored the effects of transport (diffusional and convective) in static and microfluidic-
perfused conditions. Rationalization of the infection steps and limiting phenom-
ena acting on the system highlighted the pros and cons of both conditions. Static
conditions, for example, represent the standard procedure and are thus routinely
performed with well established techniques; however, they tend to utilize high MOIs
in order to ensure high infection efficiencies, are diffusion-dependent and regulated
by unpredictable and continuously varying kinetics (since virus concentration in the
cells surroundings decreases uncontrollably due to virus degradation, consumption,
and internalization by the cells). Perfused infections, on the contrary, can be pre-
cisely controlled and the persistence of a steady state renders the system more stable
and predictable. At the steady state, the virus concentration at the cell membrane
is constant and maintained at the established optimal level, thus allowing the use
of lower MOIs to obtain higher infection efficiencies while reducing the risk of ex-
posing cultures to a hostile environment. In addition, we developed a relationship
between molar fluxes of viral particles and infection efficiencies, with molar fluxes
determined by the systems parameters and variables (geometry, flow rates, etc.).
Such variables have been translated into correlation terms that take into account
the necessity of having comparable entities for static and perfused conditions. Di-
mensionless forms, where applicable, were favored. This approach led us to a more
accurate experimental plan, where only one variable at a time was varied in parallel
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static and perfused infections; the obtained results were thus directly comparable.
Our static controls were performed using standard multiwell plates, fitting the glass
coverslips used as culture substrates. We want to point out how this choice, over
that of statically operating the microfluidic platforms, allowed us to use the same
total volumes reached in the perfused experiments; this is of paramount importance
in sight of obtaining infection efficiency data that could be compared between the
two conditions. Flow rate choices in the microfluidic experiments were translated in
corresponding infection volumes in static controls (V = Q * t), and a variable such
as MOI could then be independently changed. All together, these results show how
the microfluidic technology can be used for rational designing an infection process
with high intrinsic efficiency without the risk of viral associated-cytotoxic derived by
high MOI static treatment.
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E.1 Summary
Long-term cell culture in microfluidic devices is an essential prerequisite for “on a
chip” based biological and physiological studies. We investigated how medium de-
livery, from continuous to periodic perfusion, affects long-term cell cultures in a
microfluidic platform. Computational simulations suggested that different delivery
strategies result in different temporal profiles of accumulation and washing out of
endogenous (EnF) and exogenous (ExF) factors, respectively. Thus, cultures ex-
posed to the same overall amount of medium with different temporal profiles were
analysed in terms of homogeneity, cell morphology and phenotype. Murine and hu-
man cell lines (C2C12 and HFF) and mouse embryonic stem cells (mESC) were
cultured in microfluidic channels. Ad hoc experimental setup was developed to per-
form continuous and periodic medium delivery into the chip, tuning the flow rate,
the perfusion time, and the interval of perfusion while using the same amount of
medium volume. Periodic medium delivery with a short perfusion pulse ensured
cell homogeneity compared to standard cell culture. Conversely, a continuous flow
resulted in cell heterogeneity, with abnormal morphology and vesiculation. Only
dramatic and unfeasible increasing of perfused medium volume in the continuous
configuration could rescue normal cell behaviour. Consistent results were obtained
for C2C12 and HFF. In order to extend these results to highly sensitive cells, mESC
were cultured for 6 days in the microfluidic channels. Our analysis demonstrates
that a periodic medium delivery with fast pulses (with frequency of 4 times per day)
resulted in a homogeneous cell culture in terms of cell viability, colony morphology
and maintenance of pluripotency markers. According to experimental observations,
the computational model provided a rational description of the perfusion strategies
and of how they deeply shape cell microenvironment in microfluidic cell cultures.
These results provide new insight to define optimal strategies for homogeneous and
robust long-term cell culture in microfluidic systems, an essential prerequisite for lab
on chip cell-based applications.
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E.2 Introduction
The demand of tightly controlled cell microenvironments, high reproducibility and
high-throughput processing for multi-parametric analyses is undoubtedly increasing.
The exploding field of microfluidics offers attractive technologies, which can fulfil
these requests and extend conventional cell culture experiments for the study of bi-
ological systems, for a better insight of the physiology and for the development of
in vitro models. Hence, robust long-term microfluidic cell cultures are of paramount
importance to fully establish a highly controlled integrated system. Microfluidic
devices have become extremely relevant for cellular bioassays and tissue engineer-
ing [1]. Their reduced system dimensions allow an accurate control of the spatial
and temporal local system properties [2,3], a fast stimulation and detectable cell re-
sponse, and high-throughput arrays for multi-parametric analysis while reducing the
operating costs [4]. Various examples of long-term microfluidic cell culture are re-
ported in the literature [5–13]. Either continuous [6–10] or periodic [11–14] medium
delivery has been used to maintain cell cultures for prolonged time. Although the
complexity of microfluidic architecture has been extensively explored, and the ef-
fect of some operative variables has been analysed, the identification of an optimal
strategy for medium delivery is still an open issue. Despite being a fascinating tool
to tightly control medium composition, microfluidics showed some drawbacks when
coupled with cell culture systems. Even using the same overall amount of medium
in a time interval, it should be considered that different delivery strategies imply
different spatio-temporal profiles of metabolites and growth factors, which may sig-
nificantly influence overall cell behaviour and long-term culture stability. Due to
the high surface/volume ratio in microfluidics, frequent accumulation or washout of
extrinsic factors has been reported to end up with a long-term toxicity effect [11].
Especially for high demanding cells, nutrient supply and waste removal should be
finely balanced with the requirement of growth factors secreted by the cells. When a
continuous perfusion is applied, soluble factors can be depleted9 resulting in a culture
failure [11]. Additionally, the culture media flowing from the upstream region (inlet)
of a microfluidic chamber can accumulate or be deprived of various substances result-
ing in a different soluble environment affecting downstream cell culture behaviour [9,
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Figure E.2.1 – Microfluidics offers an
unlimited set of flow rate values within
a low shear stress range for cell cultures.
The same amount of medium (given by
the product between the flow rate and
the time of perfusion, and represented
by a rectangular area under a hyper-
bolic trend line) can be managed by
varying the flow rate and the perfusion
interval. Three different operative con-
ditions with the same experimental per-
fused medium volume are represented.
Each condition in the plot results in the
same area (e.g. same volume). Assum-
ing a 6-hour cycle, C1 results in a con-
tinuous flow regime, P1 and P2 result in
discontinuous flow regime.
15]. In this article, we aim at studying the effect of different strategies in medium
delivery on long-term cell culture. In particular, we used an approach, both experi-
mental and theoretical, to rationally understand how the spatio-temporal evolution
of extrinsic factors, both secreted by the cell or delivered from the media (referred
in this paper as endogenous factors and exogenous factors, respectively), is affected
by different isovolumetric conditions of medium delivery. In order to compare cell
responses, we analysed the effect of the delivery of the same amount of medium ac-
cording to different temporal profiles, as reported in Figure 1: continuous medium
flow (C1) and periodic delivery of either fast (P2) or slow (P1) pulses were applied in
a defined time interval. Moreover, we designed a multiple channel microfluidic chip
with a high length/width ratio to investigate upstream and downstream heterogene-
ity of microfluidic cell cultures.
E.3 Materials and Methods
E.3.1 Cell culture
C2C12 (ATCC) were cultured in 89% DMEM (1 g/L glucose) (Sigma-Aldrich), 10%
FBS (Life Technologies) and 1% penicillin/streptomycin (Life Technologies) at 37
°C and humidified 5% CO2. Passaging of both cultures was performed with 0.025%
trypsin-EDTA (Life Technologies) and cells were either re-plated on culture flasks
for further expansion or seeded inside microfluidic chambers, both coated with 0.6%
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A-type pork gelatin (Sigma-Aldrich). Nanog-GFP reporter mouse embryonic stem
cells (mESC, Millipore) were cultured in MilliTrace cell expansion medium on 0.1%
A-type pork gelatine according to the manufacturer’s guidelines. mESC colonies
were passaged and dissociated in single cells with Accutase (Millipore) for 3 min-
utes. Culture channels were fed injecting cell suspension via the outlet avoiding cells
in the medium reservoir. Regarding C2C12 and HFF, initial cell density within the
chip was 15 cell/mm2 and cultures were monitored during perfusion experiments un-
til confluence was reached. mESC were seeded at 100 cells/mm2 in order to promote
aggregation and formation of small colonies. Tubings were connected to the chip 12
hours after seeding to allow complete adhesion and spreading of cells. The NANOG-
GFP fluorescent construct was monitored in live mESC cultures. mESC were fixed
at day 6 in 4% paraformaldehyde and directly characterized within the channel by
immunofluorescence for SSEA-1 surface pluripotency marker (Santa-Cruz) in 3%
bovine serum albumin. An Alexa-594 conjugated secondary antibody (Life technolo-
gies) was used for SSEA-1 fluorescent labelling. Image analysis for quantification
of mESC colony size and marker fluorescence intensity was performed with ImageJ
analysis tools.
E.3.2 Microfluidic platform
The microfluidic platform was designed to accommodate five independent parallel
channels for cell culture (18 x 1 x 0.1 mm) with well-shaped reservoirs for fresh
medium upstream and tubing connection downstream (Fig. 2). The microfluidic
layer was fabricated using standard lithographic techniques16 and molded in PDMS
with a 10:1 base/curing agent ratio (Dow Corning). A supporting borosilicate glass
slide (Menzel-Glaser) was used to seal each channel after plasma treatment of sur-
faces. The micro-perfusion apparatus (Fig. 2) was composed of the microfluidic
platform, a set of PHD2000 syringe pumps in withdraw mode (Harvard Apparatus)
and glass syringes (Hamilton). All connections between components were made us-
ing Tygon tubings (0.5 mm ID, 1.5 mm OD, Cole Parmer). A brief description of
the experimental procedures follows. Before assembling and coupling to the cell cul-
tures, all components were extensively rinsed with milliQ water (Millipore) and then
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Figure E.3.1 – Schematic top-view and rendering of the microfluidic platform. The mi-
crofluidic platform consists on a PMDS layer (5 mm thick) with five parallel channels (18 x
1 x 0.1 mm) and a bottom glass slide which serves as sealing surface for cell culture adhesion
and proliferation. Wells (3 mm wide) serve as fresh medium reservoir upstream and Tygon
tubings are connected downstream through pinholes. Tubings ends are connected to a set
of syringes which are loaded on a withdraw pump.
sterilized via autoclave treatment. Finally, tubings were rinsed with sterile culture
medium and incubated for at least 1 hour prior to the platform assembly. Sterile sy-
ringes to be connected to the outlets of the platform were filled with sterile medium in
order to avoid the elastic effect of the air, and then connected to the pinholes exiting
of the platform. The entire chip was embedded in a Petri dish providing a water bath
to limit medium evaporation. We considered a continuous and a periodic medium
delivery. These strategies were defined by a parameter   = tperf/tcycle, which is the
ratio between the perfusion time and the duration of a single cycle. Three cases were
taken into account: a continuous strategy (C1), characterized by   = 1; and 2 peri-
odic strategies, one with a long medium pulse (P1/P1’),   = 0.25-0.5 and one with
a fast medium pulse (P2/P2’),   = 0.02-0.033. Pumps were controlled through the
serial port by a customized software developed in LabVIEW (National Instruments)
in order to setup the flow rate, the time of perfusion, the time of pause, and the num-
ber of cycles, and to establish different operative conditions inside culture channels.
Microfluidic cell cultures were monitored using image acquisition in a controlled envi-
ronment (37 and humidified 5% CO2, Pecon) on a motorized DMI6000B fluorescent
microscope stage (Leica). Glucose measurements were taken with a diabetes-grade
sensor (Abbott) and data were collected withdrawing downstream tubings at the end
of the continuous set up experiments.
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E.3.3 Computational model
In the microfluidic cell culture chip, cells adhere at the bottom of the channel, which
is perfused by fresh medium. Convection and diffusion regulate the species mass
transport. Because of the cell metabolism, there is a concentration gradient between
cells and the medium bulk, hence a flux of nutrients from the bulk to the cells; on the
other hand, cells secret factors causing an inward flux. Because microfluidic systems
are typically made in PDMS, an inward oxygen flux must be considered during the
overall experiment duration due to the high gas-permeability of the PDMS (Fig. 3a).
Two different operative conditions were analysed, continuous and periodic medium
delivery. The system was described by the mass transport equations and cell growth;
in addition the Navier-Stokes equation was applied during the medium perfusion. A
2D model was used since we assumed that all concentration profiles along the width
of the culture chamber are negligible. The medium fluid dynamics in the culture
chamber was described by the Navier-Stokes equations for incompressible fluids (Eq.
1):
⇢
D⌫
Dt
=  rp+ µr2⌫ + ⇢g (E.3.1)
where ⇢ is the medium density, v is the velocity field, p is the pressure, µ the
medium viscosity, and g the gravity. At the inlet a parabolic profile was imposed
consistent in the limit at low Reynolds number, while at the outlet the pressure was
set to zero. The convection-diffusion equation was used to study species temporal
concentration profiles and no reactions occurred in the medium. Since cells are seeded
at the bottom of the channel, their cellular activity (uptake and secretion) can be
assumed as a flux (outward and inward) at the cell/medium interface. The species
mass transport was expressed by:
 ci
 t
=  rNi (E.3.2)
In Eq. 2, cI is the species concentration, and Ni is the flux which considers both
convection and diffusion phenomena:
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Ni = ⌫ci  Dirci (E.3.3)
where Di is the species diffusion coefficient in medium at 37 °C. The mathemati-
cal model was coupled with phenomenological expressions for the oxygen flux at the
top of the chamber (N ext), and for the kinetics of uptake and secretion (Ri). The
inward oxygen flux through the PDMS follows [16]:
N extO2 = K0(pO2   kO2cO2) (E.3.4)
where K0 is the global mass transfer coefficient (K0 = Pm/ , Pm is the oxygen
permeability in PDMS [18] and   is the PDMS thickness), pO2 is the oxygen partial
pressure in the incubator atmosphere and kO2 is Henry’s coefficient for oxygen. The
oxygen uptake was described as a Michaelis-Menten equation, as reported in litera-
ture for C2C12 cells [19] The glucose uptake was experimentally determined and it
was described with a first order kinetic equation.
RO2 =
VmaxcO2
cO2 +Km
(E.3.5)
RG = (k1cG + k2)⇢cell (E.3.6)
In Eq. 5, Vmax, and Km are the oxygen kinetic parameters and ⇢cell is the overall
cell density; whereas in Eq. 6, k1, and k2 are the glucose kinetic parameters. The
secretion rate of a generic endogenous factor was considered constant for each cell,
and described as a linear function of the cell number:2
REF = qEF⇢cell (E.3.7)
qEnF is the specific production rate. At the beginning, the culture chamber is
loaded with fresh cell media (cG = c0G) in equilibrium with the incubator atmosphere
(csat = pO2/kO2 ), the EnF concentration equals zero. Boundary conditions details
are reported in the Supplementary section. The cell growth was described with an
exponential law, in addition we took into account the contact inhibition:
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d⇢cell
dt
=
✓
1  ⇢cell
⇢cell
◆
(E.3.8)
Where ⇢max is the cell number at confluence, µ is the kinetic constant (µ =
log(2)/⌧d,21 where ⌧d is the doubling time). The initial condition was given by the
initial cell seeding density. Both the continuous and periodic cases were numerically
solved using the finite element method. The solution of the first case is straightfor-
ward; however the periodic case requires the solution of several cycles, each of them
is composed of two different models, a continuous state and a rest state. All algo-
rithms were implemented in COMSOL Multiphysics 3.5 (COMSOL Inc., Burlington,
MA); details are reported in the Supplementary section.
E.4 Results and discussion
E.4.1 Computational analysis of flow rate microfluidic microenvi-
ronment
As previously discussed, different phenomena relating to ExF and EnF are involved
at cell microenvironment. Accumulation of these extrinsic factors requires different
fluid dynamic conditions; high flow rate promotes high ExF concentrations, whereas
low or no flow rate favours the increase of EnF concentration. The computational
model was used to assist the development of an experimental setup and to define
proper medium flow rate. In order to provide a proof of concept of extrinsic factor
dynamics under different hydrodynamic conditions, the model describes the temporal
evolution of concentration profiles of three species: oxygen, glucose, and a represen-
tative endogenous factor secreted by cells (kinetics and mass transport parameters
are those of epithelial growth factor, a powerful mESC mitogen factor; see Table
S2). Figure 3b-c shows the behaviour of a continuously perfused microfluidic cul-
ture system, both under dynamic and steady state conditions; average dimensionless
species concentrations were considered. Figure 3b represents a typical case study
of a continuously perfused cell culture in a microfluidic system. Both oxygen and
glucose have a decreasing profile due to the cell growth that increases the consump-
tion rates of both metabolites. However, oxygen maintains high concentration due
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to the continuous inlet oxygen flux throughout the gas-permeable PDMS membrane
at the top of the system. On the other hand, EnF concentration increases in time
until reaching a steady-state when the EnF production rate equals the EnF washout
due to the medium convection. The cell growth follows the characteristic exponential
trend until confluence after about 3.5 days (data not shown). The analysis at steady-
state conditions (Fig. 3c) shows that the flow rates greatly influence the medium
composition within microfluidic channel: for instance, the higher flow rate results
in lower metabolites depletion but highest washing out of factors secreted by cells
(i.e. EnF). It is worth to underline that this phenomenon take place at relatively low
flow rate at which shear stress mechanical stimulation can be neglected; only higher
flow rates (> 102µL/h) produces shear stress capable to affect cell cultures (Fig.
S1). In order to evaluate the reliability of the computational model, a comparison
between numerical and experimental cell growth and glucose consumption rate for
murine C2C12 cells was performed. Glucose concentration was measure at different
time points by sampling under continuous perfusion experiments. Computational
results fairly described experimental data as reported in Fig. S3. It is clear that the
flow rate must be balanced to preserve the endogenous cell microenvironment and
avoiding the nutrients depletion. In our studies, we focused on the flow rates where
ExF and EnF concentration have intermediate values (Fig. 3c); we used a flow rate
equal to 0.6 µL/h as starting point for our experimental investigation; it is obvious
that this value is strongly related to the cell type.
E.4.2 Experimental comparison of continuous and periodic perfu-
sion on cell cultures
Three different operative conditions, corresponding to different values of   = tperf/tcycle
as reported in materials and methods, were exploited to investigate long-term cel-
lular behaviours inside culture channels (Fig. 1, 6a-b). Continuous and periodic
flows were applied maintaining a constant medium volume per cycle (Fig. 1). In
particular, a continuous flow at 0.6 µL/h (C1, continuous perfusion) was applied in
comparison with two periodic conditions, at 2.4 µL/h (P1, long medium pulse) and
30 µL/h (P2, short medium pulse) for 1.5 and 0.12 h, respectively. In each case, a
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Figure E.4.1 – Concentration profiles of extrinsic factors in a microfluidic channel. (a) Lon-
gitudinal section representation of the microfluidic channel. Arrows show the species fluxes:
the inward oxygen flux from the external atmosphere through the PDMS, NextO2 , the fluxes
of oxygen and glucose from the bulk medium to the cell interface due to their metabolism,
NO2 and NGlut, and the endogenous factor secreted by cell, NEnF . (b) Temporal evolution
of species concentration in the continuously perfused system (flow rate 0.6 µl/h, seeding
density 20 cell/mm2 for oxygen (⇥), glucose (+) and EnF (*); . (c) Steady state behaviour
of the system as function of medium flow rate (at 80% of cell culture confluence).
volume of 3.6 µL was perfused during 6 h of a single cycle, corresponding to twice
the chamber volume. Murine C2C12 cells were seeded within microfluidic channel
and cultured for at least 5 days under controlled perfusion. Shear stress resulted
< 10 2 Pa at the maximum flow rate, which it is low for inducing any effect on
cultures as previously reported.21 Continuous flow (C1) resulted in a heterogeneous
cell growth between upstream and downstream side of each channel. Cell prolifera-
tion was reduced downstream (Figure 4a-b) where mortality dramatically increased
at day 5 (Fig. 4j). Upstream, C2C12 cultures reached confluence within the fourth
day, even though cells tended to form agglomerates. Moreover, cells were charac-
terized by perinuclear vesiculation and anomalous morphologies, such as elongated
and narrowed protrusions, which were detected along the whole channel (Fig. 4c).
Measurements at day four revealed glucose depletion down to 0.2 g/L in steady state
conditions. Cultures under a periodic flow at 2.4 µL/h, with a long medium perfusion
(P1), presented lower density downstream evidencing mild abnormalities all along
the channel (Fig. 4d-f). At day 5, the first two-thirds of the channel were confluent,
but the latter third underwent pronounced mortality (Fig. 4k). When a periodic
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flow with a short pulse of fresh medium was applied (P2, 30 µL/h for 0.12 h) cells
resulted homogeneously dispersed both upstream and downstream until confluence
(Fig. 4g-h). Abnormalities were totally absent (Fig. 4i) as well as in a conventional
tissue culture dish. Without switching to a myotube-differentiating medium, the fifth
day C2C12 myoblast were almost over-confluent (Fig. 4l) and few cells started to
detach or spontaneously differentiate as well as in static cultures controls. We next
investigated whether these different strategies of medium delivery could be gener-
ally addressed to other cell types. We extended the same conditions to human HFF
fibroblasts. Similarly to C2C12, HFF cultures were successfully maintained in P2
conditions whereas the low cell viability and vesiculation was observed in C1 and P1
conditions (Fig. 4m-o). It is worth to underline that HFF were robustly maintained
at confluence in P2 condition for at least 50 days without passaging (Fig. S 5).
In order to verify if the periodic medium delivery can robustly and efficiently
apply to cell culture that are well known to show high sensitivity to environment
condition, we applied the same strategy to mouse embryonic stem cells (mESC).
Since mESCs grow as dense and thick colonies to avoid dramatic reduction of medium
layer above the cells, we increased the height of microfluidic channel to 200 µm and,
consequently, we increase medium flow rates to completely change the medium within
the entire channel (as reported in Table 1). Experiments were performed maintaining
a constant perfusion rate of 2 µl/h (12 µL over a 6-hours cycle). Consistently with
previous data, continuously perfused (C1’) mESC culture exhibited highly different
behaviours between upstream and downstream region of the channel (Fig. 5a). In
particular, mESC colony size is remarkably reduced downstream, stemness markers
were observed only in compact colonies regardless of their size whereas SSEA-1-
negative cells were observed all over the channel. Applying the same volume per
cycle with a periodic slow pulse for 3 hours (C1’, Fig. 5b), the heterogeneity between
upstream and downstream regions is partially reduced whereas differentiated cells
were observed as in the previous condition; few colonies were able to expand normally
downstream. Consistently, applying a periodic flow with a short medium pulse of
12 µL (C2’), mESC culture was homogeneous between upstream and downstream
regions in terms of colony density, morphology, diameter distribution and stemness
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Figure E.4.2 – Microfluidic C2C12 cultures at 4 days. Three different regions of microfluidic
channel were analysed, the upstream, the middle-section, and the downstream. Upstream
and downstream conditions are reported for C1, P1 and P2. C1 presented marked heteroge-
neous growth (a-b) and cellular death especially downstream. Altered morphologies resulted
all along the channel with marked perinuclear vesiculation (c). P1 determined mild differ-
ences between upstream and downstream (d-e) but still influenced cellular morphology and
vesiculation (f). Applying the P2 medium delivery, cells grew uniformly along the channel
(g-h) and did not present alteration (i). Microfluidic C2C12 cultures at 5 days. C1 cultures
reached confluence even with abnormalities but an antithetic situation followed downstream
(j), especially compared to P2 downstream channel where culture was over-confluent (l).
Insets were taken at half-length of each channel. HFF cultures suffered downstream effects
and pronounced vesiculation (m-n) as well as C2C12 while in P2, cultures evidenced normal
phenotype (o). White bars are 75 µm (c, f, i), 250 µm (others).
208 APPENDIX E. MICROFLUIDIC PERFUSION STRATEGIES
marker expression (SSEA-1 and NANOG) (Fig. 5c).
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Figure E.4.3 – Microfluidic mESC cultures at 6 days. As reported in Fig. 4 scheme, three
different regions of microfluidic channel were analysed, upstream, downstream and middle-
section. C1’ (a,d), P1’ (b) and P2’ (c,e) strategies are reported. Bright field, live green
fluorescent protein reporter and immunofluorescence (IF) analysis for pluripotency mark-
ers (NANOG-GFP, SSEA-1) are illustrated. (a,d) C1’ presented marked heterogeneous
up-/downstreamgrowth andmarked differentiation with SSEA-1 negative flattened cells (ar-
rows).(b) P1’evidenced mild heterogeneity with a still relevant number of differentiated cells
escaping mESC pluripotent colonies. (c,e) P2’ resulted in homogeneously and pluripotent
compact colonies. Scale bars are 250 µm (a-c, upstream/downstream), 125 µm (middle
section, left column), 25 µm (middle-section, right column), 600 µm (d-e).
Our results showed that the medium delivery strategy is extremely relevant for
the proper maintenance of cell homogeneity, viability and pluripotent phenotype
expression in microfluidic cell culture as depicted from the overall distribution of
mESC in microfluidic channel for continuous and optimized periodic medium deliv-
ery (Figures 5d and 5e, respectively). A quantification of mESC colony size and
pluripotency marker expression is reported in Figures 6a. mESC colonies cultured in
P2’ condition show significantly higher size and NANOG-GFP expression. In order,
P1’ and C1’ show progressive decrease of size and marker expression, with a hetero-
geneous upstream/downstream behaviour. Additional quantifications are reported
in supplementary Figures S 6 and S 7.
Medium volume and delivery frequency in periodic perfusion We next explored
whether a change in frequency and total volume over a cycle affects cell culture
quality. A comprehensive scheme of perfusion strategies is proposed in Figure 6b.
Regarding mESC, we first verified if the total volume of medium delivered per cycle
could be reduced. Using a short pulse periodic perfusion of 12 µL of medium over
a 12-hours cycle (Fig. 6c), differentiated cells appeared (morphologically flattened
and SSEA-1-negative cells) and colony area was significantly reduced at least down-
stream (Supplementary Fig. S 8 and S 9). It is likely that a minimum amount per
cycle is required to sustain proper mESC phenotype. Next, we asked if a high-quality
cell culture could be obtained by increasing the total amount of medium per cycle.
Continuous and periodic flows were applied by increasing the volume per cycle of 30
(C3’, 60 µl/h) and 4 (P1’, 16 µl/h) times respectively. C3’ condition corresponds
also to a 30-fold volume of P2’ one. Interestingly, colonies grew homogeneously
upstream/downstream with fair expression of pluripotency markers evidencing an
overall improvement in both cases (Fig. 6d-e). Despite size distribution differences
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between C3’, P4’ and P2’ is not significant (p>0.05), some colonies evidenced a
greater area in C3’ and P4’ (Supplementary Fig. S 8). NANOG-GFP reporter
showed a similar expression compared to P2’ (Supplementary Fig. S 9). It is worth
to underline that C3’ continuous perfusion resulted in a 30-fold medium volume (Fig.
6e) consumption. Then, we asked whether C2C12 could be successfully cultivated in
similar conditions. We applied a 50-fold continuous perfused volume compared to P1
(C3, Fig 6f). Consistent with mESC C3’ condition, C2C12 grew homogeneously over
the entire channel but surprisingly, they reached abnormal high cell density probably
due to the reduction of contact inhibition proliferation compared to C2 case (Fig. 4l);
consistently, we recently reported that C2C12 proliferation can be promoted by re-
ducing the endogenous factor accumulation thought cell micro-patterning techniques
regardless of cell density.30 Interestingly, spontaneous myotube formations were ob-
served only in 3-dimensional cell clusters (Fig.6f) where accumulation of endogenous
factors is likely to take place. Unfortunately, it is difficult to deeply study at which
flow-rate threshold we are expected that efficiently deliver of the ExF contained in
serum-supplemented medium can replace those secreted by cells and washed out by
the convective flux. Even using a chemically defined knockout-serum replacement
supplemented medium, we were not able to dissect the role of EnF and ExF; in par-
ticular, C2C12 grew slowly with any periodic perfusion conditions whereas mESC
behaviour was fully consistent with the use of FBS-supplemented medium (data not
shown). Additional experiments were performed with C2C12 and HFF (additional
setups in Table 1, data not shown). A 4-fold gain of the perfused volume per cycle
was tested by increasing P2 frequency and by extending P1 perfusion up to a con-
tinuous regime. A 4-fold of the medium volume used in P2 (P3) did not affect cell
culture of both cell lines. However, a continuous perfusion at 2.4 µl/h (C2) eviden-
ced the same abnormalities seen in C1 and P1, underlining an inadequate medium
delivery. Finally, abnormalities appeared even 12 h after a starting seeding of 200
cell/mm2, indicating no correlations between the culturing progression and the seed-
ing density. We also verified if the cell abnormalities seen in microfluidics can be
achieved in standard Petri culture maintaining the same cell density. Not surpris-
ingly, C2C12 evidenced vesiculation and altered morphology even in static cultures
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after 4 days in the same medium. Because the available medium volume per cell is
40-fold than the microfluidic system, and the average glucose concentration was still
significantly high (0.7 g/L), the altered morphology and vesiculation seem to be due
to a secreted factors or waste products from cells rather than a depletion of glucose
as it was seen for reduced total medium delivery (Fig. 6c for mESCs and data not
shown for C2C12) .
Regime Flow rate Perfusion Cycle Medium/cycle Optimal
(µl/h) (h) (h) (µl) strategy
C
2C
12
/H
FF
Continuous P1 0.6 6 6 3.4 - -
Periodic P1 2.4 1.5 6 3.4 -
Periodic P2 30.0 0.12 6 3.4 +++
Continuous C2 2.4 6 6 14.4 -
Continuous C3 30.0 6 6 180.0 +
Periodic P3 30.0 0.48 6 14.4 ++
m
E
SC
Continuous C1’ 6 6 6 12 - -
Periodic P1’ 3 3 6 12 -
Periodic P2’ 0.2 0.2 6 12 +++
Periodic P5’ 0.2 0.2 12 12 +
Periodic P4’ 3 3 6 48 ++
Continuous C3’ 6 6 6 360 +
Table E.4.1 – Perfusion strategies applied to murine (C2C12 and mESC) and human (HFF)
cell lines. A continuous or periodic regime have been applied with a constant total medium
perfused per cycle or with a doubled cycle period (P5’). Either the flow rate, the perfusion
time or the frequency of periodic flow were changed. Optimal strategy takes into account
culture quality and optimal reagent management.
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Figure E.4.4 – Quantification of size and NANOG-GFP fluorescence intensity within
colonies at different conditions; P2’ data are significantly different (ANOVA P < 0.05)
for both colony size and marker expression compared to C1’; mean and standard deviation
applied, n=25. (b) Comprehensive scheme of perfusion strategies per 6-hour cycle; plot
shows generic C1, P1, P2 strategies at a constant volume fitted by an hyperbolic curve;
other strategies (C2, P3, C3) have been applied to verify the effect of the total medium
perfused per cycle changing either the flow rate, the perfusion time or the frequency of peri-
odic flow (c-e) mESC cultures. (c) Doubling the cycle duration to 12 h, we applied half the
volume per cycle compared to P2’.A significant number of differentiated cells appeared all
over the channel (arrows).(d-e) Total medium volume per a 6-hour cycle has been increased
by 4 and 30 times compared to P1’ and P2’/C1’ respectively. Cultures have a homogeneous
distribution of colony size. (f) C2C12 cultured with 50 times the volume of P2/C3 with a
continuous perfusion. Scale bars are 250 µm (c-e, upstream/downstream and f), 125 µm
(c-e, middle section).
Altogether, these results evidenced that a time-limited periodic perfusion was
optimal to obtain proper cell behaviour, regardless of cell type. Even far from a
high shear stress values, prolonged continuous perfusion altered cell morphology and
culture behaviours. Cells did not benefit from an increase of the total medium
during a single cycle, although this condition provided fresh nutrients. A short
medium pulse offered the best condition for a long-term homogeneous and healthy
cell culture within the entire channel.
Computational analysis of periodic perfusion The experimental results clearly
demonstrated that periodic medium perfusion could strongly enhance the robust-
ness and the efficiency of long-term cell culture in microfluidic devices. However,
these biological evidences and their correlations with the dynamic evolution of the
microfluidic environment under discontinuous perfusion could be very complex and
difficult to understand. For instance, the complex balance between endogenous and
exogenous factors is deeply affected by inlet and outlet flux during perfusion and
by cellular consumption/production rates during un-perfused phases. The computa-
tional model was used to rationally describe the dynamic evolution of microfluidic
environment along the cyclic perfusion conditions; as previously, oxygen and glu-
cose were used to simulate metabolite requirement whereas one endogenous factor
was used as model of extrinsic cell secreted factor. In the periodic perfusion con-
figuration, the concentration of species oscillate within a range (Fig. 7a and b),
the fluctuations increase their amplitude following the increase in cell number until
the steady state, when cells reach the confluence. Figure 7a shows the concentra-
tion space for all considered species; the black line depicts the cyclic evolution of the
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species, which raises its magnitude until cells reach the confluence (red line). It must
be highlighted, that the limit-cycle for a periodic system is represented by a whole
cycle (red line). At this condition oxygen is almost constant (as already reported
in Fig. 3b), therefore we will focus on glucose and EnF that change more signifi-
cantly. The limit-cycle of two periodic perfusion conditions and the steady-state of
continuous perfusion (P1, P2 and C1, respectively) were compared measuring the
glucose and EnF concentration upstream and downstream (at 25% and 75% of the
channel length, Fig. 7b). Red and black lines depict the upstream and downstream
values, respectively. The continuous condition (C1) is represented by two circles on
the plot, whereas the limit-cycle of the periodic perfusion is as a closed curve (one
for each position along the channel), which shows the temporal evolution of glucose
and EnF trajectories for a single perfusion cycle. At P2 (30 µL/h), the culture cham-
ber conditions are more uniform, upstream and downstream curves are overlapped.
The rest phase starts from the maximum glucose concentration without EnF. The
system evolves following a descending trend (glucose decreases, EnF increases). The
perfused phase starts from a minimum glucose value (and a maximum EnF value)
and reaches the initial values of the rest phase. At P1 (2.4 µL/h), system behaviour
has a different trend than the previous one, with a transition from a convective to a
diffusive regime. Although the rest phase follows the same trajectory, maximum and
minimum values are, respectively, lower and greater than P2. For example in this
case the system cannot reach the maximum glucose concentration and the EnF is
always greater than zero. The starting and final slope of the perfusion phase plot is
remarkably higher than P2 (e.g. glucose increases rapidly whereas EnF remains al-
most constant). Finally, as reported by experimental data, the mathematical model
show that the lower is the flow rate, the less uniform are the upstream and down-
stream regions. On the other hand, because we found a transition from a convective
to a diffusive regime at P1, not surprisingly, the P1 perfusion shows higher hetero-
geneity of the culture area along the perfusion direction. Unlike the continuous case,
where cells are subjected to a constant steady state concentration of metabolite and
growth factors (Figure 7c and d at downstream), the discontinuous perfusion strat-
egy shows an oscillatory behaviour, which periodically exposes the cell cultures to
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highest level of both metabolites and extrinsic growth factors. This oscillatory be-
haviour described by the computational analysis could explain why the time-limited
periodic perfusion is more effective to perform long-term cell culture in microfluidic
environment.
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Figure E.4.5 – (a) 3D
concentration space of
the system evolution, the
black line depicts the os-
cillatory behaviour of the
system, the red line de-
picts the limit-cycle. (b)
Glucose and EnF con-
centration condition at
cell confluence (steady
state) for three experi-
mental flow rate values
- C1, P1, P2. The
red colour shows the con-
centration upstream (x
= 4.5 mm), the black
colour downstream (x =
13.5 mm). (c) Glu-
cose and (d) EnF tempo-
ral downstream evolution
per cycle. In C1, cells
are exposed to a con-
stant glucose and EnF
levels, while in discontin-
uous cases are character-
ized by cyclic evolution of
species.
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E.5 Conclusions
In this work, we investigated how different strategies of medium delivery affect the
cell behaviour for a long-term cell culture in microfluidic systems. In particular,
continuous and periodic perfusion regimes were used to assess culture behaviour.
The mathematical model here developed, was used to rational describe the spatio-
temporal profile of different species, nutrients and endogenous factor, along with
the cell growth within a microfluidic environments. Moreover, the computational
analysis at steady-state perfusion was used to identify the experimental condition
at which the flow rates strongly affect extrinsic microfluidic signals. Experimental
results show that a stable and uniform long-term microfluidic culture with minimum
medium delivery can only be achieved in a periodic regime and with a short flow pulse
(below shear stress threshold) followed by a long rest period. Other strategies can
result in long-term toxic effects, low viability, upstream/downstream heterogeneity.
These results were consistently observed for murine myoblasts, human fibroblasts
and murine embryonic stem cells. The improper culture condition observed in con-
tinuous perfusion could be partially rescued by a 50-fold increased flow rate, leading
to unfeasible medium consumption and abnormal phenotypes for the case of C2C12.
In this condition mESC grew homogeneously along the channel with proper cell size
and marker expression compared do periodic flow P2’ but required more medium per
culture area than a Petri dish. Interestingly, the continuous subministration of fresh
media with pluripotent leukemia inhibitory factor (LIF) can sustain stemness. In
periodic flow, despite the pulse withdraws secreted factors from the cells microenvi-
ronment, the static incubation period is sufficient to recover the local secreted factors
and cell processes. On the other hand, continuous perfusion results in altered and
non-homogeneous culture conditions with negative downstream viability. The ma-
nagement of a microfluidic cell culture should take into account several issues; in this
work we study the effect of medium temporal delivery on the cell microenvironment
properties. Our experimental and simulated data show that periodic perfusion can
improve microfluidic cell culture compared to the continuous condition in term of
viability. Low perfusion gives heterogeneous system behaviour along the channel
(Fig. 4-6), on the other hand, only a fast cyclic perfusion results in a homogeneous
218 APPENDIX E. MICROFLUIDIC PERFUSION STRATEGIES
cell culture proliferation throughout the whole system.
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In this Appendix are reported the detailed methods for the derivation of human
induced pluripotent stem cells in microfluidics. The full article is currently under
submission.
F.1 Material and methods
F.1.1 Cell culture and hIPS derivation
BJ fibroblast cell line was purchased from Miltenyi Biotech and cultured in EMEM
(Life Tecnologies) supplemented with 10% fetal bovine serum (Life Tecnologies),
NuFF-RQT (AMS Biotechnology) were seeded at 250 cells/mm2. All cell lines were
cultured at 37 °C and 5% CO2 atmosphere. Microfluidic cultures were perfused with
fresh medium 24 hours after cell seeding. Modified mRNAs (mmRNA) were provided
by Miltenyi Biotech and used according to the Stemgent mRNA reprogramming kit
protocol. Opti-MEM and RNAiMAX were purchased from Life Technologies.The
RNA transfection complex (RTC) was slowly added to different percentages of sup-
plemented Pluriton medium (PL) relative to the manufacturer’s standard with or
without B18R (eBioscience) and injected inside each microfluidic channel. Briefly,
a 100 ng/µl mmRNA stock solution of each factor (OCT-4, SOX2, KLF-4, c-MYC,
LIN28, NANOG, nGFP) is diluted 5-fold in Opti-MEM. RNAiMAX is diluted 10-
fold in Opti-MEM and added to an equal volume of mmRNA. After 15 minutes of
incubation, RTC is combined with PL++ (1:2500 PL Supplement and 200 ng/mL
B18R). uF-hIPS were collected either by coring the rubber of the microfluidic chip
with a biopsy punch or by a preferential detachment using a high flow rate corre-
sponding to a shear-stress of 250 dyne/cm2. hIPS were mechanically passaged on
mouse embryonic fibroblasts (MEF, Millipore) with daily changes of hIPS media
(DMEM/F12, 20% knockout serum replacement, 1% NEAA, 1% glutamine, 1% b-
mercaptoethanol (all Life Technologies), 20 ng/ml b-FGF (Peprotech)). Karyotype
was analyzed by xx (Brescia, Italy).
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F.1.2 Microfluidic platform
Microfluidic platforms were fabricated according to standard soft-lithographic tech-
niques and molded in poly-dimethylsiloxane (PDMS). Briefly, Sylgard 184 (Dow
Corning) was cured on a 200-µm-thick patterned SU-2100 photoresist (MicroChem)
in order to obtain a single PDMS mold with multiple independent channels. The
PDMS mold was punched and sealed on a 75x25 mm microscope glass slide (Menzel-
Glaser) by plasma treatment. Channels were rinsed with isopropanol and distilled
water to check proper flow. Autoclaved chips were eventually treated on the glass
bottom of each channel with a 5% water solution of (3-aminopropyl)-triethoxysilane
(APTES, Sigma-Aldrich) or 0.3% 3-(trimethoxysilyl)-propyl methacrylate (TMSPM,
Acros Organics) in ethanol for 5 minutes. Extracellular matrix proteins were either
adsorbed or chemically bound to the silanized bottom of each channel to provide
a durable coating for cell culture. Fibronectin (Sigma-Aldrich) was oxidized with
sodium meta-periodate (Sigma-Aldrich) in acetate buffer for 1 hour to produce an
amine-reactive variant (FnOX). Type-A pork gelatin (Sigma-Aldrich) was treated
with methacrylic anhydride (Sigma-Aldrich) in PBS buffer for 1 hour at 60 °C to
produce an acrylate-reactive variant (GelMA). A 10 µg/mL FnOX solution was in-
jected and reacted for 1 hour at room temperature in the dark. A TMSPM-GelMA
bonding was performed for 15 minutes by adding 0.1% ammonium persulphate and
N,N,N’,N’-tetramethylenethylenediamine (Sigma-Aldrich) prior to GelMA injection
within the each channel. Channels were extensively rinsed with DPBS prior to cell
seeding. The microfluidic chip was fully assisted by an automated medium delivery
through each culture channel. A periodic10 µL/min perfusion for 30 s was controlled
twice a day by Cavro pumps (Tecan) and a lab-made software interfacewritten in
Labview(National Instruments). Pluriton-RTC was pipetted inside each reservoir
and perfused inside the channels. Fresh PL was added to the reservoirs and auto-
matically perfused after the incubation period.
F.1.3 Immunostaining and RT-PCR
Cells were fixed in 4% (v/v) paraformaldehyde (Sigma-Aldrich) for 10 min and
stained with primary antibodies in 5% horse serum with 0.1% (v/v) Triton-X-100
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(Sigma-Aldrich). Membrane markers were stained without cell permeabilization.
Oct4 and SSEA-4 (Santa Cruz), Nanog (Reprocell), Tra-1-60 and Tra-1-81 (Mil-
lipore), Sox2 (Novus Biologicals). AFP and Brachyury-T (Sigma-Aldrich), b-III-
tubulin (Abcam). Nuclei were stained with Hoechst 33342 (Life Technologies). Im-
ages were acquired with a DMI6000B microscope (Leica). hIPS positive for alkaline
phosphatase were detected with AP-staining kit II (Stemgent) with a 10 minutes in-
cubation of the staining solution. RNA extraction was performed with iScript (Bio-
Rad). Microfluidic channels are perfused with D-PBS prior iScript injection and
solution is collected after 2 minutes. Total RNA was isolated with the RNeasymini
kit (Qiagen) and treated with DNase (Life Technologies). RNA (0.1 mg) was re-
versetranscribed into cDNAby RT (Life Technologies). PCR was performed with
Platinum Taq (Life Technologies). Electrophoresis was perfomed in a 2% (w/v)
agarose gel.
F.1.4 Differentiation protocols
Embryoid bodies. iPS colonies were treated with CTK ( ) for 30 s and mechani-
cally scratched with a serological pipette e resuspended in EB medium (DMEM/F12,
20% knockout serum replacement, 1% L-Glutammine, 1% NEAA, b-mercaptoethanol
(all Life Technologies). EB were cultured in ultra-low adhesive plates (Corning) for
20 days and then transferred on custom-made PDMS micro-wells with a matrigel
(BD) coated glass bottom. Characterization was performed after 5 days.
F.1.5 Straightforward differentiation in microfluidics.
Freshly derived uF-hIPS colonies were directly differentiated perfusing media other
than Pluriton every 12 hours.
Aspecific differentiation. EB media (without b-mercaptoethanol) was used to
randomly differentiate uF-hIPS colonies for 20 days.
Cardiac differentiation. Small molecules were used to promote cardiac differen-
tiation of hiPSC. RPMI with B27 (cardiac basal medium, CBM, Life Technologies)
were perfused twice in the first 24 hours with 10 µM Chir. CBM was used in the
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following 36 hours and CBM with 4 µM IWP-4 in the next 24 hours. CBM was used
thereafter for cardiac maturation.
Epatic differentiation. hiPSC colonies were maintained in Pluriton and ex-
panded over the channel width (1.4 mm). For hepatic differentiation cells were
treated with 100 ng/ml activin A and 0.5mM NaB for 3 days in RPMI/B27. Medium
was changed to KO-DMEM, 20%SR (both from Invitrogen), 1 mML-glutamine, 1%
NEAA, 0.1 mM b-mercaptoethanol, 1% DMSO (Sigma) for 6 days. Hepatic-like
cells were maturated with L15 medium (Sigma) supplemented with 8.3% FBS, 8.3%
tryptose phosphate broth, 10 µM hydrocortisone 21-hemisuccinate, 1 µM insulin (all
from Sigma) and 2 mM L-glutamine containing 10 ng/ml hepatocyte growth factor
and 20 ng/ml oncostatin M (both from R&D) for 6 days8.

Appendix G
Protocols
G.1 Functionalization of glass supports and hydrogel prepa-
ration
Glass functionalization for acrylc-based hydrogels is performed via silanes. General
guidelines for hydrogel production can be found here [111]. Optimization steps for
large scale production follows. Glass coverslip are oxidized with oxygen plasma (30
W for 1 minute, Harrick Plasma) and covered for 5 minutes with a thin film of
silane solution: a final 0.3% trimethoxy silyl propyl-methacrylate (Acros organics) is
dissolved in ethanol and 5% of acetic acid. Glasses are rinsed in ethanol to remove
unbound silane and then in distilled water. Once dry, coverslips can be used to
polymerize hydrogels. Large stocks of functionalized glasses can be stored at room
temperature and dark in a closed vessel for various days. Poly-acrylamide hydrogels
were produced by chemical radical polymerization with 1:1000 TEMED (Sigma-
Aldrich) and 1:100 v/v of 10% w/v ammonium persulphate (APS , Sigma-Aldrich).
30x30 cm glass supports previously treated with tridecafluoro-octyl-trichlorosilane
vapors were used for the production of hydrogel in large batches. Hydrogels were
rinsed for 10 minutes in distilled water and UV sterilized for 15 min. On sterile
Parafilm foils 50 µg/ml fibronectin (Sigma-Aldrich) drops were spotted and each
hydrogel was placed in contact with the solution at 37 °C for 2 hours.
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protein
cross-link pros cons
suitable for
large-scale
sulfo-
SANPAH
variable
between
samples and
lots
use of native
proteins
expensive, needs UV
exposure no
6-
((acryloyl)amino)
hexanoic acid
effective and
consistent
directly incorporated
during
polymerization
expensive, cross-link
lost in the hydrogel
bulk
no
hydrazine/sodium
periodate
effective and
consistent
cheap, hydrogel
activation in large
stocks and used as
necessary
protein derivation
necessary, longer
procedure
yes
Table G.2.1 – Functionalization strategies for poly-acrylamide hydrogels. Protein cross-
linking was assessed by cell seeding after extensive washes of finalized substrates with fi-
bronectin. Pros and cons are reported for each technique and suitability for large-scale
hydrogel production is evidenced.
G.2 Functionalization of poly-acrylamide hydrogels
Functionalization of poly-acrylamide hydrogel have been performed with three tech-
niques: sulfo-SANPAH [111], 6-((acryloyl)amino) hexanoic acid [79] and hydrazine
[117]. As reported in Table G.2.1, hydrazine has revealed the most effective and
convenient method for a large scale functionalization of poly-acrylamide hydrogels.
Protocol is based on Damljanovic et al. 2005 [117]. Minor changes follow. Single
drops of 70% hydrazine hydrate (Sigma-Aldrich) are placed on each hydrogel and
leave to reach until dryness in a closed glass vessel. Reaction is usually performed
overnight. Two additional water rinses have been added before and after the neutral-
ization with 5% acetic acid to properly restore a neutral pH. Hundreds of hydrogel
are prepared at once and are kept in a closed vessel. Fibronectin has been used
instead of collagen since it can serve a broader selection of cell types. Since sodium
periodate is hygroscopic, must be prepared fresh and few milligrams are sufficient
for tens of hydrogels, we opted for preparing a stock solution, easier to dissolve in
the protein solution and we performed the reaction also overnight at 4 °C. 40 µl of
oxidized protein are placed on a Parafilm foil and treated hydrogels are turned on
each drop for 1 h. Hydrogel are rinsed three times with water and then sterilized
under 280 nm UV-light for 15 minutes.
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hydrogel integration hydrogel lamination
diazonium salts [159] yes yes
acryl-terminated silanes yes yes
methacrylic anhydride no -
amine-terminated
silane/glutaraldehyde [108] yes no
Table G.3.1 – Tested bridging molecules for hydrogel integration in PS Petri dishes. At
the end of the polymerization phase some hydrogel did non integrated with the PS surface
while others laminated because of swelling few hours after placing the hydrogel in water or
buffered solutions.
G.3 Functionalization of PS support
Various techniques and operative conditions have been tested for the polymerization
of hydrogel supports on commercially available poly-styrene dishes (Table G.3.1).
Poly-styrene has been treated with an oxygen plasma (Harrick Plasma) at 30 W for
5 minutes. A 1% v/v acqueous solution of 3-aminopropyl-trimethoxysilane (Sigma-
Aldrich) was used to aminate the surface for 1 h. After several rinses with water, a 1%
v/v glutaraldehyde (Sigma-Aldrich) was used to react with the amine terminus. A
degassed acrylamide/bis-acrylamide prepolymer was poored inside the functionalized
PS vessel to produce a ⇠1 mm thick layer. Polymerization was performed at room
temperature for 1 h with 1:1000 TEMED (Sigma-Aldrich) and 1:50 v/v of 10% w/v
APS (Sigma-Aldrich). Before rinsing the gel in water, hydrogels were dehydrated
under the hood for additional 2 hours.
G.4 3D biodegradable hydrogels
G.4.1 Methacrylated HA derivation
Hyaluronic acid of 700 kDa provided by Fidia Farmaceutici s.r.l. (Italy) is derived
with methacrylated termini on the primary hydroxyl group available on dimeric
unit of HA. HA is dissolved at 0.5% w/v in water and cooled on ice. Methacrylic
anhydride is added to reach a 10X molar excess of hydroxyl groups. Reaction is
conducted vigorously stirring the solution on ice overnight. Product is distilled in
water for 24 hours using a 10 kDa cut-off cellulose membrane.
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G.4.2 Methacrylated proteins derivation
Collagen I rat tail or type-A gelatin are dissolved in phosphate saline solution at pH
7.8 at 20% w/v in 60 °C water. A 2X excess of methacrylic anhydride is added for
2 hours at 40 °C. Solution is then diluited in PBS pH 7.4 at 5% w/v to stop the
reaction. Functionalized proteins are stored at 4 °C. Since abundant amines groups
tend interact with other groups promoting a physical gelation process at high con-
centration (>2%) and low temperatures (<10 °C), the modification of amines allow
the gelation only at lower temperatures. Gelatin methacrylation can be assessed by
producing a pure gelatin cross-linked hydrogel. 1:1000 TEMED (Sigma-Aldrich) and
1:100 10% w/v solution of ammonium persulphate (Sigma-Aldrich) are mixed within
a gelatin sample. A compact hard gel is produced in <10 minutes.
